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SUMMARY 
 
The transition between morula and blastocyst stage during preimplantation development represents the 
first differentiation event of embryogenesis. Morula cells undergo the first cellular specialization and 
produce two well-defined populations of cells, the trophoblast and the inner cell mass (ICM). 
Embryonic stem cells (ESCs) with unlimited self-renewal capacity are believed to represent the in 
vitro counterpart of the ICM cells. 
A unique and complex signaling network allows embryonic stem cells (ESCs) to undergo extended 
proliferation in vitro, while maintaining their capacity for multilineage differentiation. Genuine ESC 
identity can only be maintained when both self-renewal and suppression of differentiation are active 
and balanced. Despite many efforts have been made in the past years, aimed at understanding the 
molecular factors driving and controlling pluripotency in vivo and in vitro, the precise mechanisms of 
how these processes are regulated remain largely unknown. 
Therefore, the overall goal of this thesis was to gain knowledge on the molecular mechanisms that 
control stemness in pluripotent stem cells. The work was divided into two different studies: the first 
was focused on the function of pluripotency related genes in ESCs and the second consisted in a 
genome wide expression analysis of mouse and rat preimplantation stage embryos. 
 
The activation of the LIF/STAT3 signaling was shown to be sufficient to maintain ESCs in an 
undifferentiated and pluripotent state. Thus, in a first study the importance of STAT3 in the 
establishment of ESCs was investigated. In order to identify new STAT3 target genes, ESCs 
overexpressing STAT3 were derived from a non-permissive mouse strain and their expression profiles 
were compared with wild type ESCs. Several genes were detected as potential key-players involved in 
maintenance of pluripotency in ESCs. The function of two of these genes, Pramel6 and Pramel7, was 
extensively characterized. We identify Pramel7 (preferentially expressed antigen in melanoma-like 7) 
as a novel factor crucial for maintenance of pluripotency and LIF-mediated self-renewal in ESCs. In 
vivo, Pramel7 expression was exclusively found in the pluripotent pools of cells, namely, the central 
part of the morula and the inner cell mass of the blastocyst. Ablation of Pramel7 induced ESC 
differentiation, whereas its overexpression was sufficient to support long-term self-renewal in the 
absence of exogenous LIF. Furthermore, Pramel7 overexpression suppressed differentiation in ESCs 
in vitro and in vivo. This process was reversible, as on transgene excision cells reverted to a LIF-
dependent state and regained their capacity to participate in the formation of chimeric mice. 
Molecularly, LIF directly controls Pramel7 expression, involving both STAT3-dependent 
transcriptional regulation and PI3K-dependent phosphorylation of glycogen synthase kinase 3β 
(GSK3β). Pramel7 expression in turn confers constitutive self-renewal and prevents differentiation 
through inactivation of extracellular signal-regulated kinase phosphorylation. Accordingly, 
knockdown of Pramel7 promotes ESC differentiation in presence of LIF and even on forced STAT3-
activation. Thus, with this study we demonstrated that Pramel7 represents a central and essential factor 
in the signaling network regulating pluripotency and self-renewal in ESCs. 
 
Rats represent an optimal animal model for the investigation of human diseases and in some research 
fields is often, due to its bigger size and higher genetic diversity, preferred to the mouse. Despite the 
benefits of working with rats, the impossibility of generating germ line competent rat ESCs has given 
the mouse a clear advantage over the rat in the generation of new transgenic models. All the efforts 
made for establishing authentic rat ESCs have failed in the last 30 years and only recently, by using 
defined culture conditions, genuine pluripotent rat ESCs have been established for the first time, from 
different strains. Although, both mouse and rat ESCs can be derived from the ICM cells, they differ in 
their in vitro stability.  
We aimed in our study at the identification of differences at the transcriptional level between the 
mouse and the rat during the developmental period in which the ICM cells are formed, since they 
represent the source of ESCs derivation. We performed a microarray analysis in which we compared 
Summary 
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the transcriptome of mouse and rat morula, blastocyst, and ICM. This is the first study investigating 
the gene expression changes during the transition from morula to blastocyst in the rat preimplantation 
development. Moreover, it represents a new example of statistical approach for cross species analysis, 
applicable also to other species comparisons, that allows to highlight the species-specific behaviour of 
genes within important pathways and families. In order to identify alternative regulation of important 
molecular mechanisms the investigation of differential gene expression between the two species was 
extended at the level of signaling pathways, gene families, and single selected genes of interest. This 
study reports for the first time that in the pluripotent pool of cells of the rat and mouse preimplantation 
embryo substantial differential regulation of genes is present, which might explain the difficulties 
observed for the derivation and culture of rat ESCs using murine conditions. Some of the genes 
differentially expressed are already known to be important factors in the maintenance of pluripotency 
in ESCs, like for example Sox2 or Stat3, or play a role in reprogramming somatic cells to pluripotency 
like c-Myc, Klf4 and p53 and would therefore represent interesting candidates to further analyze in 
vitro in the rat ESCs.  
The differential regulation of critical genes could represent the starting point for analyzing their 
function in vitro in mouse and rat ESCs. Furthermore, this knowledge could be critical for the 
improvement of the derivation and maintenance of rat ESCs. A broader knowledge on the molecular 
mechanisms that occur in rat ESCs would improve the efficiency of establishing stable authentic 
pluripotent rat ESCs and therefore it would facilitate the generation via gene targeting of transgenic rat 
models, which are indispensable for the biomedical research. 
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XI 
ZUSAMMENFASSUNG 
 
Das erste Differenzierungsereignis während der Embryonalentwicklung in der Präimplantationsphase 
ist der Übergang vom Morula- zum Blastozystenstadium. 
Dabei durchleben die Morulazellen die allererste zelluläre Spezifizierung, welche in zwei voneinander 
unterscheidbaren Zellpopulationen resultiert, dem Trophoblasten und der inneren Zellmasse (ICM). Es 
wird angenommen, dass embryonale Stammzellen (ES-Zellen) mit ihrer Fähigkeit, sich unendlich 
erneuern zu können, das in vivo-Pendant zu den Zellen der inneren Zellmasse darstellen. 
Die Kultivierung und Proliferation von embryonalen Stammzellen in vitro wird durch einen 
einzigartigen und komplexen Signalverbund ermöglicht. Dieser hält die Zellen in einem pluripotenten 
Zustand, ohne dass diese die Eigenschaft verlieren, Gewebe aller drei Keimblätter bilden zu können. 
Dieser Zustand kann nur erreicht werden, wenn einerseits der Selbsterneuerungsmechanismus 
funktioniert und andererseits die Differenzierung in genügendem Masse unterdrückt wird, was 
bedeutet, dass eine bestimmte Balance zwischen Selbsterneuerung und Differenzierung gewährleistet 
sein muss. In den letzen Jahrzehnten wurde ein enormer Aufwand betrieben, um dem molekularen 
Geheimnis der Pluripotenzerhaltung in vitro und in vivo auf den Grund zu kommen. Trotzdem ist 
immer noch sehr unklar, wie die Mechanismen genau funktionieren. 
Das Gesamtziel dieser Studie war es deshalb, weiteres Wissen über die molekularen Prozesse, welche 
die Pluripotenzerhaltung kontrollieren, zu erlangen. Die Arbeit wurde anfänglich in zwei verschiedene 
Studien aufgeteilt: Die erste befasste sich mit der Funktion von Genen, welche mit Pluripotenz in 
Verbindung gebracht werden können, die zweite bestand in einer vergleichenden 
Genexpressionsanalyse von Maus- und Rattenembryonen während verschiedenen 
Präimplantationsstadien. 
 
Es ist bekannt, dass die Aktivierung des LIF/STAT3 Signalwegs ausreicht, um ES-Zellen in einem 
undifferenzierten und pluripotenten Zustand zu erhalten. Deshalb untersuchten wir in einem ersten 
Ansatz die Wichtigkeit von STAT3 in der Etablierung von ES-Zellen. Um neue STAT3-Zielgene zu 
identifizieren, wurden STAT3-überexprimierende ES-Zellen aus einem nicht-permissiven Hintergrund 
etabliert, um später deren Expressionsprofil mit demjenigen von Wildtyp ES-Zellen zu vergleichen. 
Mehrere Gene zeigten eine veränderte Expression. Einige von ihnen wurden als potentielle 
Schlüsselfaktoren der Pluripotenzerhaltung in Betracht gezogen. Von Pramel6 und Pramel7, zwei 
dieser Kandidatengene, wurde die Funktion umfassend analysiert. Dabei stellte sich heraus, dass 
Pramel7 (preferentially expressed antigen in melanoma-like 7) eine wichtige Rolle in der Erhaltung 
der Pluripotenz und in der vom LIF/STAT3 Signalweg vermittelten Selbsterneuerung von ES-Zellen 
einnimmt. Es zeigte sich weiter, dass Pramel7 in vivo exklusiv in vollumfänglich pluripotenten Zellen 
exprimiert wird, also im zentralen Zellkompartement des Morulastadiums und in der inneren 
Zellmasse der Blastozyste. In vitro wurde beobachtet, dass das Fehlen von Pramel7-Expression zur 
Differenzierung von ES-Zellen führt, dessen Überexpression hingegen zur Folge hatte, dass die 
Selbsterneuerung der Zellen ohne Zugabe von exogenem LIF über längere Zeit aufrecht erhalten 
werden konnte. Darüber hinaus unterdrückte die Überexpression von Pramel7 die Differenzierung von 
ES-Zellen in vitro und in vivo. Dieser Prozess ist umkehrbar: Nach der Entfernung des Pramel7-
Transgens, welches die Überexpression verursachte, wurden die Zellen erneut LIF-abhängig und 
erlangten die Fähigkeit, Chimären zu bilden. Auf molekularer Ebene wird Pramel7 direkt durch LIF 
kontrolliert, einerseits via STAT3-abhängige Transkriptionsregulation, andererseits durch PI3K-
abhängige Phosphorylierung der Glycogen Synthase Kinase 3β (GSK3β). Pramel7-Expression 
wiederum gewährleistet konstitutive Selbsterneuerung und verhindert Differenzierung durch 
Inhibition der Phosphorylierung der extracellular signal-regulated kinase (ERK). Dementsprechend 
begünstigt der Knockdown von Pramel7 die Differenzierung von ES-Zellen, auch unter Zugabe von 
exogenem LIF und sogar nach erzwungener STAT3-Expression. Zusammenfassend wurde in dieser 
Studie gezeigt, dass Pramel7 eine zentrale und wichtige Rolle im pluripotenzerhaltenden 
Signalverbund der Selbsterneuerung von ES-Zellen darstellt. 
Zusammenfassung 
 XII 
 
Die Ratte ist ein optimales Modell für die Untersuchung von menschlichen Krankheiten. In einigen 
wissenschaftlichen Bereichen wird sie der Maus vorgezogen, hauptsächlich wegen dem grösseren 
Körper und der höheren genetischen Diversität. Trotz dieser Vorteile war es für lange Zeit nicht 
möglich, keimbahnkompetente ES-Zellen von Ratten zu generieren, was der Maus im Bereich der 
Herstellung von transgenen Modellen einen klaren Vorteil verschaffte. In den letzten 30 Jahren 
schlugen trotz grösster Anstrengungen alle Versuche fehl, authentische Ratten ES-Zellen zu 
generieren. Erst kürzlich gelang es einer Forschungsgruppe funktionelle ES-Zellen von verschiedenen 
Rattenstämmen unter definierten Kulturbedingungen zu derivieren. Obwohl nun ES-Zellen aus der 
inneren Zellmasse von Maus und Ratte hergestellt werden können, unterscheiden sich die Zelllinien 
der verschiedenen Spezies in ihrer Stabilität in vitro. 
  
Die zweite Studie setzte sich zum Ziel, Unterschiede zwischen Maus und Ratte während der 
Transition vom Morula- zum Blastozystenstadium auf transkriptioneller Ebene aufzudecken, da die 
Zellen der inneren Zellmasse der Blastozysten das Ursprungsmaterial für die Generierung von ES-
Zellen darstellen. Dafür wurde eine Microarrayanalyse durchgeführt, in welcher die Transkriptome 
von Morulae, Blastozysten und innerer Zellmassen der Maus und der Ratte verglichen wurden. Dies 
ist die erste Studie, welche die Veränderungen der Genexpression während dem Übergang vom 
Morula- zum Blastozystenstadium untersucht. Darüber hinaus repräsentiert sie einen neuen 
statistischen Ansatz für die Expressionsanalyse zwischen zwei verschiedenen Spezies und ist auch auf 
andere Artenvergleiche anwendbar, was das Bestimmen von artenspezifischem Verhalten von Genen 
in wichtigen Signalwegen und Genfamilien ermöglicht. Um eine unterschiedliche Regulation von 
wichtigen molekularen Mechanismen zu identifizieren, wurde die Detektion von sich zwischen den 
beiden Spezies unterscheidender Genexpression auf das Niveau von Signalwegen, Genfamilien und 
ausgewählter Einzelgene angelegt. Die Untersuchung zeigt zum ersten Mal, dass sich die 
Genexpression im pluripotenten Zellpool von Embryonen des Präimplantationsstadiums zwischen 
Maus und Ratte teilweise substantiell unterscheidet. Dies könnte mit ein Grund sein, weshalb es bis 
anhin so schwierig war, ES-Zellen der Ratte unter Mausbedingungen zu generieren und zu kultivieren. 
Einige der Gene, bei welchen zwischen den Arten eine unterschiedliche Expression hat festgestellt 
werden können, sind schon länger als wichtige Faktoren in der Pluripotenzerhaltung von ES-Zellen 
bekannt, dazu gehören unter anderem Sox2 oder Stat3, oder sie spielen eine Rolle in der 
Reprogrammierung von somatischen zu pluripotenten Zellen, wie c-Myc, Klf4 und p53. Diese Gene 
könnten deshalb interessante Kandidaten für weitere in vitro Analysen von ES-Zellen der Ratte sein. 
Diese unterschiedliche Regulierung von kritischen Genen könnte ein Auslöser für die Untersuchung 
von deren Funktion in vitro an ES-Zellen von Maus und Ratte sein. Des Weiteren könnte dieses 
Wissen zu Verbesserungen in der Etablierung von ES-Zellen von Maus und Ratte führen. Dafür bedarf 
es auch in Zukunft eines umfangreicheren Verständnisses der molekularen Mechanismen, welche für 
die Kontrolle und Erhaltung von Pluripotenz verantwortlich sind. Dies, um authentische und 
pluripotente ES-Zellen der Ratte zu derivieren und somit auch die Herstellung von transgenen Tieren 
via Gentargeting zu erleichtern, denn solche Modelle sind in der biomedizinischen Forschung 
unentbehrlich. 
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OUTLINE 
 
This thesis comprises several parts, which I would like to outline here. 
 
The introduction provides basic information about embryonic stem cells (ESCs) and their applications. 
After the first chapter focusing on the derivation and maintenance of murine ESCs in culture, a second 
chapter follows regarding the rat as an animal model for the research. Furthermore, preliminary study 
are mentioned where rat ESCs have been established for the first time. In the last part of the 
introduction a general overview of the molecular signature of ESCs is reported. This part of the 
introduction is a shorter version of a work written for the book “Embryonic Stem Cells: The Hormonal 
Regulation of Pluripotency and Embryogenesis”, where I wrote the chapter “Molecular mechanisms of 
pluripotency” (Casanova et al., 2011a). In the last part of the introduction the aims of the work are 
reported. 
 
The results section consists in the publications obtained during the PhD. This chapter is divided into 
two main parts, which represent the two projects I was working on. In the first section are reported the 
papers of two consecutive studies, which aimed at the characterization of newly identified potential 
STAT3 target genes in murine ESCs. In the last part the results of my second project in the form of a 
manuscript that as recently been submitted are reported. In this study we analyzed the whole genome 
expression in the mouse and in the rat preimplantation embryos, with the intention of highlighting 
differences in the gene regulation in the two species for an improvement of the ESCs derivation.  
The three papers are listed at the end of the thesis as Annex. 
 
The discussion section follows the structure used in the results part, being divided into two main 
chapters that represent the two projects of my PhD. Regarding the first project, the relevant findings 
obtained from the study on Pramel7 gene are discussed and follow-up studies are described. 
Additionally, there is a short discussion about the gene Pem/Rhox5, which we detected differentially 
regulated upon STAT3 overexpression, but we did not so far further characterize its function in the 
context of maintenance of pluripotency in vivo as well as in vitro. 
Concerning my second project on mouse and rat cross-species genome wide expression analysis in the 
preimplantation embryos, are initially discussed the technical problems we had to overcome for the 
collection of all the embryos needed for the microarray analysis. Thereafter, the data obtained from the 
cross-species comparison are briefly discussed and put in the context relative to ESCs. Seen that this 
study is the first approach aimed at the identification of differential gene regulation in the two species, 
this paragraph ends with some remarks about follow-up studies which intend identify from our 
analysis genes involved in the maintenance of pluripotency in rat ESCs.  
The outlook, finally, proposes experimental approaches for a further characterization of the molecular 
mechanisms controlling pluripotency in ESCs, on the basis of our findings in both the projects 
performed during my PhD. 
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 1 
A. INTRODUCTION  
 
Embryonic stem cells (ESCs) are pluripotent cells, which can be isolated from the inner cell mass 
(ICM) of blastocyst stage embryos. They are defined by two properties: they can indefinitely self-
renew in vitro and they can contribute to the formation of all cells of an adult organism, including 
functional gametes for genome transmission. Due to their pluripotent state ESCs can be used for 
various applications, like the generation of knockout or transgenic animals, and potentially as a cell 
source for cell therapy in regenerative medicine. Alternatively self-renewing cells with pluripotent 
potential can also be generated by specifying germ cells with extrinsic factors (Matsui, 1992) or by 
reprogramming somatic cells using gene transfection to generate the so called induced pluripotent 
stem cells (iPSCs) (Nakagawa et al., 2008; Takahashi and Yamanaka, 2006). 
Due to the fundamental characteristics of ESCs, developmental biology, regenerative medicine and 
cancer biology are more and more interested in understanding the molecular mechanisms controlling 
stem cells. Even though a lot of efforts have been made in the past years to elucidate the factors that 
regulate stem cell self-renewal and pluripotency, the precise mechanism of how these processes are 
regulated remains largely unknown. For a reliable establishment of ESC cultures in vitro, the 
characterization of further marker genes is of fundamental importance. Therefore one of the aims of 
this PhD thesis was to functionally characterize Pramel7, a newly identified pluripotency-related gene 
(Cinelli et al., 2008). In vivo pluripotent cells do exist only transiently during the embryo 
preimplantation development; therefore an analysis of the naturally existing pluripotent cells could be 
of advantage for a better understanding of the molecular mechanisms that occur in vitro, in the ESCs. 
For this reason the second intent of this work was to compare in a genome-wide study the 
pluripotency-related gene networks in the mouse and in the rat morula and blastocyst stage embryos, 
by performing an analysis of the transcriptome. The purpose of this study was to identify differences 
and similarities in the molecular processes that occur in the two species in the two analyzed 
developmental stages. These findings could in the future help in the identification of important genes 
involved in the maintenance of pluripotency in rat ESCs.  
 
1. Pluripotent embryonic stem cell 
Stem cells can be found in embryos, fetuses, or in adults, and by definition, they have the ability to 
reproduce themselves for a long period of time while keeping the capability to differentiate into 
diverse cell types. Adult stem cells are undifferentiated cells, found throughout the body after 
embryonic development, that multiply by cell division to replenish dying cells and regenerate 
damaged tissues. Pluripotent embryonic stem cells have broader potential since they are able to 
generate all types of cells that form the three germ layers (mesoderm, endoderm, and ectoderm) from 
which all the cells of the body arise. Besides ESCs, two other type of cells have been derived from the 
early mouse embryo that can be regarded as stem cells: the trophoblast stem cells, and the 
extraembryonic endoderm cells (Martin, 1981; Tanaka et al., 1998). Nevertheless immortal pluripotent 
cell lines with self-renewing capacity can exclusively be obtained by culturing ICM cells of the 
blastocyst (Fig. 1). 
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Fig. 1: Development of mouse blastocyst. The outer layer of the late morula forms an epithelium called the 
trophectoderm. Around embryonic day E3, the blastocoel forms and moves the inner cell mass to one end of the 
blastocyst. During late blastocyst stage, just prior to hatching from the zona pellucida, cells of the inner cell mass 
become organized into epiblast and primitive endoderm populations. The isolated ICM give rise to the 
pluripotent ESCs once cultivated under the appropriate culture conditions.  
 
 
1.1 Historical overview 
During the seventies it was observed that transferring 1 to 7.5 days old mouse embryos to the extra-
uterine site in a histocompatible host, induces the generation of teratocarcinomas. These tumors 
contain stem cells called embryonal carcinoma cells (ECCs), which can be isolated and cultivated in 
vitro. Due to their ability to differentiate into diverse cell types and to participate to the development 
of normal adult mice once injected into blastocysts, they have been extensively used as a model 
system for developmental studies. These findings raised the question about the origin of these 
pluripotent cells and if there was the possibility to generate pluripotent cell lines directly from the 
embryo and not from a teratocarcinoma. Few years later two laboratories independently answered this 
question. 
In the year 1981, M. J. Evans and M. H. Kaufman established for the first time in vitro progressively 
growing cultures of embryo-derived cells by cultivating mouse blastocyst embryos (Evans and 
Kaufman, 1981). The transient existence of a population of pluripotent cells during this developmental 
stage was already known, nevertheless all the attempts to obtain stable cultures of pluripotent cells 
have been unsuccessful. Comparison between cell surface antigens and protein patterns synthesis with 
the established culture of ECCs showed high homology with the epiblast cells of the early 
postimplantation mouse embryo. Due to the difficulties to isolate early implanted embryos and 
because of the small amount of cells forming the epiblast population, Evans and Kaufman used 
diapause-induced blastocyst. This is a particular phenomenon that has evolved in certain mammals to 
overcome sub-optimal conditions for pregnancy. Thus, mice can temporary arrest embryogenesis just 
before implantation at the blastocyst stage. This condition is induced by maternal hormones, but can 
be artificially provoked by ovariectomy and hormonal treatment. Even though during this time, which 
in the mouse can persist for weeks, no further development of the blastocysts occurs there is a gradual 
increase in the cell number. Taking advantage of this phenomenon, Evans and Kaufman could isolate 
from the uterus of ovariectomized mouse females 4 to 6 days delayed blastocysts (Evans and 
Kaufman, 1981). After 4 days in culture the trophectoderm cells of the blastocysts developed into 
giant trophoblast cells whereas the ICM cells formed round, compact structures. Once transferred on 
dishes containing a layer of inactivated fibroblasts (referred as to feeders), the ICM-derived cells 
started actively to proliferate and formed colonies that resembled the ones generated by ECCs. 
Importantly, a typical characteristic of ECCs is an unstable karyotype and usually they do not contain 
the Y chromosome. Analysis of the ICM-derived cells showed a stable diploid karyotype and both XX 
and XY cell lines were established and maintained in culture for several passages. The authors termed 
these embryo-derived cells EK cells to distinguish them from the tumor-derived EC cells. The 
pluripotent potential of the EK cells was confirmed by subcutaneously injection into mouse flanks and 
subsequent formation of tumors that contained derivatives of all the three germ layers. When 
cultivated in the absence of feeders, the same cells formed embryoid bodies that differentiated into 
specialized cell types (Evans and Kaufman, 1981).  
In the same year also in a second laboratory embryo-derived pluripotent cell lines were established for 
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the first time; Martin G. R. called these cells embryonic stem cells (ESCs) (Fig. 2) (Martin, 1981). 
 
 
 
 
Fig. 2: Establishment of ESCs culture. The ICMs of blastocyst stage embryo are isolated and cultivated for few 
days on a layer of mitotically inactivated fibroblast cells (feeders). ICMs are then dissociated into single cells, 
which are plated into a new culture dish prepared with feeders. Single cells grow and form colonies of 
proliferating ESCs.  
 
 
It was believed that the ability of ECCs to proliferate was due to the production of autocrine factors 
that promoted growth and/or blocked differentiation. Therefore with this assumption, Martin 
cultivated blastocyst stage embryos in an ECC-conditioned medium (Martin, 1981). The isolated 
blastocysts were subjected to immunosurgery treatment, which allow the isolation of the ICM cells by 
selectively killing the trophoblast cells (Solter and Knowles, 1975). The obtained ICMs were then 
cultivated on a layer of feeders with the ECC-conditioned medium. After one week these cells formed 
many ECC-like colonies and were expanded for several passages without the need of conditioned 
medium, confirming the idea that proliferating cells endogenously express factors required for 
maintaining their characteristics. This was not the case for the ICMs cultivated without the 
conditioned medium, which very early stopped to proliferate. Different lines of ESCs were established 
using this protocol and all of them retained the ability to differentiate in vitro as well as in vivo. Martin 
hypothesized the existence of a cell-autonomous production of a factor able to sustain ESCs 
proliferation. Nevertheless, because ICMs cultivated in absence of ECC-conditioned medium did not 
generate ESCs, the possibility that the feeders produced this proliferation-promoting factor was 
excluded (Martin, 1981). Not many years later it was demonstrated by other laboratories that the use 
of diapause-blastocysts or of ECC-conditioned medium was dispensable for a successful generation of 
pluripotent ESCs (Axelrod, 1984).  
In 1988 A. Smith and colleagues isolated a soluble glycoprotein that prevents stem cell differentiation 
and established that ESC self-renewal is dependent on paracrine signals produced from the feeders on 
which ESCs are cultivated (Smith et al., 1988). The principal factor required for self-renewal was 
shown to be leukemia inhibitory factor (LIF) (Gearing et al., 1987; Williams et al., 1988). Lif 
knockout feeders were reported to be unable to support ESCs self-renewal (Stewart et al., 1992), 
indicating that supply of LIF was a key attribute of feeders. 
 
1.2 Derivation and maintenance of embryonic stem cells 
Derivation and maintenance of murine ESCs in vitro was originally achieved by using feeders and/or 
LIF in combination with fetal calf serum and/or the growth factor bone morphogenetic protein (BMP) 
(Smith et al., 1988; Ying and Smith, 2003). However, the same culture conditions are not sufficient for 
derivation of ESCs from most of the mouse strains and not at all from the rat. The genetic background 
strongly affects the efficiency of ESC isolation. Even though ESCs were discovered more than 25 
Introduction 
 4 
years ago only limited number of ESCs of proven ability to colonize the germ-line have been obtained 
and only a few mouse strains other than 129 (Simpson et al., 1997). Only after adjusting the culture 
conditions, germ line competent inbred ESCs could be established, e.g. from C57BL6/J (Keskintepe et 
al., 2007; Ledermann and Bürki, 1991), DBA/1lacJ (Roach et al., 1995), BALB/c (Kawase et al., 
1994; Noben-Trauth et al., 1996), and CBA mice (Lodge et al., 2005). Recently it has been shown that 
extrinsic stimuli (like LIF, serum, and feeders) are dispensable for derivation and maintenance of the 
pluripotent state. Culture conditions free from feeders, serum and cytokines were established by using 
a combination of small-chemical molecules, which inhibit the fibroblast growth factor (FGF)/mitogen-
activated protein kinase (MEK)/extracellular signal-related kinase (ERK1/2) and the glycogen 
synthase kinase 3 (GSK3) (Ying et al., 2008). These culture conditions are known as 3i or 2i and have 
been applied for derivation of ESCs from non-permissive mouse strains like non-obese diabetic 
(NOD) mice (Nichols et al., 2009a). Nevertheless in absence of LIF or 2i, murine ESCs exit self-
renewal and differentiate into different cell types, demonstrating that maintenance of the 
undifferentiated stem cell phenotype is not completely cell-autonomous (Fig. 3).  
 
 
 
Fig. 3: ESCs self-renewal and differentiation. Undifferentiated ESCs have small size and have a high nuclear to 
cytoplasmic ratio (left), which is lost once the cells differentiate (right). Undifferentiated ESCs form round shape 
and compact colonies that can be indefinitely expanded, either in presence of LIF and feeders or only 2i. On the 
other hand in absence of these factors ESCs differentiate and form monolayer colonies, which lose the compact, 
round shape typical for undifferentiated cells.  
 
 
On the molecular level, pluripotent ESCs are characterized by the expression of specific cell surface 
glycoproteins such as the stage-specific embryonic antigen 1 (SSEA-1) (Solter and Knowles, 1978) as 
well as by the presence of transcription factors such as OCT3/4 (Schöler, 1991; Schöler et al., 1989) 
and Nanog (Chambers et al., 2003). High expression levels of alkaline phosphatase also characterize 
ESCs. Furthermore, ESCs exhibit a short G1 phase of the cell cycle (Rohwedel et al., 1996) and a high 
telomerase activity (Thomson et al., 1998). Other essential properties of ESCs include growth as 
multicellular colonies, normal and stable karyotypes, and prolonged undifferentiated culture. 
 
1.3 Manipulation of ESCs genome: a powerful tool 
Pluripotent cells, which can differentiate into all types of cells in vivo as well as in vitro, represent an 
important source from which we can learn and study different molecular processes. ESCs with their 
wide differentiation potential are useful tools for studying developmental processes that take place in 
vivo in the embryo. The developmental potency of murine ESC is routinely tested with three different 
assays: first, in vitro by giving the right extrinsic signals ESCs can be differentiated into a variety of 
cell types; second, ESCs once injected into immunosuppressed mice forms teratomas that are 
composted from cells of all the three germ layers; third, ESCs injected into a host blastocyst take part 
to the development of the embryo. 
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For understanding the function of one gene, loss of function and gain of function mutations are 
necessary. While gain of function mutations are routinely produced in mammals including mouse and 
rat by injecting DNA into one of the pronuclei of the fertilized egg, targeted loss of function 
(knockout) mutations can routinely only be generated for the species where ESCs are available. 
Therefore, due to their properties, one of the biggest interests of ESCs has been their utility as cellular 
vectors for engineering the genome (Fig. 4A). With gene targeting, via transfection with modified 
homologous DNA, the genome of ESCs can be manipulated. Once the transgenic ESCs are returned to 
the embryo microenvironment they can participate in its development and produce viable chimeras 
(Fig. 4B). This technique of gene targeting via ESCs is one of the most powerful tools to investigate 
gene regulation and function in vivo and for modeling human genetic disorders and diseases. Since the 
establishment of murine germline competent ESCs the mouse is by far the most studied model 
organism. 
 
A 
 
 
B 
 
 
Fig. 4: A. Gene targeting in ESCs. ICM isolated ESCs are genetically modified by electroporation with a vector 
containing the desired transgene (shown in green). Thereafter ESCs are treated with selection media for 
enriching the population carrying the modified gene. B. Gene targeted mouse. The transgenic ESCs (green dots) 
are injected into the blastocoel of host blastocyst and after few hours ESCs migrate into the ICM. Injected 
embryos are then transferred to pseudo-pregnant female. Transgenic ESCs participate to the embryo 
development generating chimeric mice. Mating chimeric mouse with wild type mouse proves germ line 
transmission of the mutation.  
 
 
Introduction 
 6 
2. The rat: an important animal model 
Rats represent an optimal animal model for the investigation of human diseases and in some research 
fields is often, due to its bigger size and higher genetic diversity, preferred to the mouse. Due to its 
bigger size compared to the one of the mouse, interventions such as organ transplantation or in vivo 
functional analyses such as blood pressure measurements are easier to perform. Moreover, the higher 
genetic diversity allows the overcoming of species specific alterations (Canzian, 1997). Therefore, rats 
are preferred for instance, for the study of neurodegenerative diseases and disorders affecting higher 
brain function, such as depression and addiction, or for studies of transplantation biology, toxicology 
and drug development.  
Despite the benefits of working with rats, the impossibility of generating germ line competent rat 
ESCs has given the mouse a clear advantage over the rat in the generation of new transgenic models. 
With a lot of efforts transgenic rats have been generated by using alternative techniques, like random 
mutagenesis with ENU (N-ethyl-N-nitrosourea), gene knockdown with RNA interference, or genome 
modification of somatic cells combined with nuclear-transfer (Hasuwa et al., 2002; Zan et al., 2003; 
Zhou et al., 2003). Nevertheless, all these approaches have major limitations compared to the gene 
targeting procedure via ESCs used for generating transgenic mice. For example, for generating the 
first two knockout rats using the random mutagenesis ENU, about 2000 pups have been screened 
before the mutation was found in the gene of interest (Zan et al., 2003). ENU induces heritable genetic 
changes and was estimated to functionally mutate one allele every 1000 alleles analyzed (Justice et al., 
1999; Noveroske et al., 2000). One major problem of using this technique is that the mutations are 
randomly generated into the genome, therefore a large number of animals have to be generated before 
a mutation hits the selected gene. Moreover, even if the selected gene is mutated and functionally not 
active anymore, ENU causes always more than one single mutation in the genome. Therefore, in 
ENU-treated animals it is not to exclude that the phenotype seen is directly caused by the mutation in 
the gene of interest but rather to an accumulation of random mutations. However, the first two 
knockout rats for the breast cancer suppressor genes Brca1 and Brca2 showed different phenotypes 
than a similar model in the mouse (Zan et al., 2003). Interestingly, in the mouse functional mutation in 
Brca2 gene has lethal effect on the embryo (Friedman et al., 1998; Suzuki et al., 1997). In the rat, in 
contrast no lethal phenotype was observed but only growth defects and gonadal atrophy (Zan et al., 
2003). Thus, these divergent results demonstrate how the species influence the final phenotype of the 
mutation and illustrate the importance of having different animals at disposal to use as models for 
investigating human diseases. 
 
2.1 Rat embryonic stem cells 
Despite the big potential of ESCs and the advantages that working with rat as disease model offers, all 
the efforts made for establishing authentic rat ESCs have failed in the last 30 years (Iannaccone et al., 
1994; Ruhnke et al., 2003; Vassilieva et al., 2000). 
Only recently, by using molecular defined culture conditions (2i conditions: Ying et al., 2008), for the 
first time genuine pluripotent rat ESCs have been established from different strains (Buehr et al., 2008; 
Li et al., 2008). 
Interestingly, the presence of serum in the medium induced fast differentiation of rat ESCs, even in 
presence of LIF (Li et al., 2008). Interestingly, murine ESCs can be established and cultivated under 2i 
conditions in absence of LIF and feeders. However, this is not the case for rat ESCs, which need a 
feeder layer and besides the presence of 2i they are also cultivated in LIF containing medium (Buehr 
et al., 2008). These differences might explain why all attempts to derive rat ESCs, by using conditions 
developed for mouse ESCs culture, have failed in the last 30 years.  
 
In sum, finding the right culture conditions allows the establishment of authentic ESCs apparently 
without strain and species limitations, at least for the mouse and the rat. Nevertheless, the most crucial 
point remains the understanding of the molecular mechanisms that govern ESCs pluripotency, seen 
that ESCs and the induced pluripotent stem cells (iPSCs) hold great promise for the therapeutic 
treatment of human diseases. 
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3. The molecular signature of ESCs 
The unique characteristics of ESCs are due to the particular molecular signature that these cells 
exhibit. The mystery of pluripotency will be unravelled once the interplay between transcription 
factors, pathways and the epigenetic machinery will be understood. The following paragraphs present 
a review of the most important molecular and cellular mechanisms that regulate stem cell self-renewal 
and pluripotency prevalently in mouse ESCs, since they are the most investigated ESCs. 
 
3.1 The core transcription factors: OCT3/4, SOX2, and Nanog 
A critical role in maintaining ESC identity is played by a set of transcription factors centred on the 
OCT3/4 (Nichols et al., 1998; Schöler, 1991), the SRY-related HMG-box gene 2 (SOX2) (Yuan et al., 
1995), and Nanog (Chambers et al., 2003; Mitsui et al., 2003). Genome-wide studies have highlighted 
the co-localization of these three transcription factors in ESCs chromatin, increasing the complexity of 
the transcriptional networks that direct ESC identity.  
 
3.1.1 The transcription factor OCT3/4 
OCT3/4 is a member of the POU transcription factor family; it recognizes an 8-base pairs DNA 
sequence found in the promoters and enhancer regions of many ubiquitously expressed and cell-
specific genes (Ruvkun and Finney, 1991). The gene encoding OCT3/4 is named Pou5f1. OCT3/4 was 
first identified as an active binding factor in the extract of undifferentiated embryonic stem and 
embryonal carcinoma cells (Lenardo et al., 1989; Schöler, 1991). The presence of OCT3/4 protein in 
ESCs and embryonal carcinoma cells first suggested an association with the early stage of mouse 
embryogenesis. During the mouse development, it is first detected in oocytes and its expression 
declines during the first two cleavages divisions, but it reappears at the 4-8 cell-stage, where it is 
expressed in all the nuclei. Subsequently it is reduced in the trophectoderm and becomes restricted to 
the ICM. In the post-implantation embryos, OCT3/4 is localized in the epiblast but disappears as cells 
undergo differentiation, with expression persisting in the germ cells (Palmieri et al., 1994). The 
importance of OCT3/4 during early embryogenesis was also highlighted by the fact that embryos 
lacking the Pou5f1 gene die after implantation due to the absence of the ICM (Nichols et al., 1998). 
The requirement of OCT3/4 in the maintenance of developmental potency was determined by using a 
conditional expression and repression system in ESCs (Niwa et al., 2000). A critical amount of 
OCT3/4 is needed to sustain self-renewal, and up- or downregulation induces differentiation of the 
ESCs. Overexpression of this factor promotes differentiation into primitive endoderm and mesoderm, 
whereas repression of it causes loss of pluripotency and differentiation into trophectoderm (Fig. 5). 
Effectively, in vivo OCT3/4 is abundant in the ICM cells of the blastocyst and down-regulated in the 
trophectoderm, whereas in the primitive endoderm the level of expression increases (Palmieri et al., 
1994). These findings highlight the fundamental function of OCT3/4 in preventing dedifferentiation of 
epiblast cells or of ESCs into trophectoderm lineage. The sole exogenous expression of OCT3/4 is 
sufficient to generate pluripotent stem cells from mouse neural stem cells (Kim et al., 2009) and 
together with three other transcription factors it is essential in the reprogramming of somatic cells into 
the pluripotent state (Nakagawa et al., 2008; Takahashi and Yamanaka, 2006). While the other factors 
involved in reprogramming are replaceable by family members or other factors, without OCT3/4 no 
reprogramming occurs (Nakagawa et al., 2008). Moreover knockdown experiments in ESCs showed a 
very dramatic change in gene expression compared to the one caused for example by Nanog or SOX2 
knockdown (Ivanova et al., 2006) implying OCT3/4 as a chief selector for ESC fate decision. 
Of the known OCT3/4 target genes, four have been shown to be essential for the maintenance of 
pluripotency: Sox2, the undifferentiated transcription factor 1 (Utf1), Rex1/Zfp42 and Nanog. The 
regulatory regions of these genes contain an octamer element capable of binding OCT3/4. As we will 
describe in the following paragraphs, Sox2 is not only an OCT3/4 target gene but also serves as a 
cofactor for OCT3/4 (Okumura-Nakanishi et al., 2005). Although OCT3/4 and SOX2 have 
independent roles in determining other cell types, in pluripotent cells they act synergistically to drive 
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transcription of their target genes. Furthermore, this complex was found to promote transcription of 
the Nanog homeoprotein (Rodda et al., 2005) (Fig. 5). 
 
3.1.2 The transcription factor SOX2 
SOX2 is a member of the sex-determining region of the Y chromosome-related (SRY-related) high-
mobility group (HMG) box (SOX) family of transcription factors. SOX2 has an expression pattern 
similar to that of OCT3/4 through the mouse preimplantation development. SOX2 expression is also 
associated with precursor cells of the developing central nervous system and indeed can be used to 
isolate these cells. Like OCT3/4 downregulation of SOX2 correlates with a commitment to 
differentiation, and is no longer expressed in cell types with restricted developmental potential. In 
contrast to OCT3/4, the phenotypic lethal consequences of the absence of SOX2 expression in the 
embryo are visible only after implantation (Avilion et al., 2003). This is due to an accumulation of 
maternal SOX2 in the cytoplasm of the oocytes, which persist in all cells at least until the blastocyst 
stage, and not like OCT3/4 maternal transcripts, which last only till the 2-cell stage embryo (Palmieri 
et al., 1994). Thus, mutant embryos lacking the Sox2 gene die presumably when the maternal SOX2 
becomes diluted causing the differentiation of the epiblast cells into trophectoderm or extraembryonic 
ectoderm (Avilion et al., 2003) (Fig. 5). As mentioned before, loss of OCT3/4 causes differentiation of 
the epiblast cells into trophectoderm derivatives (Niwa et al., 2000). Avilion et al. proposed that the 
presence of both transcription factors is required for the formation and maintenance of epiblast cells. 
An upregulation of OCT3/4 and the accompanying downregulation of SOX2 lead to differentiation 
towards extraembryonic ectoderm. 
The regulatory regions of the Sox2 gene contain an octamer element capable of binding OCT3/4 
(Tomioka et al., 2002; Yuan et al., 1995). A possible interaction of these two factors was also 
proposed by the fact that almost all the SOX2-OCT3/4 target genes have both the octamer and sox 
heptamer elements separated by either 0 or 3 base pairs (Reményi et al., 2003; Williams et al., 2004). 
The Pou5f1 gene has different regulatory regions that are important for its expression. The distal 
enhancer, which contains the conserved region CR4, was shown to be required for ESC-specific 
OCT3/4 expression (Nordhoff et al., 2001). Two regulatory regions (the SRR1 and SRR2), known to 
confer ESC-specific expression, were also found in the Sox2 sequence. Using a chromatin 
immunoprecipitation (ChIP) assay Chew et al. first demonstrated that SOX2 and OCT3/4 interact with 
the enhancers of Pou5f1 and Sox2 genes. Moreover OCT3/4 and SOX2 knockdown experiments 
showed a reduced enhancer activity, confirming that both factors positively control their reciprocal 
expression (Chew et al., 2005). The same authors hypothesized a transcriptional regulatory network 
consisting of auto-regulatory and multi- component loops. In an auto-regulatory system the gene 
product binds to its own regulatory element allowing its continued and stable expression. In a multi-
component system, the OCT3/4 factor binds to the Sox2 regulatory element and vice versa generating 
a bi-stable system with the possibility to switch between the two different states (Chew et al., 2005) 
(Fig. 5). 
We described before that Sox2 null embryo die after implantation, because of differentiation of the 
epiblast cells. The same findings are reproducible also in vitro, where ESCs lacking Sox2 gene 
differentiate primarily into trophectoderm-like cells. Thus, SOX2 was defined to be indispensable for 
maintaining ESCs pluripotency. However, the transcription of many OCT3/4-SOX2 target genes was 
not affected in ESCs null for Sox2. These findings suggested that SOX2 regulates the expression of 
OCT3/4 through the regulation of multiple transcription factors (Masui et al., 2007). So, it seems that 
the main contribution of SOX2 in ESCs is to maintain OCT3/4 expression. Consistent with this idea is 
the finding that enforced expression of OCT3/4 can rescue ESCs from differentiation induced by the 
loss of Sox2 (Masui et al., 2007). Not to forget is also that SOX2 is one of the four transcription 
factors, which together are able to induce reprogramming to pluripotency in differentiated cells 
(Takahashi and Yamanaka, 2006). Furthermore, large-scale ChIP studies have shown the OCT3/4-
SOX2 complex closely localized to another important regulator of pluripotency, the Nanog 
transcription factor. 
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Fig. 5: The “trinity” of nuclear regulators that control stem cell identity: OCT3/4, SOX2, and Nanog 
transcription factors. Transcriptional regulatory network of the three factors and the effects on cell fate after 
altering their transcriptional levels. (From Casanova et al., 2011a)  
 
 
3.1.3 The transcription factor Nanog 
Nanog is a homeodomain protein, which acts as an intrinsic effector of ESCs self-renewal. During 
ESCs differentiation, Nanog mRNA declines markedly, and its expression is retained only in 
undifferentiated cells. In the mouse embryo its first expression appears in the compacted morula and it 
is localized to the interior cells, the future ICM. In blastocysts, the expression is confined to the ICM 
and absent from the trophectoderm. In the later blastocyst, Nanog is further restricted to the epiblast 
and excluded from the primitive endoderm; it is then down regulated after implantation (Chambers et 
al., 2003; Mitsui et al., 2003). At day E11.5-E12.5 Nanog expression marks the pluripotent germ cells. 
Overexpression of Nanog in ESCs was found to allow proliferation of undifferentiated ESCs in 
absence of LIF (Chambers et al., 2003). After transfection with Cre-recombinase, in which the Nanog 
expression cassette has been eliminated, these cells reverted to LIF-dependence, demonstrating that 
this phenotype was directly attributable to Nanog overexpression. Following exposure to a 
differentiation-promoting agent, like retinoic acid, cells overexpressing Nanog remained, in contrast to 
the Cre-reverted cells, morphologically undifferentiated and expressed OCT3/4. Cre-reverted cells 
were injected into mouse blastocysts and contributed to the generation of germline competent 
chimeras. Even though cells overexpressing Nanog self-renew in a cytokine independent manner, the 
presence of LIF confers to these cells an enhanced self-renewing capacity (Chambers et al., 2003). 
A reduction in the level of Nanog causes ESCs to differentiate to extraembryonic endoderm lineages 
(Chambers et al., 2007; Ivanova et al., 2006) (Fig. 5). In vivo the absence of Nanog during embryo 
development results in early lethality. ICM of Nanog null blastocysts failed to proliferate and 
differentiated into parietal endoderm-like cells, demonstrating that its expression is essential for 
maintenance of pluripotency of the ICM cells (Mitsui et al., 2003). Interestingly, ESCs upon targeted 
deletion of the Nanog gene can self-renew indefinitely and can contribute to the generation of 
chimeric animals (Chambers et al., 2007). This indicates that loss of Nanog in ESCs does not affect 
pluripotency once this was established. Nevertheless, even though Nanog null cells colonize the germ 
layers of the chimeric mice and they are recruited to the germ line, primordial germ cells lacking 
Nanog fail to mature on reaching the genital ridge (Chambers et al., 2007). These data confirm that 
Nanog is specifically required for the formation of germ cells. 
The fact that STAT3 activation in presence of LIF was not increased in cells overexpressing Nanog 
(Mitsui et al., 2003) and the fact that these cells did not differentiate in presence of a JAK/STAT3 
inhibitor (Chambers et al., 2003), clearly demonstrate the existence of a parallel and LIF/STAT3-
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independent mechanism sustaining pluripotency in ESCs. In vivo these findings are confirmed by the 
fact that Nanog is absolutely required for epiblast formation, while STAT3 is dispensable.  
Several studies showed that Nanog and OCT3/4 factors overlap substantially in their target genes, 
causing sometimes, also by cooperation, the activation or suppression of the expression of target 
genes. Mapping of the binding sites of OCT3/4 and Nanog in the mouse ESC genome showed that a 
substantial proportion of the genes were occupied by both factors, in some cases Nanog-OCT3/4 were 
found to co-localize, in other cases they bound independently (Loh et al., 2006). In the same study it 
was shown that the OCT3/4-regulated target genes predominantly repress trophectoderm markers 
whereas Nanog activates the transcription of Pou5f1 and Sox2 evidencing a possible role of Nanog in 
controlling the levels of both OCT3/4 and SOX2 (Fig. 5). These factors in turn control the 
downstream genes involved in the maintenance of pluripotency or inhibition of differentiation (Loh et 
al., 2006). Interestingly promoter-sequence analyses showed the presence of a Sox-Oct element on the 
Nanog promoter. Two different groups demonstrated that both OCT3/4 and SOX2 bind to the Nanog 
promoter therefore driving its transcription (Kuroda et al., 2005; Rodda et al., 2005). 
ESCs under conventional culture conditions (namely with serum and LIF) are in a dynamic state, that 
fluctuates between a stable state, in which Nanog expression is high, and an unstable state, where 
Nanog expression levels are low (Kalmar et al., 2009; Singh et al., 2007). As a consequence ESCs 
form a heterogeneous population where pluripotent ESCs exhibit a highly variegated gene expression 
pattern. When induced to differentiate only ESCs with low levels of Nanog expression are able to 
commit in a stable manner (Chambers et al., 2003). The levels of Nanog expression in an ESC are 
related to its probability to differentiate or not. In this model the advantage is that in a heterogeneous 
population, there is always a subpopulation of cells pre-primed for differentiation. Such priming 
would be an advantage in situations where the cells must be ready within a short period to respond to 
diverse signaling (Kalmar et al., 2009).  
Although there are other transcription factors associated with ESC self-renewal and pluripotency, a 
large number of studies support the notion that the trio SOX2, OCT3/4 and Nanog are the main 
regulators that generate and maintain the pluripotent state in vivo and in vitro. This idea is also 
corroborated by the fact that all three factors play an essential role in reprogramming somatic cells 
(Meissner et al., 2007; Okita et al., 2007; Takahashi and Yamanaka, 2006). 
 
3.2 Signaling through cytokine receptors: LIF/gp130 pathways  
LIF belongs to the family of interleukin (IL)-6-type cytokines and exerts its effects by binding to a 
two-part receptor complex, which consists of the low-affinity LIF receptor (LIFRβ) and the 
glycoprotein 130 (gp130). LIF induces heterodimerization of the LIFRβ and gp130 resulting 
predominantly in the activation of the JAK/STAT3 (Janus kinase/Signal transducer and activator of 
transcription signal) transduction pathway, which promotes self-renewal in ESCs. Several studies 
showed that LIFRβ receptor is not sufficient to mediate the signal to maintain ESCs self-renewal, 
whereas gp130 is (Niwa et al., 1998; Starr et al., 1997). These results indicate that gp130 is the main 
component of the activated LIFRβ/gp130 receptor. Interestingly, activation of LIFRβ/gp130 receptor 
through the binding of LIF leads also to the activation of the mitogen-activated protein kinase 
(MAPK) and the phosphatidylinositol-3 phosphate kinase (PI3K) pathways, which together with the 
JAK/STAT3 pathway are essential for regulating biological responses in ESCs. 
In the embryo the epiblast is the transient population of cells from which the fetus is derived. Because 
of their characteristics, ESCs seem to be the in vitro counter part of the epiblast cells in vivo. However, 
in contrast to the LIF dependency of ESCs, early epiblast cells do not require LIF stimulation, since 
Lif null embryos develop normally into later stages (Stewart et al., 1992) and embryos carrying 
mutations on the LIFRβ and gp130 receptor develop normally, at least until mid-gestation (Li et al., 
1995; Nakashima et al., 1999; Ware et al., 1995). Nevertheless, it has been shown that the embryos do 
express LIF, LIFRβ and the gp130 mRNA indicating a possible function of this pathway also in vivo. 
It has been shown that diapause embryos carrying mutation on the LIFRβ and the gp130 receptors fail 
to restore normal embryogenesis (Nichols et al., 2001). These findings highlight the absolute 
requirement for LIF/gp130 signaling in the epiblast during diapause and give also an explanation why 
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ESCs are LIF dependent. However this is a facultative situation, because the pathway is dispensable 
for early development without diapause. 
 
3.2.1 JAK/STAT3 signaling and self-renewal  
Binding of the cytokine LIF to the receptor results in conformational changes in the intracellular part 
of the receptor. Cytosolic tyrosine kinases of the JAK family are then recruited to the receptor. The 
activated receptor phosphorylates the tyrosine residues in the kinase molecule that become docking 
sites for the STAT3 transcription factors. When bound to the receptor, STAT3 molecules are 
phosphorylated on the tyrosine 705 (Tyr705) residues and dimerize with another phosphorylated 
STAT3. The dimers are then translocated to the nucleus in a regulated manner where they bind to 
promoter and enhancer regions of their target genes (Fig. 6). Between the STAT3 target genes there 
are the Socs genes (Suppressor of cytokine signaling), whose encoded proteins generally act in a 
negative feedback loop to suppress further STAT3 signaling (O'Sullivan et al., 2007) (Fig. 6). 
Although overexpression of STAT3 promotes stem cell self-renewal and maintenance of pluripotency 
in the absence of LIF and in presence of serum (Cinelli et al., 2008; Matsuda et al., 1999), inactivation 
of STAT3 in LIF-maintained ESCs promotes spontaneous differentiation (Niwa et al., 1998). Even 
though these lines of evidence establish STAT3 as an essential component of the LIF-dependent self-
renewal in ESCs, the downstream target genes of activated STAT3 have remained elusive. In order to 
isolate these genes, several studies based on ChIP analysis or on microarray technology have been 
performed. 
Recently Cartwright et al. indicated a role for the transcription factor c-MYC in self-renewal by 
functioning as a key target of LIF/STAT3 signaling (Cartwright et al., 2005). Like other genes 
involved in the maintenance of pluripotency, such as Nanog (Chambers et al., 2003), Klf2 (Hall et al., 
2009), Pem/Rhox5 (Cinelli et al., 2008; Fan et al., 1999) and Pramel7 (Cinelli et al., 2008), 
constitutive expression of c-MYC renders self-renewal independent of LIF (Cartwright et al., 2005). 
On the other hand expression of a dominant negative form of c- MYC promotes differentiation 
(Cartwright et al., 2005). c-MYC is a transcription factor that controls many different biological 
processes, such as cell proliferation, growth, differentiation and apoptosis. Several studies have shown 
the importance of this gene in embryonic development, since homozygous deletion of c-Myc in the 
mouse results in embryonic lethality before E10.5 of gestation (Davis et al., 1993).  
Not surprisingly, c-MYC is one of the four transcription factors found to be able, together with 
OCT3/4, KLF4, and SOX2, to reprogram somatic cells into undifferentiated, induced pluripotent stem 
cells (iPSCs) (Takahashi and Yamanaka, 2006). 
The fact that overexpression of the transcription factor Nanog does not increase significantly the level 
of phosphorylated STAT3, and vice versa the overexpression of STAT3 seems not to affect Nanog 
expression, leads to the conclusions that Nanog is not a direct transcriptional target of STAT3, nor 
does it regulate STAT3 activity (Chambers et al., 2003). Moreover increased STAT3 activity 
maintains pluripotency even when Nanog expression is reduced (Bourillot et al., 2009), confirming 
that these two transcription factors are regulated through different signals. Nevertheless, in a recent 
study it was shown that 55% of the putative STAT3 target genes display binding sites for Nanog, and 
41% of the putative Nanog target genes display binding sites for STAT3 (Chen and Daley, 2008). 
These results suggest that both transcription factors co-regulate the expression of a large number of 
target genes, whose expression is involved in the maintenance of the undifferentiated state in ESCs.  
Recently Hall et al. showed that OCT3/4 in addition to the LIF/STAT3 signaling activates the 
Krüppel-factors KLF4 and KLF2 and that their overexpression reduces LIF dependence (Hall et al., 
2009). However only KLF2 was able to sustain pluripotency in absence of either LIF or Stat3, and was 
shown to be OCT3/4 induced. KLF4 was shown to be selectively induced by LIF/STAT3 but was not 
sufficient in absence of the LIF/STAT3 signaling to sustain prolonged ESCs self-renewal. 
Interestingly, like c-MYC, also KLF4 is one of the four transcription factors that are able to reprogram 
somatic cells into undifferentiated, self- renewing cells (Takahashi and Yamanaka, 2006). 
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Fig. 6: gp130/LIF dependent STAT3 pathway (see 1.3.2.1) and MAPK/ERK pathway (see 1.3.2.2). 
Differentiation and self-renewal signaling converge downstream to the LIF receptor. (From Casanova et al., 
2011a)  
 
 
In the molecular mechanisms involved in the maintenance of pluripotency in ESCs extrinsic stimuli 
converge with intrinsic circuitries in a synergistic manner propagating the undifferentiated and self-
renewing state in ESCs. STAT3 is an important regulator of mouse ESC self-renewal and it is known 
to inhibit differentiation into both mesoderm and endoderm lineages (Ying et al., 2003) by preventing 
the activation of lineage-specific differentiation programs. However its mechanisms of action remain 
to be better elucidated. 
 
3.2.2 gp130-dependent activation of the MAPK/ERK pathway  
Self-renewal and differentiation converge downstream from the LIFRβ/gp130 receptor. The binding of 
the cytokine LIF to the heterodimeric receptor activates not only the JAK/STAT3 pathway but also the 
mitogen-activated protein kinase (MAPK) pathway that culminates in the activation of the 
extracellular signal-regulated kinases (ERK1/2). Since it has been shown that ERK regulates early 
differentiation in vivo and in vitro (Kunath et al., 2007; Nichols et al., 2009b), the balance between 
self-renewal and differentiation has to be maintained in order to preserve the undifferentiated state of 
ESCs. 
Active gp130 receptor can also associate with the protein tyrosine phosphatase SHP-2 (Fukada et al., 
1996), which acts as a positive effector of the MAPK signaling cascade. Interaction between active 
gp130 receptor and SHP-2 phosphatase induces the recruitment of GAB1. The complexes formed by 
the gp130 receptor, SHP-2 and GAB1 proteins, through the activation of further kinases (RAS/RAF 
and MEK) result in the activation of the ERK1 and ERK2 kinases (Takahashi-Tezuka et al., 1998) 
(Fig. 6). Burdon et al. confirmed that after stimulation with LIF, ERK1 and ERK2 were activated 
through phosphorylation of SHP-2 (Burdon et al., 1999). Surprisingly, they also showed that 
suppression of the SHP-2/ERK signaling was not affecting propagation of stem cells, but on the 
contrary it was enhancing ESCs self-renewal (Burdon et al., 1999). This study indicates that SHP-
2/ERK signaling activation is a necessary component of the normal differentiation processes. 
Differentiation of ESCs into embryoid bodies in vitro was associated with an induction of expression 
of G1 cyclins, a lengthening of the G1 phase and a decrease in the rate of cell division (Savatier et al., 
1996). ESCs typically exhibit a short G1 phase of the cell cycle (Rohwedel et al., 1996) and high rate 
of cell divisions. Entrance into the G1 phase of the cell cycle is a prerogative for cell differentiation. 
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ERK signaling is known to regulate proliferation and survival of somatic cells (Lloyd, 1998), and in 
vivo phosphorylated ERK has been detected from the 2-cell stage till the blastocyst stage (Wang et al., 
2004). Incubation of 2-cell stage embryos with an ERK inhibitor results in a developmental arrest at 
the four-cell stage embryo; however, normal embryo development can be restored once the inhibitor is 
removed (Maekawa et al., 2007). In contrast to many mammalian cells, where ERK activity is 
essential for the cell cycle progression from G0/G1 to S phase (Lewis et al., 1998), during the 
development from the 2-cell to the 8-cell stage embryo, ERK signaling seems to be essential in the 
G2/M transition (Maekawa et al., 2007). This confirms that the ERK1/2 pathway is required for 
progression of early cell division cycles in the preimplantation embryo.  
Interestingly, the ERK pathway may be able to inhibit the JAK/STAT3 pathway at the level of 
STAT3. It has been shown that ESCs knockout for Shp2 phosphatase after LIF stimulation showed an 
increased phosphorylation of STAT3 when compared to the wild type cells (Chan et al., 2003). This 
data supports the evidence that the two pathways seem to converge and thereby determine the choice 
between self-renewal and differentiation (Fig. 6). 
Recently, Ying et al. cultivated ESCs in a serum-free medium containing B27- and N2- supplement in 
presence of selective small-chemical inhibitors of the FGF receptor and the ERK kinase in 
combination with a GSK3 inhibitor, the so called 3i or 2i conditions (Ying et al., 2008). While the first 
two inhibitors are involved in selectively blocking differentiation signals induced by the ERK 
pathway, the third inhibitor is used for blocking the negative regulation on biosynthetic pathways 
driven by the GSK3 protein (Ying et al., 2008). This work indicates that by inhibiting differentiation-
inducing signals from the MAPK pathway by 3i/2i it is possible to maintain self-renewal in absence of 
LIF/STAT3 stimulation. This was confirmed by the fact that under these conditions neither STAT3 
nor SOCS3 activation was detected. Moreover, it was possible to establish Stat3 null cells, which did 
not show morphologically differences when compared with the wild type cells. All the different cell 
lines established under the 3i conditions expressed the typical pluripotency markers like OCT3/4 and 
Nanog and were able to contribute to chimera formation and germ line transmission (Ying et al., 
2008). 
 
3.2.3 gp130-dependent activation of the PI3K pathway  
There are three distinct classes of phosphatidylinositol-3 phosphate kinase (PI3K); members of the 
class IA family of PI3Ks are activated via the LIF/gp130 receptor (Fig. 7). The products of PI3K 
transmit the signals through downstream effectors including the serine/threonine protein kinase B 
(PKB, also known as AKT). AKT has been implicated in many cellular processes like regulation of 
the cell cycle progression, cell death, adhesion, migration, metabolism and tumorigenesis. 
Initially it was shown that this pathway was implicated in the control of proliferation in ESCs 
(Jirmanova et al., 2002; Takahashi et al., 2003). Paling et al. demonstrated that LIF induced PI3K 
signal activation in ESCs is involved not only in the regulation of cell proliferation but also in their 
self-renewal (Paling et al., 2004). ESCs incubated with LIF and a small chemical PI3K inhibitor 
(LY294002) showed less alkaline phosphatase activity compared to the untreated control cells, 
indicating a reduced ability of LIF to promote self-renewal. However these cells did not show altered 
levels of phosphorylated STAT3 when compared to the control cells. This result led to the conclusion 
that Stat3 is not a target of PI3K action. The loss of self-renewal and the consequent differentiation of 
the cells after inhibition of PI3K were explained by an increase in ERK phosphorylation upon LIF 
stimulation (Paling et al., 2004). These findings are consistent with other studies were it was reported 
PI3K playing a role in negatively regulating ERK activity in ESCs (Hallmann et al., 2003). Paling et 
al. demonstrated that self-renewal was restored after incubation with both ERK and PI3K inhibitor, 
therefore confirming that the regulation of ERK activity by PI3K signaling contributes to the 
determination of ESCs self-renewal. 
Long term treatment of ESCs with the PI3K inhibitor LY294002 was shown to inhibit the proliferation 
and to induce cell cycle arrest at the G1 phase (Jirmanova et al., 2002). It is known that PI3K/AKT 
controls cell-cycle regulation: AKT promotes the G1 to S phase transition by facilitating the formation 
of cyclin/CDK complexes (Brazil et al., 2004). ESCs lack cell-cycle inhibitory mechanisms, which are 
typical of differentiated cells. Only after differentiation ESCs acquire these mechanisms (Burdon et 
al., 2002). It is therefore possible that AKT-mediated maintenance of self-renewal in ESCs is due to its 
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ability to block the cell-cycle inhibitory mechanisms and consequently block differentiation 
(Watanabe et al., 2006). 
 
 
 
Fig. 7: Summary of gp130/LIF-induced activation of PI3K, STAT3 and ERK1/2 pathways. (From Casanova et 
al., 2011a)  
 
 
3.3 Other pathways involved in the maintenance of pluripotency in ESCs 
3.3.1 Signaling through the TGF-β  pathway: BMP and Nodal/Activin 
Transforming Growth Factor β (TGF-β) signaling controls diverse sets of cellular processes, including 
cell proliferation, recognition, differentiation, apoptosis, and specification of developmental fate, 
during embryogenesis as well as in mature tissues. Moreover, it has been implicated in the progression 
of many cancers, functioning both as an antiproliferative and as a tumor-promoting factor. The TGF-β 
family members bone morphogenetic proteins (BMPs), Nodal and Activin have been implicated in the 
development and maintenance of various stem cells, including ESCs.  
BMP, Nodal and Activin act through the transmembrane type I and type II serine/threonine kinase 
receptors, leading to their dimerization. The activated receptor recruits SMAD molecules, which carry 
then the signal from the cell surface to the nucleus.  
In serum-free culture, LIF is insufficient to maintain the undifferentiated state of murine ESCs (Ying 
et al., 2003). On the other hand the overexpression of STAT3 alone is enough to sustain pluripotency 
in ESCs in a LIF-independent manner, however in presence of serum and feeders (Cinelli et al., 2008; 
Matsuda et al., 1999). These observations suggest that there must be other factors in the serum or 
produced by the feeders, which suppress differentiation and concomitantly, efficiently sustain self-
renewal in ESCs. One of these signals was shown to be the bone morphogenetic proteins (BMPs). 
BMPs bind to the Activin receptor-like kinases (ALKs) ALK2, ALK3, and ALK6, and activate the 
Inhibitor of differentiation (Id) genes through the activation of the receptor-regulated SMAD2, 
SMAD5 and SMAD8 (Ying et al., 2003). In a serum-free culture, ESCs differentiate into neural 
precursors under the influence of autocrine FGF signal even in presence of LIF (Ying and Smith, 
2003) indicating that other signals are required for suppressing neural differentiation. The combination 
of LIF and BMP4 or BMP2 was found to be sufficient to maintain the undifferentiated state of ESCs 
in serum-free medium (Ying et al., 2003). However, withdrawal of LIF and retention of BMP causes 
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differentiation into epithelial-like cells. This lead to the conclusion that the self-renewal response to 
BMP is dependent on continuous LIF signaling and that the BMP main function is therefore to 
antagonize the neural differentiation induced by LIF in absence of serum (Ying and Smith, 2003). This 
was corroborated by the fact that ID overexpression in ESCs enables serum-free self-renewal in the 
sole presence of LIF. Upon LIF withdrawal, ID overexpressing cells differentiated into non-neuronal 
precursors, therefore demonstrating that these genes contribute to the ESCs self-renewal by 
complementing the blockade of other lineages induced by STAT3.  
These findings clearly indicate that the cooperation between LIF/STAT3 and BMP/SMAD pathway is 
required for maintaining ESCs in serum-free media. Nevertheless the balance has to be critically 
regulated, since depletion of the LIF/STAT3 signaling induces BMP-dependent promotion of 
differentiation and overexpression of SMAD1/4 overrides the effect of LIF and causes non-neural 
differentiation (Ying and Smith, 2003). Recapitulating, high expression of BMP leads to 
differentiation into mesoderm and endoderm lineages, whereas neural differentiation is suppressed. On 
the other side, low level of BMP also induces differentiation into mesoderm. Therefore, support of 
pluripotency by BMP pathway is highly dose-dependent and needs to be counter-regulated by STAT3 
signaling. 
 
Nodal/Activin signaling has been shown to be essential in vivo for the induction of mesoderm and 
endoderm lineages and for the determination of the left-right axis during embryogenesis. Nodal 
knockout show a reduced epiblast cell population that display very low expression of the pluripotency 
marker OCT3/4 and arrest the development before gastrulation (Robertson et al., 2003). 
Nodal expression in mouse ESCs is high, and was found to build an active signaling together with 
SMAD2. Thus, stimulation of ESCs with Activin or Nodal leads to an increase in SMAD2 
phosphorylation and a higher ESCs proliferation, whereas inhibition of SMAD2 activation reduces 
cell proliferation (Ogawa et al., 2007). 
In serum-containing medium, both BMP and Nodal/Activin pathways are autonomously activated in 
ESCs. Ogawa and colleagues showed that after overexpression of the inhibitors SMAD6 and SMAD7, 
ESCs proliferation significantly decreased, being the effect in SMAD7 transfected ESCs much more 
dramatic. The SMAD7-dependent inhibition of cell proliferation was reversible after excision of the 
transgene; moreover this was not affecting ESCs pluripotency since injection of the SMAD7-reverted 
cells produced live chimeras (Ogawa et al., 2007). In serum-free medium the SMAD7 induced 
blockade of proliferation is more reduced, leading to the conclusion that soluble TGF-β-related 
molecules in the serum are also involved in the SMAD7-dependent growth inhibition (Ogawa et al., 
2007). Further analyses demonstrated that ESCs autonomously activate Nodal/Activin signaling by 
producing these ligands in serum-free conditions; in presence of serum the soluble TGF-β-related 
molecules might increase the endogenous Nodal/Activin activity leading to an enhanced cell 
proliferation (Ogawa et al., 2007). 
If the involvement of the Nodal/Activin pathway in maintaining mouse ESCs has still not been 
completely elucidated, this is not the case for human ESCs (hESCs), where it plays a fundamental role 
in the maintenance of pluripotency. Like mouse ESCs, hESCs do express all the components of the 
LIF/STAT3 pathway but in contrast to the mouse cells, they cannot be maintained pluripotent in 
presence of LIF (Humphrey et al., 2004). This indicates that signaling through this pathway is 
insufficient to prevent differentiation of hESCs and indicates the existence of other pathways involved 
in the regulation of pluripotency in hESCs. Interestingly, mouse epiblast stem cells derived from the 
E5.5-E6.5 postimplantation embryos can also not be maintained undifferentiated in presence of LIF or 
BMP4. Like hESCs, mouse epiblast stem cells require FGF4 and Nodal/Activin signaling for self-
renewal (Brons et al., 2007; Tesar et al., 2007). In conclusion, even though all the components of the 
Nodal/Activin pathway are highly expressed in both hESCs and mouse ESCs, the outcome of these 
signaling is different in the two species.  
 
3.3.2 The canonical Wnt pathway 
The WNT pathway plays crucial roles in controlling genetic programs of embryonic development and 
adult homeostasis. WNT signals are transduced depending on their functions through different 
receptors and members: The canonical WNT pathway is known to be involved in transmitting signals 
Introduction 
 16 
for cell fate determination, whereas the non-canonical WNT pathway is involved in controlling cell 
movements and tissue polarity. 
Canonical WNT signaling starts when the extracellular WNT ligand binds members of the Frizzled 
and LDL receptor family. The main player of the cascade is the cytoplasmic protein β-catenin. When 
the WNT ligand activates the pathway, β-catenin translocates to the nucleus where it interacts with 
other members of the signaling pathway for activating target genes. 
The tumor suppressor adenomatous polyposis coli (APC), AXIN and the glycogen synthase kinase 3β 
(GSK3β) are the components of the cytosolic destruction complex responsible for the proteasomal β-
catenin degradation in absence of WNT ligand.  
Several publications support the role of the WNT/β-catenin pathway in maintaining pluripotency in 
ESCs, although the precise mode of action needs still to be clarified. It has been shown that the feeders 
used for the cultivation of ESCs represent a potential source of WNT ligands, or that ESCs 
conditionally expressing a constitutive active form of β-catenin were able to maintain the 
undifferentiated state in a LIF-independent manner (Hao et al., 2006). This study demonstrated that 
the WNT-mediated maintenance of pluripotency was depending on β-catenin stabilization. Moreover, 
constitutive activation β-catenin induced an upregulation of STAT3 mRNA and protein. In serum-free 
medium the WNT pathway is not sufficient for sustaining ESCs self-renewal, however if 10 U/ml of 
LIF are added to the medium, ESCs form compact colonies and show OCT3/4 expression suggesting a 
synergistic effect of both pathways; the WNT pathway effectively upregulating STAT3 mRNA and 
the LIF pathway phosphorylating the protein and finally activating STAT3 target gene expression 
(Hao et al., 2006). 
Nevertheless, in β-catenin knockout ESCs the expression of the core pluripotency factors Nanog, 
OCT3/4 and SOX2 is still present indicating that β-catenin regulates the expression of several 
stemness genes, but is not directly required for maintenance of pluripotency (Anton et al., 2007).  
Recently it has been shown that β-catenin can form a complex with and modulate the activity of 
OCT3/4 (Kelly et al., 2011). Gsk3α/β knockout ESCs expressing a dominant-negative form of TCF1 
or TCF4 had attenuated β-catenin/TCF gene transactivation, but surprisingly were not rescued with 
respect to their ability to differentiate into neurectoderm and self-renewed in the absence of exogenous 
factors (Kelly et al., 2011). It was therefore postulated that the contribution of β-catenin in the 
maintenance of pluripotency in ESCs is exerted through a TCF-independent mechanism (Kelly et al., 
2011). 
Despite the recent findings the role of the WNT pathway in regulating pluripotency in ESCs is still not 
clear and further analysis would be needed in order to clarify its real contribution in the pluripotency-
related processes.  
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4. Aim of the work 
The overall goal of this thesis was to gain knowledge on the molecular mechanisms that control 
stemness in the embryonic stem cells. The work was divided into two different projects: the first was 
focused on the function of pluripotency related genes in ESCs and the second project consisted in a 
genome wide expression analysis of mouse and rat preimplantation stage embryos.  
 
Project number 1: Functional characterization of newly identified pluripotency-related genes 
in murine ESCs 
 
Project number 2: Cross-species genome wide expression analysis of late mouse and rat 
preimplantation embryo development 
 
4.1 Project 1: Functional characterization of newly identified pluripotency-related 
genes in murine ESCs 
 
4.1.1 Expression profiling in transgenic FVB/N embryonic stem cells overexpressing 
STAT3 
The aim of this part of the study was to analyze the function of selected genes, which were 
differentially regulated in the STAT3 overexpressing cells (Cinelli et al., 2008). To achieve this goal, 
vectors containing the ORF of the genes Hexokinase II, Pem/Rhox5, Dppa3/Stella, Pramel7, and 
Pramel6 have been cloned for their functional characterization in ESCs. ESCs overexpressing these 
genes have been generated and analyzed for their ability to be propagated in the absence of LIF in the 
medium.  
 
Based on these preliminary results we selected the genes Pramel7 and Pramel6 for further 
characterizations. 
 
4.1.2 Pramel7 mediates LIF/STAT3 dependent self-renewal in embryonic stem cells 
Given that the candidate genes showed a differential expression in transgenic FVB/N ESCs, we 
hypothesized they could play a role in the stabilization of pluripotency in ESCs (Cinelli et al., 2008). 
Therefore, the aim of this part of the project was to extensively analyze and characterize the function 
of Pramel6 and especially of Pramel7 in the maintenance of pluripotency in murine ESCs.  
 
For this purpose transgenic ESCs were generated, which overexpressed in a constitutive manner either 
Pramel6 or Pramel7. The capability of both genes to maintain ESCs in an undifferentiated state was 
analyzed by cultivating these cells in the absence of LIF on Lif knockout feeders. Moreover, the 
pluripotent state of the transgenic cells, maintained through the sole overexpression of Pramel6 and 
Pramel7 was investigated by generating chimeric mice. The confirmation of their undifferentiated and 
pluripotent state in vitro was investigated by immunoassay and real-time PCR analysis.  
 
The differentiation potential of Pramel7 and Pramel6 overexpressing cells was monitored in vitro 
(embryoid bodies formation, neural differentiation) as well as in vivo (teratoma formation, blastocyst 
injections).  
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Finally the molecular mechanisms which drive the transcription of Pramel7 were investigated in 
transgenic and wild type ESC lines.  
 
 
4.2 Project 2: Cross-species genome wide expression analysis of late mouse and 
rat preimplantation embryo development 
 
The aim of this project was to identify differentially regulated mechanisms in the mouse and the rat 
morula and blastocyst stage embryos with the purpose of increasing the knowledge about the 
regulation of pluripotency in rat ESCs.  
 
With this intention, morulae, blastocysts, and ICMs were collected from both species and a whole 
genome microarray analysis was performed.  
In a first part of the study we analyzed separately for the mouse and for the rat, the differentially 
expressed genes in the three cell populations. We next performed a cross-species analysis in order to 
highlight similarities and differences between the gene expressions in the two species. Important 
signaling pathways were investigated and compared between the mouse and the rat, as well as the 
expression patterns of gene families.  
Finally the expression of genes known to be involved in the maintenance of ESCs in vitro, were 
analyzed and compared in the two species.  
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B. RESULTS 
 
1. Functional characterization of new pluripotency-related genes 
in murine ESCs 
 
Despite 30 years of research and the discovery of many factors indispensable for maintaining and 
generating pluripotent ESCs, still many questions are open. The LIF/STAT3 pathway plays a crucial 
role in the maintenance of pluripotency in ESCs. Although lines of evidence establish STAT3 as an 
essential component of the LIF-mediated self-renewal in ESCs, the downstream target genes of 
activated STAT3 have remained elusive. Moreover, as mentioned before, the genetic background 
strongly impairs the efficiency of establishing genuine ESCs. So that for many years, ESCs of proven 
ability to colonize the germ-line have been obtained at very low frequency in only a few mouse strains 
other than 129 (Simpson et al., 1997).  
 
In the next chapters are reported two studies, where we identified new pluripotency-related genes upon 
overexpression of STAT3 in murine ESCs.  
 
The resulting papers are attached as Annex at the end of this Thesis.
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1.1 Expression profiling in transgenic FVB/N embryonic stem cells 
overexpressing STAT3 
 
Besides finding the right culture conditions, manipulating the expression of specific genes known to 
safeguard the pluripotent state of ESCs, represents a good method for generating stable ESC lines.  
 
Matsuda et al. demonstrated that overexpression of the transcription factor STAT3 maintained the 
undifferentiated state of 129/SvJ-derived ESCs (Matsuda et al., 1999). 
The authors generated a chimeric STAT3-estrogen receptor (STAT3-ER) composed of the entire 
coding region of STAT3 and the ligand-binding domain of the estrogen receptor. Dimerization of the 
chimeric STAT3 was activated after treatment with the estrogen derived 4-hydroxy-tamoxifen (4-
OHT). ESCs cultivated in presence of 4-OHT were able to self-renew in the absence of LIF (Matsuda 
et al., 1999).  
 
We adopted the same system used in the study from Matsuda et al. and we were able to generate 
germline competent ESCs from the non-permissive FVB/N mouse strain by overexpressing STAT3. 
This indicates that overexpression of STAT3 is not only sufficient to maintain already established 
ESCs pluripotent, but is also able to increase the efficiency of derivation of ESCs from the ICM of 
strains where normally derivation of viable ESCs is otherwise impaired. Moreover, we compared by 
microarray analyses the gene expression differences between FVB/N wild type ESCs cultivated in 
presence of LIF and STAT3 overexpressing transgenic ESCs cultivated in presence of tamoxifen and 
identified potential new STAT3 target genes.  
 
This study was published in 2008. The paper (Cinelli, P.; Casanova, E. A.; Uhlig, S.; Lochmatter, P.; 
Matsuda, T.; Yokota, T.; Rülicke, T.; Ledermann, B. & Bürki, K. (2008). Expression profiling in 
transgenic FVB/N embryonic stem cells overexpressing STAT3. BMC Dev Biol, 8, 57) is reprinted 
and attached at the end of this Thesis (Annex 1). 
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1.2 Pramel7 mediates LIF/STAT3 dependent self-renewal in embryonic stem cells 
 
The central role of the LIF/STAT3 pathway in maintaining pluripotency in ESCs cultures has been 
repeatedly demonstrated in the last years (Cinelli et al., 2008; Hall et al., 2009; Matsuda et al., 1999; 
Schoonjans et al., 2003; Yang et al., 2010). Nevertheless, only few STAT3 target genes have been 
identified. 
 
In our previous work we identified a set of genes with differential expression upon STAT3 
overexpression. The generated transgenic cells possessed characteristics typical of pluripotent ESCs 
and showed germline transmission. These properties were not present in the wild type ESCs. We 
therefore reasoned that some of the genes differentially expressed in the transgenic cells might play a 
role in controlling pluripotency.  
 
We concentrate our efforts on the Pramel7 gene, which was found to be upregulated in the FVB/N 
transgenic ESCs (Cinelli et al., 2008). In parallel we analyzed another member of the Pramel family, 
the Pramel6 gene, which was also upregulated in the previous microarray study. 
We first addressed the question whether Pramel7 and Pramel6 are involved in maintaining ESCs 
pluripotent. For this purpose we generated clones overexpressing one or the other gene and cultivated 
these cells in the absence of LIF. The sole overexpression of Pramel7 upon withdrawal of LIF was 
able to sustain self-renewal in ESCs. On the contrary, Pramel6 seemed not to play a central role in 
maintaining ESCs undifferentiated. We therefore further extensively investigated the function of 
Pramel7 only.  
Knock down experiment for Pramel7 induced clear differentiation of wild type ESCs, despite the 
presence of LIF in the medium. Moreover, also in STAT3 overexpressing cells the silencing of 
Pramel7 induced differentiation of the ESCs, confirming the importance of this gene in maintaining 
ESCs in a self-renewing and undifferentiated state. Of importance, Pramel7 overexpression 
completely abolished differentiation of ESCs.  
Furthermore, we demonstrated that Pramel7 transcription is directly controlled by STAT3 
transcription factor. Interestingly, we found that the LIF/PI3K pathway, through the activation of the 
GSK3β, is involved as well in regulating Pramel7 transcription. This finding showed for the first time 
a common target of both LIF/STAT3 and LIF/PI3K pathways.  
 
These results have been published in Stem Cells Journal. The paper (Casanova E. A.; Shakhova O.; 
Patel S. S.; Asner I. N.; Pelczar P.; Weber F. A.; Graf U.; Sommer L.; Bürki K. and Cinelli P. (2011). 
Pramel7 mediates LIF/STAT3 dependent self-renewal in embryonic stem cells. Stem cells 29(3):474-
85.) is reprinted and attached at the end of this Thesis (Annex 2). 
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2. Cross-species genome wide expression analysis of late mouse 
and rat preimplantation embryos 
 
The molecular events that take place during mammalian preimplantation development represent a 
good model for studying regulatory networks that determine cell fate decisions. Of particular interest 
is the switch between morula and blastocyst stages, the first differentiation event of embryogenesis, a 
period where pluripotent cells are formed. Understanding how this population of cells is generated and 
maintained is of fundamental importance also for understanding the molecular mechanisms that 
control pluripotency in ESCs.  
 
As mentioned in the Introduction part of this Thesis, the rat represents in many research fields an 
optimal animal model for studying human diseases. Nevertheless, the lack of pluripotent rat ESCs for 
many years bound the researchers to work with mouse models, where indeed ESCs were available. 
Only recently, almost 30 years after the establishment of the first murine ESC line, genuine rat ESCs 
have been generated (Buehr et al., 2008; Li et al., 2008). Nevertheless, these cells have to be cultivated 
under different conditions compared to the murine ESCs, and seem to be more sensitive to 
differentiation stimuli. Thus, murine ESCs differ from the rat ESCs in their molecular mechanisms.  
 
We reasoned that a comparison of the whole genome expression in the late preimplantation embryo 
stages could be of advantage for elucidating the molecular mechanisms involved in the generation and 
maintenance of the pluripotent cells. Moreover, we aimed at the identification of similarities and 
differences in the gene regulation between the mouse and the rat preimplantation embryos, which 
could explain the differences observed in vitro for the ESCs between the two species. Therefore, we 
isolated morula, blastocyst, and ICMs from both the species and we performed microarray analysis.  
 
We first performed a general investigation of the gene expression in the two species separately. We 
then investigated and compared the gene expression in the mouse and in the rat for genes involved in 
11 signaling pathways, that we selected from GeneGo. Moreover, we performed a cross species 
analysis also with 11 families of genes known to be important during development as well as in the 
maintenance of pluripotency.  
 
With this study we were able to show for the first time that many molecular processes as well as 
signaling pathways are strongly differentially regulated in the mouse and in the rat morula and 
blastocyst. The knowledge that important factors are differentially expressed in the mouse and in the 
rat ICM, for instance, could be of advantage for improving the derivation and maintenance of rat 
ESCs.  
 
These results have been recently submitted. The manuscript (Casanova Elisa A.; Okoniewski Michal 
J.; Cinelli Paolo. Cross-species genome wide expression analysis of late mouse and rat 
preimplantation embryos) is attached at the end of this thesis (Annex 3). 
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C. DISCUSSION AND OUTLOOK 
 
Due to the fundamental characteristics of ESCs, developmental biology, regenerative medicine and 
cancer biology are more and more interested in understanding the molecular mechanisms controlling 
stem cells. Even though a lot of efforts have been made in the past years to elucidate the factors that 
regulate stem cell self-renewal and pluripotency, the precise mechanism of how these processes are 
regulated remains largely unknown. The identification of new genes responsible or involved in the 
maintenance of pluripotency will be of advantage not only for a better understanding of how 
pluripotency is maintained but also for improving the establishment of ESCs from non-permissive 
strains and species.  
Moreover, a major goal of ESC research is to elucidate the decision-making processes in lineage 
commitment and cell type differentiation of pluripotent cells. Therefore, understanding and controlling 
cell fate determination remains a major challenge for the efficient in vitro analysis of gene function 
but also for defining which conditions are optimal for prolonged cultivation of robust pluripotent 
ESCs.  
As mentioned before, for many years the empiric approaches based on experience with mouse ESCs 
have not resulted in the establishment of stable rat ESC lines. Therefore, we have become interested in 
the analysis of the molecular pathways connected with pluripotency in ESCs in order to isolate factors 
that could be useful for improving the establishment and the stabilization of ESCs from non-
permissive mouse strains and from the rat.  
 
This work was divided into two major projects: The first was an analysis of new identified genes 
involved in the maintenance of pluripotency in murine ESCs; the second project was a whole genome 
study of preimplantation embryos from the mouse and the rat. Both projects aimed at dissecting the 
molecular mechanisms that regulate pluripotency, the first in vitro in the ESCs whereas the second in 
vivo in the morula and blastocyst stage embryos.  
 
1. Functional characterization of newly identified pluripotency-
related genes in ESCs (Project 1) 
 
The starting point for this project was the demonstration that the activation of the LIF/STAT3 pathway 
during the cultivation of blastocysts supports ICM outgrowth and clearly favours the establishment of 
new ESC colonies in the non-permissive FVB/N mouse strain (Cinelli et al., 2008). Interestingly, the 
expression of the classical pluripotency markers (OCT3/4, SSEA-1, and alkaline phosphatase) was 
similar in the transgenic FVB/N ESCs and in the wild type FVB/N ESCs. Nevertheless, only the 
transgenic cells were able to participate to the embryo development and show germ line transmission, 
indicating that they were authentic pluripotent ESCs (Cinelli et al., 2008). Even though these lines of 
evidence establish STAT3 as an essential component of the LIF-dependent self-renewal in ESCs, the 
downstream target genes of activated STAT3 had remained elusive.  
Due to the pluripotent characteristic of the transgenic FVB/N ESCs, not observed in the wild type 
cells, a microarray study was performed in order to identify new potential STAT3 target genes. The 
differentially expressed genes obtained from this study represent potential critical factors involved in 
the determination of the pluripotent state.  
 
Thus, the aim of this part of the study was to analyze the function of selected genes, which were 
differentially regulated in the STAT3 overexpressing cells (Cinelli et al., 2008). The overexpression of 
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genes that are considered potential partners in maintaining and stabilizing pluripotency in cultured 
ESCs is a powerful tool for elucidating their function. Therefore, based on preliminary results and 
because their function was largely unknown, we generated ESCs overexpressing either the gene 
Pramel7 or Pramel6 for elucidating their role in the maintenance of pluripotency in ESCs.  
 
Pramel7 and Pramel6 are part of the Pramel family that contains a large number of members, with 
temporal and spatial expression highly restricted to well-defined stages of the preimplantation 
embryonic development. These genes are similar to the preferentially expressed antigen in melanoma 
(PRAME) protein and are therefore named as PRAME-like (Pramel) genes. 18 PRAME-like genes and 
15 pseudogenes were predicted in the orthologous region of mouse chromosome 4 (Birtle et al., 2005). 
Members of the Pramel family are also the oogenesins, which are specifically expressed in the oocyte 
(Dadé et al., 2003) but they have been detected also in the nuclei of the late one-cell- to early two-cell 
stage embryos (Minami et al., 2003). The expression of the Pramel4 gene for instance is restricted to 
the 8-cell stage and disappears almost completely in the blastocyst (Zeng et al., 2004), whereas the one 
of Pramel3 is detected only in the two-cell stage embryos.  
The expression of Pramel6 and Pramel7 is restricted to the preimplantation embryos (Bortvin et al., 
2003). Precisely, Pramel6 is expressed in all the cells of the morula and blastocyst, whereas the 
expression of Pramel7 is restricted to the inner cells of the morula and to the ICM cells of the 
blastocyst (Cinelli et al., 2008). Thus, a large body of evidence suggests that the members of the 
Pramel gene family might play in vivo a role in orchestrating the switch between the different 
preimplantation developmental stages.  
The expression patterns in vivo of Pramel6 but especially of Pramel7, in addition to the fact that both 
are upregulated in ESCs upon STAT3 overexpression (Cinelli et al., 2008), makes these genes 
interesting candidates for the analysis of their function in the maintenance of pluripotency in ESCs.  
 
Our results demonstrate that Pramel7 is a new direct STAT3 target gene, fundamental for the LIF-
mediated maintenance of pluripotency and for the inhibition of differentiation (Casanova et al., 
2011b). The JAK/STAT3 pathway was shown to be essential and sufficient in mouse ESCs to mediate 
LIF signals thereby contributing to the maintenance of pluripotency (Matsuda et al., 1999; Smith et al., 
1988). Even though a complete bypass of LIF signaling is possible under certain circumstances (Ying 
et al., 2008), optimal self-renewal is obtained by combination of LIF and 2i. These observations 
together with our findings confirm the LIF/STAT3-pathway as an essential component in ESCs. 
This is of interest also because overexpression of Pramel7 completely abolishes the capability of ESCs 
to differentiate in vitro as well as in vivo (Casanova et al., 2011b). Curiously, the overexpression of 
Nanog in ESCs does not impair the generation of teratomas composed from all the derivatives of the 
three germ layers (Casanova et al., 2011b), leading to the assumption that these two genes act 
differently in the processes that regulate pluripotency. Taken together, our data demonstrated that 
Pramel7 represents a central and essential knot in the signaling network regulating pluripotency and 
self-renewal in ESCs.  
 
However, although we were able to confirm that Pramel7 is a direct new target of STAT3 and actually 
that the LIF/STAT3 mediated maintenance of pluripotency is highly Pramel7 dependent, the exact 
mechanisms of function of this gene remain elusive. 
We have elaborated a hypothetical mechanism (Fig. 8), in which STAT3 together with the kinase 
GSK3β drive the expression of Pramel7 (Casanova et al., 2011b). Moreover, the fact that upon forced 
expression of Pramel7 ESCs fail to differentiate and under some conditions die, lead to the assumption 
that Pramel7 transcription has to be strictly regulated in vitro. The biological function of Pramel7 and 
the mechanisms by which this protein is able to maintain pluripotency in ESCs are still unknown. Our 
data indicate that Pramel7 could maintain pluripotency through direct repression of differentiation by 
preventing the phosphorylation of the ERK protein (Fig. 8). Nevertheless further analyses will be 
necessary to confirm these observations. 
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Fig. 8: Hypothetical transcriptional mechanisms, which drive Pramel7 expression. Schematic representation of 
Pramel7 transcription directly controlled by the LIF/STAT3-pathway but also by the LIF/PI3K-pathway. 
LIF/gp130 receptor leads to the activation of three different pathways: the LIF/STAT3, the LIF/PI3K/GSKβ3 
and the LIF/MEK/ERK-pathway. Pramel7 transcription is directly controlled by the transcription factor STAT3 
whereas its phosphorylation is probably regulated by the GSK3β kinase. The combinatorial effect of LIF/STAT3 
and GSK3β drives and controls Pramel7 transcription, which in turn blocks phosphorylation of ERK and 
therefore ESCs differentiation. (From Casanova et al., 2011b) 
 
 
Even though in the past years many different key factors could be identified, how they interact with 
each other and control the pluripotent cell identity is still largely unknown. Search for recognizable 
domains in the ORF of Pramel7 revealed the presence of leucine-rich repeats (LRRs). The presence of 
LRR domains and the fact that aminoacid sequence analysis did not reveal the existence of any 
conserved domains typical for transcriptional factors indicates that the Pramel gene family might not 
directly regulate gene transcription but rather act via protein-protein interaction. It was therefore 
decided to identify possible interaction partners of Pramel7 by a yeast two- hybrid screen. Bait 
containing the full-length sequence of Pramel7 fusioned to LexA was generated and used to screen an 
ESC library specifically prepared for this analysis. Three independent clones could be isolated, all 
containing the coding sequence of Uhrf1.  
The Uhrf1 gene encodes a member of RING-finger E3 ubiquitin ligase and was shown to be involved 
in processes like genome methylation (Karagianni et al., 2008) and histone modifications (Citterio et 
al., 2004). Furthermore, Uhrf1 was shown to directly target different promoters and regulate the 
protein expression levels of cell cycle regulators like pRB (Jeanblanc et al., 2005). 
 
The result obtained from the yeast two- hybrid screen generated a large body of open questions and 
possible hypothesis about the function of Pramel7 and its involvement in epigenetic processes. These 
topics are now further analyzed in the laboratory.  
 
In conclusion, our data show that the combined activity of STAT3 and GSK3β controls Pramel7 
transcription, which in turn regulates the phosphorylation of ERK leading to the inhibition of ESC 
differentiation. Accordingly, Pramel7 ablation causes ESC differentiation, whereas its overexpression 
sustains long-term self-renewal in the absence of LIF. These observations prove Pramel7 as an 
essential factor of the signaling network regulating pluripotency and self-renewal in ESCs (Casanova 
et al., 2011b). 
Nevertheless, further analyses aimed at the characterization the mechanisms involved in the Pramel7-
dependend maintenance of pluripotency in ESCs are needed.  
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The gene expression analysis performed in the STAT3 overexpressing ESCs highlights the differential 
expression of other interesting genes, which might contribute in the maintenance and stabilization of 
pluripotency in ESCS. One promising candidate is the gene Pem/Rhox5, which was upregulated in 
ESCs upon STAT3 overexpression (Cinelli et al., 2008). Its expression in vivo is restricted in the 
morula and the whole blastocyst stage embryos and after implantation it is restricted to the 
extraembryonic tissues. Furthermore, Pem/Rhox5 was shown to be expressed in ESCs, primordial 
germ cells and teratocarcinoma cells (Payer et al., 2003).  
Similar to Pramel7, the overexpression of Pem/Rhox5 in ESCs is sufficient for maintaining the cells in 
a self-renewing and undifferentiated state in the absence of LIF in the medium (Cinelli et al., 2008). 
This is in accordance with a previous study where it was shown that embryoid bodies overexpressing 
this gene were not able to differentiate (Fan et al., 1999). Interestingly, the same authors declared that 
teratomas generated from ESCs overexpressing Pem/Rhox5 consisted in only undifferentiated 
embryonal carcinoma-like cells. In contrast to this study, we obtained out of four injections into 
NOD/SCID mice of Pem/Rhox5 overexpressing cells, only one teratoma that contained differentiated 
tissue similar to the teratomas obtained from the wild type ESCs (Casanova et al., 2011b). Thus, 
Pem/RHox5 overexpressing cells show at least to some extent a similar differentiation defect like the 
Pramel7 overexpressing cells. Nevertheless, this experiment should be repeated in order to clarify the 
function of Pem/Rhox5 in differentiation processes. Two previous studies suggested different potential 
function of this gene. One hypothesis is that Pem/Rhox5 first helps to maintain the undifferentiated 
state of the cells, and in a second step promotes a defined cell population of undifferentiated stem cells 
for differentiation into extra embryonic lineages (Fan et al., 1999). Another group proposed an 
alternative mechanism of function in which Pem/Rhox5 directs early differentiation to specific 
lineages, but does actively maintain the undifferentiated state (Sasaki et al., 1991).  
In sum, the clarification of the function of Pem/Rhox5 in the maintenance of pluripotency needs 
further analysis. 
 
The ESCs overexpressing Pem/Rhox5 in a constitutive manner are already available in the laboratory. 
These cells can be further analyzed in a similar way as for the Pramel7 overexpressing cells. Upon 
Cre-recombination the overexpression of Pem/Rhox5 can be reduced to the wild type level. This 
analysis would allow the clarification if ESCs maintained only through the overexpression of 
Pem/Rhox5, in the absence of LIF, retain their pluripotent potential upon injection into a blastocyst. 
Furthermore, also available in the laboratory are transgenic mice generated in previous works which 
express in a tamoxifen-inducible manner Pem/Rhox5. By using the two systems available in the 
laboratory, the clarification of the function of Pem/Rhox5 can be analyzed both in vivo, during 
embryogenesis, but also in vitro, in ESCs. Furthermore, the analysis could be performed in parallel in 
mouse as well as in rat ESCs.  
 
2. Cross-species genome wide expression analysis of late mouse 
and rat preimplantation embryo development (Project 2) 
 
The aim of this project was to identify differentially regulated mechanisms in the mouse and the rat 
morula and blastocyst stage embryos with the purpose of increasing the knowledge about the 
regulation of pluripotency in rat ESCs.  
 
In the year 2007, when we started this project, it was not possible to establish authentic rat ESCs. 
Moreover, all the attempts to generate rat ESCs by using culture conditions established for murine 
ESCs failed. Only one year later (2008) the first report was published where it was demonstrated the 
generation of pluripotent rat ESCs by using the 2i culture conditions (Buehr et al., 2008; Li et al., 
2008). Even though the 2i conditions are also used for establishing mouse ESCs, some discrepancies 
between the establishment of rat or mouse ESCs are still present. In fact, rat ESCs are successfully 
generated with the 2i conditions only when feeders and LIF are present. These prerequisites are not 
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necessary for establishing murine ESCs, which are routinely cultivated and established in feeders- and 
LIF-free conditions. Thus, even these findings corroborated the hypothesis that on the molecular level 
pluripotency is regulated in a different way in the two species. Since in vivo pluripotent stem cells 
transiently exist only in morula and blastocyst stage embryos, we considered these cells as a reliable 
source for gaining insight into the molecular processes that regulate pluripotency in the mouse and in 
the rat. 
 
The first part of this project was to isolate morula and blastocyst stage embryos from both species, and 
with part of the blastocysts to perform immunosurgery in order to separate the ICM from the 
trophoblast cells. Moreover, the pool of collected embryos had to be large enough to allow the 
extraction of sufficient amounts of RNA for performing the microarray analysis.  
In the case of the isolation of the mouse embryos we could superovulate the females so that with high 
efficiency we reached the adequate number of embryos in a reasonable period of time. To mention is 
the fact that embryos were isolated weekly and then stored at -80°C till the final numbers of embryos 
were collected. The major problem was to preserve the RNA present in the embryos during the whole 
“collection time” in a good manner, in order to then isolate high quality RNA for the microarray 
analysis.  
As mentioned before, for the mouse females an established protocol was available so that we could 
collect the embryos in a short time, and after adjusting the storing conditions, we were able to extract 
an adequate amount of RNA in a good quality.  
In contrast, the collection of the rat embryos took longer time compared to the same procedure 
performed for the mice. Initially, we followed a previously established protocol in the laboratory used 
for superovulating rat females (i.p. injections of 15IU pregnant mare’s serum gonadotropin (PMSG) 
and 15IU human chorionic gonadotropin at 48h intervals). Nevertheless, no embryo could be isolated 
observing this protocol. A possible explanation is that this protocol has been established for the 
collection of cumulus–oocyte complexes, a much more early stage compared to the morula and 
blastocyst stage we wanted to isolate. Moreover, the effect of the hormones used increase the number 
of mature oocyte but do not prepare the female for a real pregnancy, this means that the so-obtained 
embryos cannot implant into the uterus wall. For this reason also for the collection of mouse embryos, 
we used to isolate the embryos at the morula stage, just before they reached the uterus.  
 
We next followed a new protocol developed by Popova et al. (2005) but also in that case, although we 
were able to isolate morulae, we did not observe a real increase in the numbers of embryos. Moreover, 
the quality of the so-obtained embryos was very low. Thus, since we were not able to induce the 
oestrus of the females by using the superovulation technique, we recurred at the natural ovulation. The 
impossibility to superovulate the rat females had as a consequence that we sacrificed a larger numbers 
of rats for collecting all the embryos needed for the study. Moreover, the impossibility to induce the 
oestrus in the females caused a large delay in the accomplishment of the collection of all the rat 
embryos.  
Rat females were checked every afternoon for the oestrus by measuring the vaginal impedance, which 
fluctuates markedly across different phases of the cycle (Ramos et al., 2001). The females in oestrus 
were mated for 12h with the males, and the day after was considered as day E0.5 of pregnancy. 
Pregnant females were sacrificed either at day E4 or at day E4.5, the former for isolating morula and 
the latter for isolating blastocyst stage embryos. Due to the bigger size of the rat uteri, a larger volume 
of medium was used for flushing the embryos. This rendered the identification of the embryos much 
more difficult than in the case of the mouse.  
The collection of all the morula, the blastocysts, and the ICMs from the rat lasted for almost one year. 
Finally an adequate number of embryos was obtained and the quality of the extracted RNA was good 
as well, so that we could perform the microarray analysis also for the rat embryos. 
 
From our genome wide cross species analysis in the three cell populations (morulae, blastocysts, and 
isolated ICMs), we were able to highlight differential expression of important genes like β-catenin, c-
Myc, or Smad4 (see Casanova et al., submitted Manuscript). All of them are part of essential signaling 
pathways that play critical functions during the embryo development, and their differential regulation 
strongly affects the activation or inhibition of the pathways in which they are involved. Some of the 
genes identified with a differential expression in the two species are known to be important factors in 
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the maintenance of pluripotency in ESCs, like it is the case for instance for Sox2 or Stat3, and would 
therefore represent interesting candidate to further analyze in vitro in the rat ESCs.  
Moreover, our study represents also the first genome wide gene expression analysis in the morula and 
blastocyst of the rat and shows a new example of statistical approach for cross species analysis that 
could be applicable also for other species. The so-obtained data allows highlighting the species-
specific behaviour of genes within important pathways and families through the creation of own gene 
networks (Fig. 9).  
 
 
 
 
Fig. 9: Network of selected genes that show different expression patterns in mouse and rat in the comparison 
blastocyst versus morula. The graph has been created with GeneGo network editor tool (From Casanova et al, 
submitted Manuscript March 2011).  
 
 
The goal of this study, as mentioned before, was to highlight differences and similarities in the gene 
expression in the morula and the blastocyst from mouse and rat, in order to identify important genes 
involved in the maintenance of pluripotency in ESCs, and especially of rat ESCs.  
With the microarray analysis reported in the submitted manuscript, only the first part of the original 
goal is achieved. Actually, we were able to highlight differential regulation of important factors 
between the two species. However, these data represent only a preliminary analysis. In order to 
achieve the second goal of this project, namely increase the knowledge about the regulation of 
pluripotency in rat ESCs, a list of candidate genes have to be selected out of the obtained data. 
 
The interesting genes, which might encode for important factors involved in the stabilization and 
maintenance of pluripotency in the rat ESCs, should be selected on the basis of different criteria: 
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- Their expression in the morula and in the blastocyst of the rat. Like for Nanog or for Pramel7, 
genes exclusively expressed in the inner part of the morula and in the ICM cells of the 
blastocyst represent good candidates for a further analysis in ESCs.  
- The expression in vivo should be compared to the expression of the homolog in the mouse 
embryos. The expression at the RNA level can be drastically different or might be not, 
therefore an analysis on the protein level could be of advantage for clarifying differential 
regulations. 
- The present knowledge about the function of the selected genes should be critically analyzed. 
The interactions of the selected genes with important pathways should be considered as well 
(see Fig. 9). 
- Finally, of course the expression of the newly selected genes should be confirmed in the rat 
ESCs, and maybe, compared to the one observed in the mouse ESCs. In this case, the analysis 
of the function of the genes can be investigated by using the classical gain or loss of function 
analyses.  
 
The high throughput technologies is a constantly developing field, therefore gene chips containing the 
sequences of recently identified or mapped genes are regularly generated. In our study, in the case of 
the rat gene expression analysis, we noted that many genes were not mapped on the rat chip, excluding 
therefore a complete cross-species comparison. Some important genes might therefore not be present 
in the data obtained. An example of not mapped genes on the rat chip (but present on the mouse chip) 
is Pramel7.  
Nowadays, newly developed rat chips contain the sequences of Pramel7 and other newly mapped 
genes in the rat genome. Thus, these new chips could reveal the expression changes of a broader range 
of genes.  
 
In conclusion, this study represents a good starting point for further analysis aimed at the identification 
of new factors related to pluripotency in both species.  
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3. Outlook 
Although a number of valuable advances towards understanding the molecular mechanisms 
controlling and regulating pluripotency have been made, still many questions remain open.  
ESC lines that keep their pluripotency after transfection and selection procedures are essential for the 
introduction of selected targeted mutations into the germ-line of the model animals. Thus, the 
identification of new genes able to stabilize ESCs would represent an important step for the stem cell 
research.  
 
Concerning the first study reported in this Thesis, the identification of Pramel7 as a crucial factor in 
ESCs, represents a start for further analyses, not only focused on the role of Pramel7 but maybe also 
extended to other members of the Pramel family. Seen the selected temporo-spatial expression of the 
Pramel genes, elucidating their molecular functions in the preimplantation development would give 
important information about the regulation of developmental processes. The members of the Pramel 
family are highly conserved through the evolution; therefore an investigation and comparison of their 
expression and functions in the mouse and in the rat could for instance explain why the 
preimplantation embryo development is shifted in the two species. 
 
The results reported for Pramel7 in ESCs revealed that this gene plays a critical function in murine 
ESCs. Thus, the characterization of Pramel7 in rat ESCs would certainly be a next fundamental step to 
perform, in order to analyze if it could stabilize derivation and maintenance of rat cells. Preliminary 
data lead to assume a possible implication of Pramel7 in epigenetic processes. Since epigenetics is the 
power which drives a large part of the reprogramming mechanisms, a careful analysis of Pramel7 in 
the context of reprogramming (iPSCs) would give important information about its function.  
Of course, all the above-reported analyses could be extended to other members of the Pramel family, 
which might play important functions in the determination and generation of pluripotent cells. 
Understanding these mechanisms is essential because ESCs and iPSCs hold great promise for the 
therapeutic treatment of human diseases. 
 
The interaction of Pramel7 with Uhrf1 opens a number of questions regarding the molecular function 
of these proteins in ESCs. Answering these questions rendered indispensable the generation of 
antibodies against Pramel7, which are at the moment tested. The recently availability of Pramel7 
antibodies represents another usable tool for the characterization of this gene.  
 
The advent of the modern high throughput technologies will open new possibilities in understanding 
the mechanisms ruling cell fate. All this will lead to the discovery not only of new mechanisms and 
key players determining pluripotency, but also will allow expanding the knowledge how to drive 
controlled differentiation of pluripotent cells towards pure populations of precursors and terminally 
differentiated cells, by identifying the right signals and culture environments. 
 
The genome wide cross species analysis that we performed comparing the mouse and the rat morula 
and blastocyst, will allow the identification of new factors implicated in differentiation and 
pluripotency processes. The selected pool of genes should then be analyzed in vitro, in murine and rat 
ESCs. The generation of transgenic mouse and rat ESCs overexpressing those genes will answer the 
question about their involvement in the maintenance of pluripotency. Moreover, some of these new 
candidate genes could play a critical role in the stabilization of ESCs in both the species. The 
functional characterization of these genes might dramatically improve the establishment of authentic 
ESCs and iPSCs from different strains and from different species, in particular the rat.  
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Abstract
Background: The transcription factor STAT3 is a downstream target of the LIF signalling cascade. LIF
signalling or activation is sufficient to maintain embryonic stem (ES) cells in an undifferentiated and
pluripotent state. To further investigate the importance of STAT3 in the establishment of ES cells we have
in a first step derived stable pluripotent embryonic stem cells from transgenic FVB mice expressing a
conditional tamoxifen dependent STAT3-MER fusion protein. In a second step, STAT3-MER
overexpressing cells were used to identify STAT3 pathway-related genes by expression profiling in order
to identify new key-players involved in maintenance of pluripotency in ES cells.
Results: Transgenic STAT3-MER blastocysts yielded pluripotent germline-competent ES cells at a high
frequency in the absence of LIF when established in tamoxifen-containing medium. Expression profiling of
tamoxifen-induced transgenic FVB ES cell lines revealed a set of 26 genes that were markedly up- or down-
regulated when compared with wild type cells. The expression of four of the up-regulated genes
(Hexokinase II, Lefty2, Pramel7, PP1rs15B) was shown to be restricted to the inner cell mass (ICM) of the
blastocysts. These differentially expressed genes represent potential candidates for the maintenance of
pluripotency of ES cells. We finally overexpressed two candidate genes, Pem/Rhox5 and Pramel7, in ES
cells and demonstrated that their overexpression is sufficient for the maintenance of expression of ES cell
markers as well as of the typical morphology of pluripotent ES cells in absence of LIF.
Conclusion: Overexpression of STAT3-MER in the inner cell mass of blastocyst facilitates the
establishment of ES cells and induces the upregulation of potential candidate genes involved in the
maintenance of pluripotency. Two of them, Pem/Rhox5 and Pramel7, when overexpressed in ES cells are
able to maintain the embryonic stem cells in a pluripotent state in a LIF independent manner as STAT3 or
Nanog.
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Background
ES cell lines that maintain their pluripotency after trans-
fection and selection procedures are essential for the
introduction of selected targeted mutations into the
mouse germ-line. Pluripotent ES cells are established in
vitro from the inner cell mass (ICM) cells of explanted
blastocyst-stage embryos [1-3]. Murine ES cells are main-
tained in a pluripotent state by co-culturing with mitoti-
cally-inactivated feeder cells, such as embryonic
fibroblasts, and/or the addition of leukaemia inhibitory
factor (LIF: [4,5]). These ES cells can be maintained indef-
initely in the presence of LIF, and express markers of the
undifferentiated and pluripotent state, including the
POU-domain transcription factor OCT-3/4 (POU5F1), a
factor that is essential for the development of the ICM
(reviewed by [6]; [7]). Upon removal of LIF, the cells rap-
idly lose self-renewal capacity and differentiate into a vari-
ety of cell types. LIF belongs to the Interleukin-6 family of
cytokines and the members of this family have diverse
effects on a variety of cell types [8]. The shared usage of
signal transducers (i.e. gp130) in the multichain cytokine
receptor complexes clearly explains the functional redun-
dancies of these cytokines (reviewed by [9]).
The pathway by which LIF signalling acts to promote ES
cell self-renewal has been partially well studied (reviewed
by [10]). LIF signals via heterodimerization of the two
class I cytokine receptors, the low affinity LIF receptor
(LIFR) and the common subunit, gp130. The cytoplasmic
domain of gp130 contains several tyrosinase residues that
are phosphorylated by associated JAK (Janus kinase)
kinases after ligand-stimulated dimerization. Four of
these phosphorylated tyrosines have been identified as
putative interaction sites with the SH2 (Src homology 2)
domain of the transcription factor STAT3 (signal trans-
ducer and activator of transcription; [11]). Stimulation of
gp130 signalling in ES cells also phosphorylates SHP-2
(SH2-domain-containing tyrosine phosphatase) and
leads to activation of the mitogen-activated protein
(MAP) kinases ERK1 and ERK2 [12]. Inhibition of the
SHP-2/RAS/ERK pathway promotes self-renewal and sup-
presses differentiation and treatment of mouse ES cells
with the MAPK-inhibitor PD098059 [13] was shown to
enhance self-renewal [14].
Matsuda et al. (1999) have shown that activation of the
STAT3 transcription factor is sufficient to maintain mouse
ES cells in an undifferentiated state in the absence of LIF
[15]: An inducible transgene construct encoding the entire
STAT3 coding region fused to the mutated ligand-binding
domain of the estrogen receptor (STAT3-MER) was intro-
duced into ES cells. ES cells expressing the STAT3-MER
fusion protein maintained their undifferentiated state in
the presence of OHT and in the absence of LIF [15]. This
study highlighted the importance of STAT3 pathway in
maintenance of ES cell pluripotency in vitro. However, the
in vivo relevance of the LIF pathway is to date still not
clear; LIF expression can be detected in the trophectoderm
(TE) of the blastocyst whereas LIF receptor is expressed in
the ICM. However, neither LIF mutants [16] nor mutants
of the receptors LIFR [17,18] and gp130 [19] result in any
defects in the development of the ICM or early epiblast.
Recent evidence suggests that the LIF pathway is necessary
for survival of the mouse epiblast during diapause [20].
ES cell lines derived from different mouse strains exhibit
variable degrees of LIF dependency as demonstrated in
STAT3 gene targeting experiments by Raz et al. [21]. ES
cells heterozygous for a STAT3 mutation could only be
established from E14 cells (129P2/OlaHsd; [22]). Tar-
geted clones from other cell lines were invariably trisomic
for chromosome 11 that carries the STAT3 locus, and thus
retained normal levels of activated STAT3.
To date it is unclear if higher amounts of STAT3 in the
inner cell mass of blastocyst support the survival and der-
ivation of pluripotent ES cells, especially in so called non-
permissive mouse strains like FVB/N. The inbred mouse
strain FVB/N is widely used for the generation of trans-
genic animals [23], however only one germline compe-
tent ES cell line has been reported [24]. We therefore, in a
first step, generated FVB/N transgenic mice overexpressing
a tamoxifen inducible STAT3 (STAT3-MER). Our data
demonstrated that overexpression of STAT3 in the ICM of
the blastocyst supports the establishment of ES cells in the
FVB/N mouse strain. ES cell lines overexpressing STAT3-
MER were germline-competent whereas the only WT line
that we could establish was not germline-competent.
Recent studies have begun to identify key players involved
in the intracellular signal transduction pathways regulat-
ing stem cell renewal and proliferation. Several transcrip-
tion factors including the OCT-3/4 have been shown to be
essential to maintain pluripotency in the ICM, but none
had been shown to function independently of the LIF
pathway with exception of the newly identified home-
obox transcription factor Nanog, that directs pluripotency
in mouse ICM and mouse ES cells and functions inde-
pendently from LIF dependent STAT3 activation [25,26].
Nanog is detected in the ICM and early germ cells, as well
as in the ES and embryonic carcinoma (EC) cell lines
derived from these stages [25]. Overexpression of Nanog
relieves mouse ES cells cultured without feeder cells in the
presence of serum from dependence on LIF stimulation
for self-renewal whereas Nanog-deficient mouse ES cells
loose pluripotency and differentiate into extra embryonic
endoderm lineages [26].
We have further focused our study on the STAT3 pathway
in order to elucidate the differences between WT and
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STAT3 overexpressing embryonic stem cells. We per-
formed microarray-analysis comparing WT and STAT3-
MER overexpressing FVB/N ES cells and identified a pool
of genes that were differentially expressed. From the
microarray dataset, we screened for potential candidates
of pluripotency by their expression pattern in the early
preimplantation embryo. Among these, we confirmed
Pem/Rhox5 and Pramel7 as regulators of pluripotency
using functional studies: ES cells overexpressing Pem/
Rhox5 and Pramel7 were able to maintain typical pluripo-
tent ES cell morphology in the absence of LIF, as well as
the characteristic pluripotency-related markers SSEA-1
and Oct4 in a similar extent as Nanog which was used as
a positive control. This clearly demonstrates that these
two STAT3-pathway related genes are involved in the
maintenance of pluripotency.
Results
Generation of transgenic mice overexpressing STAT3-MER
We produced FVB/N transgenic mice overexpressing a
fusion protein composed of the entire coding region of
mouse STAT3 and the modified ligand-binding domain
(G525R) of the mouse estrogen receptor [15]. The modi-
fied ligand-binding domain binds the synthetic steroid
ligand 4-hydroxytamoxifen (4OHT) but not 17?-estradiol
[30]. The expression of the transgene is driven by a
chicken ?-actin promoter and therefore is expected to be
ubiquitously expressed. After injection of the construct
into the pronucleus of fertilized FVB/N eggs we obtained
seven positive founder animals. When crossed with wild-
type FVB/N partners, six of them showed germline trans-
mission. A multiple tissue analysis was performed, by
western blotting, in order to define animals exhibiting
ubiquitous expression (data not shown). Two of highest
STAT3-MER expressing lines (Tg741 and Tg743) were
selected for further experiments. Both transgenic lines
contained a single integration of the transgenic cluster and
were maintained in a hemizygous state by constant breed-
ing with WT FVB/N mice.
Overexpression of inducible active STAT3-MER enables 
the establishment of germline competent ES cells from 
FVB/N blastocysts
In order to test if the overexpression of STAT3-MER would
allow the establishment of germline competent ES cells
from the FVB/N mouse strain, morulae were flushed from
the uterotubal junction 3 days after mating and cultured
overnight in M16 medium (Sigma). Fully expanded blas-
tocysts were transferred onto MEF as described in "Meth-
ods". Full-grown ICMs were picked from the outgrown TE
and dissociated mechanically into groups of cells and
these aggregates reseeded onto embryonic feeder fibrob-
lasts. 3–4 days later, compact stem cell colonies could be
identified. Single colonies were dissociated as described
above and reseeded. Non-differentiating clonal lines were
further passaged and split after 2–3 generations for further
characterization. Embryos were cultivated in medium
containing either LIF or OHT. We were able to establish
both wild type and transgenic ES cell lines. However, even
if ICMs from WT embryos were able to outgrowth from
the TE in presence of OHT it was impossible to generate
ES cell colonies during the further steps of cultivation and
WT ES cells were only obtained when LIF was present in
the medium (Table 1). When using OHT-supplemented
medium without LIF 43–71% of the embryos from both
Tg741 and Tg743 transgenic lines yielded ES cell lines, all
of which were transgenic (Table 1). Because the mice used
were hemizygous for the transgene, and therefore only
50% of the embryos is expected to be transgenic, it is fair
to assume that we were able to derive ES cells from virtu-
ally all the transgenic embryos. These results strongly indi-
cate a supportive effect of active STAT3-MER on the
maintenance of pluripotent ES cells. The newly estab-
lished ES cell lines overexpressing STAT3-MER were culti-
Table 1: Establishment of FVB/N ES cells
Founder Line No Of embryos Medium Supplements No of ICM picked No of stem cell colonies Cell lines Transgenic
WT 15 LIF 8 (53%)* 5 (62%)** 5 -
15 OHT 4 (27%)* 0 (0%)** - -
741 28 OHT 23 (82%)* 10 (43 %)** 7 7 (100 %)#
743 28 OHT 14 (50%)* 10 (71 %)** 10 10 (100 %)#
741-F1 26 OHT 18 (69%)* 8 (44 %)** 8 8 (100 %)#
* percent ICM per plated embryo; ** percent colonies per picked ICM
# percent transgenic per cell lines
WT FVB/N or hemizygous FVB/N males carrying the STAT3-MER transgene (lines 741 and 743) were mated with WT FVB/N females. Blastocysts 
were cultivated either in presence of LIF or OHT. Outgrown ICM's were picked and cultivated till ES cell colonies were visible. Cells were tested 
for the presence of the transgene by PCR analysis. As expected it was possible to establish WT ES cells only in presence of LIF but not when OHT 
alone was added to the culture. Furthermore in presence of OHT both transgenic lines 741 and 743 generated ES cell colonies that were carrying 
the transgene. Because theoretically only 50% of the blastocysts were expected to be transgene it is to assume that the establishment frequency 
was almost 100%. After generation of germline competent chimera with the newly established 741 cell line hemizygous transgenic F1 animals were 
generated and mated with WT FVB/N females. In this breeding the establishment efficiency in presence of OHT was similar to one observed in the 
parental blastocysts indicating that the STAT3-MER induced stabilization is kept also in the F1 generation.
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vated further only in presence of OHT without LIF. In
order to confirm the pluripotency of these ES cells, karyo-
typically normal male cells from both transgenic lines
(Tg741 and Tg743) were injected into C57BL/6 host blas-
tocysts. Chimeric males were identified by the absence of
eye (pink) and coat (albino) pigmentation and mated to
wildtype FVB/N females. Germline transmission of the
FVB/N ES cell genome resulted in albino offspring (Figure
1D). None of the 5 FVB WT ES cell lines was able to pro-
duce chimeras when injected into C57BL/6 blastocysts
(data not shown). To confirm that overexpression of
active STAT3 supports the survival and derivation of
pluripotent ES cells also in the F1 generation, transgenic
germline F1 offspring from the line Tg741 were mated to
Characterization of the 743 transgenic ES cell lineFigure 1
Characterization of the 743 transgenic ES cell line. A. Phosphorylation/dephosphorylation analysis of Tyr705 in endog-
enous and transgenic STAT3. After 24 hours of LIF and OHT deprivation cells were cultivated till their homogenization in 
presence of either LIF or OHT. During LIF or OHT deprivation no changes in the protein expression levels could be detected, 
but after 24 hrs the Tyr705 residue of both transgenic and WT STAT3 was completely dephosphorylated. 10 minutes after 
addition of LIF the tyr705 residue of both STAT3 was phosphorylated whereas after addition of OHT complete phosphoryla-
tion was obtained only after 6 hrs. B. Dephosphorylation of Tyr705 was analyzed by eliminating LIF or OHT from respectively 
WT or 743 cells. Kinetics for the dephosphorylation were slower then for the phosphorylation, only after 48 hrs dephosphor-
ylation of WT Tyr705 was complete whereas complete dephosphorylation of STAT3-MER occurred only after 72 hrs. C. 
Nanog and STAT3 expression levels were tested by RTQ-PCR. Values are normalized with ?-actin and the values indicate fold 
changes compared to the WT. Both WT and 743 ES cell lines expressed Nanog and the transgenic 743 ES cells have an 
increased Nanog expression compared to WT. D. After injection of 743 in C57BL/6 host blastocysts a 50–60% chimera was 
generated. Littermates from the crossing of the chimera with a WT FVB/N female generated white littermates, 50% of which 
were hemizygous for the transgene, indicating germline competence of the 743 cell line.
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wildtype animals. Blastocyst stage embryos were isolated
and cultivated as previously described, if cultivated in
presence of OHT stem cell lines could be established from
44% of the embryos, all lines being transgenic (Table 1).
Characterization of the newly established FVB/N ES cells 
overexpressing STAT3-MER
The expression level of STAT3-MER in the ES clones
obtained from the line 743, was tested by western blot
(see Figure 1A and 1B). Upon LIF stimulation STAT3 is
phosphorylated on the tyrosine residue (Y705), dimerizes
and can bind DNA [31,32]. In order to test if OHT is able
to induce STAT3-MER phosphorylation FVB/N ES cells
expressing STAT3-MER were first deprived of LIF or OHT
for 24 hrs, after this time the Tyr705 residues of both the
endogenous STAT3 and STAT3-MER were completely
dephosphorylated. After the 24 hrs deprivation cells were
stimulated either with LIF or OHT for 10 minutes up to 24
hours and further cultivated in presence of LIF or OHT till
their homogenization. Cell extracts were separated by
SDS-PAGE, blotted and probed with anti-STAT3 and anti-
phospho (Y705) antibodies. LIF stimulation induced
tyrosine phosphorylation of both endogenous STAT3 and
STAT3-MER (Figure 1A). As previously observed [15],
endogenous STAT3 was rapidly phosphorylated whereas
phosphorylation kinetics of STAT3-MER were slower. In
ES cells derived from Tg743 stimulation with OHT
resulted in a strong tyrosine phosphorylation of STAT3-
MER, but only a limited phosphorylation could be
detected for endogenous STAT3 (Figure 1A). During the
24 hours of induction with either LIF or OHT expression
of Oct4 was confirmed (data not shown). Dephosphor-
ylation kinetic of Tyr705 was also analyzed by eliminating
LIF or OHT from the medium of respectively WT or 743
cells. Kinetics for the dephosphorylation were slower then
for the phosphorylation, only after 48 hrs dephosphoryla-
tion of WT Tyr705 was complete whereas complete
dephosphorylation of STAT3-MER occurred only after 72
hrs. Dose dependence for dephosphorylation could also
be observed. In ES cells derived from the Tg743 line,
expressing higher amounts of STAT3-MER, dephosphor-
ylation was slower compared to cells derived from the
lower expressing Tg747 line (data not shown).
ES cells overexpressing STAT3-MER express the typical 
ES-cell markers
ES cells, as well as cells of the ICM of mouse blastocysts,
express a panel of markers that are used to characterize
undifferentiated, pluripotent embryonic cells, between
them Nanog, alkaline phosphatase, OCT-3/4 and SSEA-1
are the most typically used. Nanog expression was tested
by RTQ-PCR; both WT and 743 ES cells expressed Nanog
and a light overexpression could be detected in the 743
cells if compared with WT cells after normalization with
the housekeeping gene ?-actin (Figure 1C). The expres-
sion of the transcriptional factor OCT-3/4 and the surface
marker SSEA-1 was tested by immunohistochemistry (Fig-
ure 2A); WT FVB as well as both transgenic lines 743 and
741 expressed both markers. Furthermore, all three cell
lines expressed the marker alkaline phosphatase (Figure
2B). In all cases the expression was restricted to the ES
cells and no signal could be detected in the inactivated
fibroblast used as feeder cells.
Microarray analysis
Even though it was possible to establish WT FVB ES cells
in presence of LIF and these cells express the typical mark-
ers for ES cells they were not able to generate chimeric
mice. This suggests that overexpression of STAT3-MER
could increase the level of pluripotency in FVB ES cells. In
order to understand the difference between the WT cells
and the germline competent 743 cells we decided to com-
pare the gene expression profiles of both lines. We com-
pared three independently cultivated dishes of WT FVB
cells cultivated in the presence of LIF with three independ-
ently cultivated dishes of the transgenic 743 cells overex-
pressing STAT3-MER cultivated in the presence of OHT.
Total RNA was isolated and an expression analysis was
performed by hybridizing U74v2 Affymetrix chips con-
taining probes covering the complete mouse transcrip-
tome (36'000 transcripts). Analysis was performed with
dCHIP by using both the PM/MM (perfect match/mis-
match) difference model and the PM (perfect match) only
model in order to compare the results [33]. Genes show-
ing expression changes higher then 1.5 fold were consid-
ered. As control, we first confirmed that the
overexpression of STAT3-MER in the 743 line was 33
times higher than in the WT cells. We further identified a
set of 26 differentially regulated genes, 13 were upregu-
lated (Table 2) whereas 13 were downregulated (Table 3).
In situ Hybridization
In a first step we analyzed which of the differentially
expressed genes had already previously been described in
the literature to be expressed during preimplantation
mouse development and therefore potentially play a role
in maintenance of pluripotency. Eight genes out of the 26
identified were considered as candidates to have a poten-
tial function in determination and maintenance of
pluripotency in ES cells. For these genes in situ hybridiza-
tion was performed in order to define the regions of pre-
implantation embryos in which they were expressed. The
temporo-spatial expression was analyzed by whole mount
in situ hybridization of morulae and blastocysts. Four
genes, Pramel7, Lefty2, Protein Phosphatase 1 regulatory
subunit 15B and hexokinase II were expressed only in the
central part of the morula and in the ICM of the blastocyst
(Figure 3A). The other five genes, Pramel6, Eif2s2, Pem/
Rhox5, Dppa3 and Skp2 were found to be expressed in all
cells of the morula and blastocysts (Figure 3A). Because
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Immunohistochemical analysis of WT, 741 and 743 ES cell linesFigure 2
Immunohistochemical analysis of WT, 741 and 743 ES cell lines. All three cell lines express the nuclear marker OCT-
3/4 and the surface marker SSEA-1 (A) and alkaline phosphatase (B). The expression of all markers was restricted to ES cells. 
Mouse fibroblast used as feeder cells are negative for OCT-3/4, SSEA-1 and alkaline phosphatase. Scale bar in both large and 
small panels: 100 ?m.
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the Pramel7 expression was restricted to the central part of
the morula and in the ICM of the blastocyst, a more exact
analysis of the preimplantation stages was performed
(Figure 3B). Expression of Pramel7 starts at the compacted
morula stage, no expression could be detected in earlier
developmental stages indicating that this gene fulfils the
requirements for being a potential candidate involved in
maintenance of pluripotency. A similar expression pattern
can be observed for Nanog [25].
Overexpression of Pem/Rhox5 and Pramel7 is sufficient for 
maintenance of ES cells in the absence of LIF
In order to test if Pramel7 is able to maintain pluripotency
without direct activation of the STAT3 cascade through LIF
the full-length cDNA of Pramel7 was inserted in the pflox-
edNanog vector (see Chambers et al., 2003) instead of the
cDNA of Nanog, and the vector was electroporated in E14
ES cells. In parallel the full-length cDNA of Pem/Rhox5
was also cloned in the same way into the pfloxedNanog
vector. Pem/Rhox5 was previously described to play a role
in maintenance of pluripotency, but it is not yet known if
it is transcriptionally regulated through STAT3. As a con-
trol for the experiments the pfloxedNanog vector itself
was also electroporated in E14 cells. All electroporated
cells were selected with puromycin and resistant colonies
were picked and expanded. After testing for the presence
of the vectors by PCR the positive clones were analyzed by
real time PCR and the clones with the strongest expression
were used for further experiments. In order to test for the
capacity of maintaining pluripotency in absence of LIF,
the cells were cultivated for 8 days without addition of LIF
to the medium. After 8 days in culture IHC was performed
in order to detect the expression of OCT-3/4, SSEA-1 and
alkaline phosphatase (Figure 4). E14 WT ES cells started
after 4 days to differentiate and showed the typical flat-
tened morphology of differentiating cells (data not
shown), after 8 days the cells were completely differenti-
ated and no longer expressed OCT-3/4 and SSEA-1.
Nanog overexpressing cells as expected maintained their
pluripotent state also in absence of LIF. Both Pramel7 and
Pem/Rhox5 overexpressing clones showed a similar
behaviour as Nanog overexpressing cells. The colonies
maintained the typical round shaped morphology and
expression of OCT-3/4 and SSEA-1 was present indicating
that these two genes were able to maintain pluripotency
also in absence of LIF.
Table 2: Upregulated genes
Probe set Identifier RefSeq Chr MM/PM fold 
change
MM/PM p-value 
(t-test)
PM fold 
change
PM p-value 
(t-test)
RTQ-PCR fold 
change
98524_f_at X-linked myotubular 
myopathy gene 1 
(Mtm1)
NM_019926 X 1.87 0.018906 1.91 0.017234 n.d.
94375_at Hexokinase 2 (Hk2) NM_013820 6 1.6 0.018958 1.61 0.015899 1.79 ± 0.11
95545_at Insulin-like growth 
factor 1A (Igf1)
NM_010512 10 2.34 0.003079 1.6 0.007358 n.d.
98059_s_at lamin A (Lmna) NM_001002011 3 1.58 0.070634 1.47 0.035881 n.d.
95562_at Nuclear domain 10 
protein 52 (Ndp52)
NM_029755 11 2.66 0.065377 2.08 0.057843 6.72 ± 0.67
101368_at Reproductive 
homeobox 5 
(Rhox5/Pem)
NM_008818 X 1.68 0.029649 1.82 0.013529 3.64 ± 0.3
103470_at Pramel6 NM_178249 2 6.18 0.02356 4.14 0.027034 10.0 ± 0.37
93245_at Pramel7 NM_178250 2 3.51 0.051948 2.77 0.052927 8.51 ± 0.92
95609_at Protein phosphatase 
1, regulatory 
(inhibitor) subunit 
15b (Ppp1r15b)
NM_133819 1 1.6 0.024109 1.5 0.022545 1.56 ± 0.12
92232_at suppressor of 
cytokine signaling 3 
(Socs3)
NM_007707 11 1.75 0.053978 1.56 0.015837 2.34 ± 0.35
101449_at tripartite motif-
containing 41 
(Trim41)
NM_145377 11 - - 4.11 0.000819 1.07 ± 0.17
160365_at Eukaryotic 
translation initiation 
factor 2, subunit 2 
beta (Eif2s2)
NM_026030 2 1.98 0.040383 1.96 0.042002 1.80 ± 0.09
160420_r_at tubulin, alpha 3A 
(Tuba3a)
NM_009446 6 2.07 0.080906 1.93 0.078476 n.d.
Genes upregulated after STAT3-MER activation through OHT. Microarray values are given as fold changes ratios relative to normalization derived 
from dCHIP. 13 genes were found to be significantly upregulated when compared with WT FVB/N cells cultivated in presence of LIF. Only genes 
with a 1.5× fold increase were considered as significant. The mRNA expression levels (mean ± standard deviation, n = 3) of relative to FVB WT 
control cells were validated by real time PCR analysis, RTQ-PCR values are ratios relative to ?-actin (housekeeper gene) expression. For all 
selected genes measured, RT-PCR corroborated the rank order of magnitude of expression measured on the microarrays. Calculations were 
performed with both the PM/MM (perfect match/mismatch) difference model and the PM (perfect match) only model in order to compare the 
results.
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Discussion
ES cell lines derived from different mouse strains exhibit
variable degrees of LIF dependency and to date it was
unclear if higher amounts of STAT3 in the inner cell mass
of blastocyst could support the survival and derivation of
pluripotent ES cells in non-permissive mouse strains. Our
work indicates that the activation of the STAT3 pathway
during cultivation of blastocysts supports ICM outgrowth
and clearly favors the establishment of new ES cell colo-
nies in the so called non-permissive FVB mouse strain.
Even though we were able to establish WT FVB/N ES cells
in the presence of LIF these cells were not fully pluripotent
and were unable to generate chimeras. Only through the
overexpression of STAT3-MER cells we were able to estab-
lish germline competent FVB/N ES cells. Furthermore, in
presence of OHT both transgenic lines 741 and 743 gen-
erated ES cell colonies with a very high efficiency. Theoret-
ically only 50% of the blastocysts were expected to be
transgenic and this is also the establishment efficiency we
obtained. It is therefore fair to assume that the establish-
ment frequency was almost 100% (Table 1).
Interestingly no changes in the regulation of the classical
marker for pluripotent ES cells could be detected between
WT and 743 cells. Alkaline phosphatase, OCT-3/4, SSEA-
1 were correctly expressed in both wildtype and transgenic
ES cell lines (see Figure 2A and 2B). RTQ-PCR showed a
slight upregulation of Nanog in the 743 ES cells (Figure
1C). If this upregulation is due to a direct or an indirect
interaction with STAT3 has to be further analyzed. The dif-
ferent roles of the LIF pathways and of Nanog are yet not
very clear. ES cell populations are heterogeneous and it is
also known that Nanog is expressed discontinuously in
pluripotent cells in the embryo and it is therefore to
assume that Nanog and the LIF pathway interact to some
extent in controlling the different events that regulate
pluripotency and self-renewal. The recent findings of
Chambers et al. (2007) corroborate this hypothesis. The
authors demonstrated that Nanog expression was specifi-
cally required for both the formation of the ICM and of
the germ cells, rather than for the housekeeping machin-
ery of pluripotency embryonic, and that stem cells could
self-renew indefinitely in the permanent absence of
Nanog [34].
We were further interested in the identification of the
molecular changes induced through STAT3-MER overex-
pression. We therefore decided to identify STAT3-pathway
related genes by expression profiling. In general, there is
great interest in identifying the signature of stemness by
the constellation of genes that stem cells express. DNA
microarray technology allows the discovery of a large
number of genes that are thought to be the molecular sig-
nature of mouse ES cells. Recently, global transcription
profiles of undifferentiated ES cells and blastocyst have
been reported by several groups, most of these studies
were comparing differentiated versus undifferentiated
Table 3: Downregulated genes
Probe set Identifier RefSeq Chr MM/PM fold 
change
MM/PM p-
value (t-test)
PM fold 
change
PM p-value 
(t-test)
RTQ-PCR 
fold change
97283_at developmental pluripotency-
associated 3 (Dppa3)
NM_139218 6 -2.16 0.10982 -2.81 0.047749 -11.4 ± 1.51
133948_at Eukaryotic translation 
initiation factor 2C 4 (Eif2c4)
AI504948 17 -1.53 0.044727 -1.46 0.018363 n.d.
134566_at Left-right determination factor 
2 (Lefty2)
NM_177099 1 -2.7 0.029827 -2.32 0.025196 -2.35 ± 0.23
103389_at aminoadipate-semialdehyde 
synthase (Aass)
NM_013930 6 -2.07 0.077262 -1.71 0.100000 n.d.
167617_r_at transmembrane protein 109 
(Tmem 109)
NM_134142 19 -1.89 0.036619 -1.73 0.042999 n.d.
166131_at enabled homolog (Enah) NM_001083120 1 -1.55 0.008738 -1.46 0.016412 n.d.
138014_at nucleoporin 153 (Nup 153) NM_175749 13 -1.55 0.012282 -1.49 0.011324 n.d.
167824_f_at S-phase kinase-associated 
protein 2 (p45/Skp2)
NM_013787 15 -1.74 0.054672 -1.62 0.073491 -1.27 ± 0.03
100499_at syntaxin 3 (Stx3) NM_001025307 19 -2.09 0.033994 -2.03 0.036655 n.d.
166600_at KH domain containing, RNA 
binding, signal transduction 
associated 3 (Khdrbs3)
NM_010158 15 -1.66 0.027322 -1.52 0.035974 n.d.
93568_i_at 
93569_f_at
RIKEN cDNA 2610042L04 
gene
BC096548.1 14 -3.29 0.069938 -2.94 0.070848 n.d.
161004_at RIKEN cDNA 1700097N02 
gene
XM_001479022 17 -2.12 0.100000 -2.24 0.002726 n.d.
167843_f_at similar to RIKEN cDNA 
1110051B16 gene
XM_001472554 14 -2.71 0.004646 -1.81 0.003623 n.d.
Genes downregulated after STAT3-MER activation through OHT. 13 genes were found to be significantly downregulated when compared with WT 
FVB/N cells cultivated in presence of LIF. Only genes with a 1.5× fold decrease were considered as significant. The expression levels of selected 
genes were confirmed by real time PCR analysis. Calculations were performed with both the PM/MM (perfect match/mismatch) difference model 
and the PM (perfect match) only model in order to compare the results.
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In situ hybridization of the eight selected genesFigure 3
In situ hybridization of the eight selected genes. A. Dppa3, Eif2s2, Pem/Rhox5 and Pramel6 exhibited a general expres-
sion in all cells of the morula and of the blastocyst. Expression of Hexokinase II, Lefty2 and PP1s15B was restricted to the cells 
of the inner part of the morula and to the ICM in the blastocyst. Sense probes in the same concentration of the antisense 
probes were used as negative controls for the hybridization. B. In situ hybridization with a Pramel7 antisense riboprobe of pre-
implantation embryos (a: two-cell embryo, b: four-cell embryo, c: eight-cell embryo; d, e: compacted morula, f, g: blastocyst, h: 
negative control with sense riboprobe). Magnification 40×.
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cells [35-38]. In our study the FVB/N WT cells and the
FVB/N cells overexpressing STAT3-MER are very similar,
they just express different amounts of the transcription
factor STAT3 and therefore we assumed that they would
differentially regulate only a few genes. We compared
gene expression changes between FVB/N ES cells overex-
pressing activated STAT3 cultivated in the presence of
OHT and the absence of LIF and WT FVB cells cultivated
in the presence of LIF by microarray analysis and identi-
fied a group of 26 genes that showed significant differen-
tial expression. From this list we preselected interesting
genes by a careful literature and gene-expression databank
analysis and identified which genes were characteristically
expressed during the mouse preimplantation develop-
ment.
These genes can be attributed to different categories
according to their function: The first group contains regu-
latory members of the STAT3 pathway that are involved in
the regulation of downstream events of the JAK/STAT cas-
cade (like SOCS-3, protein phosphatase-1 regulatory sub-
unit 15B and Eif2s2), the second group of genes is
involved in the regulation of ES cell metabolism, whereas
the third group contains genes that are involved in
pluripotency maintenance and cell viability.
In the first group, among others, we found upregulation
of SOCS-3 in STAT3-MER overexpressing cells. SOCS3 is a
member of the suppressor of cytokine signalling (SOCS)
family which has been implicated in the negative regula-
tion of several pathways, in particular the JAK/STAT path-
way, which can in turn induce SOCS expression and form
a negative feedback circuit. The transcriptional upregula-
tion of SOCS-3 confirms that the functional overexpres-
sion of STAT3-MER induces the activation of the classical
LIF-dependent negative feedback mechanism (for a
review see [39]). Previously Duval et al. (2000) showed
that expression of SOCS-3, but not SOCS-1 and SOCS-2,
was stimulated in ES cells in presence of LIF. The author
further demonstrated that, uncontrolled overexpression
Immunohistochemical analysis of WT E14 ES cells and E14 overexpressing, Nanog, Pem and Pramel7Figure 4
Immunohistochemical analysis of WT E14 ES cells and E14 overexpressing, Nanog, Pem and Pramel7. IHC 
analysis with OCT-3/4 and SSEA-1 and staining for alkaline phosphatase were performed after cultivation of the cells for 8 days 
without adding LIF to the medium. E14 ES cells differentiated under these conditions and lost the expression of OCT-3/4 and 
SSEA-1 and alkaline phosphatase. Both Pem/Rhox5 and Pramel7 overexpressing cells maintained the expression of the pluripo-
tency markers. Nanog overexpressing cells, used as a control for the experiment, as expected maintained their pluripotency. 
Scale bar in both large and small panels: 100 ?m.
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of SOCS-3 leads to repression of LIF-dependent transcrip-
tion and severely reduces cell viability. This suggests that
the disturbance of a well-balanced SOCS protein content
has adverse effects on cell survival [40]. Since the FVB ES
cells overexpressing STAT3-MER were viable and pluripo-
tent, it is safe to assume that the SOCS-3 upregulation
observed in presence of OHT is a modulatory reaction due
to the overproduction of STAT3 in these cells. Through
this compensatory mechanism the cells are able to main-
tain a properly activated LIF signalling cascade. It seems
that the upregulation of SOCS-3 is a direct transcriptional
activation mediated through STAT3 because the promot-
ers of both mouse and rat SOCS-3 genes contain putative
STAT1/STAT3 binding elements, which are necessary and
sufficient for LIF-dependent activation of the SOCS-3 pro-
moter activity in reporter assays [41,42].
We also found protein phosphatase 1 regulatory subunit
15B (PP1rs15B) and the elongation initiation factor 2
subunit 2 (eIF2s2) to be among the upregulated genes.
PP1rs15B is a constitutively expressed inhibitory subunit
of PP1, one of the major eukaryotic serine/threonine
phosphatases. PP1rs15B dephosphorylates the ?-subunit
of eIF2 [43]. The microarray data confirm an upregulation
of both PP1rs15B and eIF2s2 indicating that these pro-
teins may be involved in the control of the STAT3 overex-
pression, whether these genes have a function in
maintenance of pluripotency is still unclear.
In the second group we found hexokinase II to be
increased in cells overexpressing STAT3, this confirms the
importance of this isozyme for embryo viability and indi-
cates that a correct energetic balance is extremely impor-
tant in the late stages of preimplantation and at the
beginning of postimplantation in the embryos.
The third group of differentially expressed genes com-
prises molecules involved in the maintenance of pluripo-
tency and cell viability. Some of the identified genes were
previously correlated with pluripotency [44] or with
embryo viability in somatic nuclei derived cloned blasto-
cysts [45].
Lefty2 is regulated by pathways such as Smad2/3 and
WNT and by OCT-3/4, which support stemness. Lefty is
also induced upon exit from the state of stemness, includ-
ing forced in vitro differentiation and LIF withdrawal.
When LIF is withdrawn, the expression of Lefty increases
within 48 hours of cytokine withdrawal [37]. Similarly,
retinoic acid that induces differentiation leads to
increased expression of Lefty in mouse embryonic carci-
noma cells [46]. Differentiation of stem cells to embryoid
bodies also leads to increased expression of Lefty in vitro
[47]. Therefore, Lefty might be important both to the
stemness and differentiation events that follow the exit
from this state.
Murine Pem/Rhox5 is an X-linked homeobox-containing
gene [48,44], whose homeodomain shares important
structural features with two other homeobox genes, which
are expressed in extra embryonic lineages and during sper-
matogenesis [49,50]. The Pem/Rhox5 protein is expressed
in the late morula stage, in TE and ICM of blastocyst and
after implantation in extra embryonic tissues, in the pari-
etal and visceral endoderm, but not in the primitive ecto-
derm derivatives. Pem/Rhox5 is also expressed in ES cells,
in primordial germ cells and in teratocarcinoma cell lines
[51]. Overexpression of Pem/Rhox5 had no phenotype in
ES cells, but completely inhibited differentiation into the
three primary cell lineages, when ES cells were cultured as
embryoid bodies in suspension without LIF [52]. Two dif-
ferent models of action for Pem/Rhox5 are possible. Fan
et al. (1999) suggested that Pem/Rhox5 first helps to
maintain the undifferentiated cell state, and in a second
step promotes a defined cell population of undifferenti-
ated stem cells for differentiation into extra embryonic
lineages [52]. Sasaki et al (1991) proposed an alternative
in which Pem/Rhox5 directs early differentiation to spe-
cific lineages, but does maintain actively the undifferenti-
ated state [44]. Our data are in line with previous studies
and indicate that Pem/Rhox5 plays an important role in
maintaining pluripotency of ES cells in absence of LIF
(Figure 4)
Furthermore, overexpression of STAT3-MER induced dif-
ferential expression of four genes (Dppa3, NDP52l1,
Pramel6, Pramel7) that were identified as a set of OCT-3/
4 related genes that were not correctly reactivated in
somatic nuclei derived cloned embryos and therefore rep-
resent genes that are necessary for embryo viability [45].
Dppa3 (developmental pluripotency-associated 3; Stella;
PGC7; Crg1) is preferentially expressed in primordial
germ cells, oocytes and preimplantation embryos. In blas-
tocysts, Dppa3 is expressed in TE and ICM and in the early
postimplantation embryos Dppa3 expression disappears.
The expression re-emerges when at day E7.5 the first pri-
mordial germ cells (PGCs) appear [53]. Dppa3 knockout
mice are compromised in development; some embryos
develop to the two or four cell stage, but fail to reach 8-cell
stage [45,54]. Dppa3 was proposed by Sato et al. to play a
role in germ line specification in mice by preventing nas-
cent germ cell populations from a somatic cell fate and by
retaining their pluripotency [53]. The embryonic function
of NDP52l1 (Nuclear dot protein 52) is to date unclear
but it is capable of forming dimers and contains leucine
zipper motifs indicating a possible function in splicing
processes [55].
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Pramel6 and Pramel7 (preferentially expressed antigen in
melanoma like 6 and 7) are prevalently expressed in pre-
implantation embryos and embryonic pluripotent cells
[45]. Our results confirm these expression patterns and
clearly show that whereas Pramel6 is typically expressed
in all cells of the morula and blastocyst, Pramel7 is
expressed only in the inner part of the morula and in the
ICM of the blastocyst. The function of the Pramel genes in
embryonic development is unknown, but interestingly,
PRAME inhibits retinoic-acid induced differentiation in
mouse embryonic carcinoma F9 cells [56]. Recently Kaji et
al (2006) showed that Pramel6 and Pramel7 expression is
mediated by Mbd3, a component of the nucleosome
remodelling and histone deacetylation (NuRD) complex
[57]. Kaji et al. proposed that the Mbd3/NuRD-mediated
silencing of Pramel6 and Pramel7 in ES cells offers an epi-
genetic environment in which Mbd3/NuRD is not abso-
lutely required but facilitates differentiation. Furthermore
the authors describe that Mbd3 deficiency leads to down
regulation of Dppa3 in ES cells. Taken altogether, expres-
sion pattern analysis suggests that Dppa3, Pramel6 and
Pramel7 are collaborating in deciding the fate of ES cells.
We were further interested in clarifying if some of the
identified STAT3-pathway related genes could individu-
ally maintaining pluripotency in ES cells. Pem/Rhox5 and
Pramel7 were chosen for this experiments: Pramel7
because of its characteristic expression pattern in the cen-
tral part of the morula and in the inner cell mass of the
blastocyst, an expression pattern which is very similar to
the one observed for Nanog [25] and is typical for a gene
involved in maintenance of pluripotency. Pem/Rhox5
because it was previously described in the literature as a
gene blocking the differentiation capacity of the ICM and
of ES cells [52,51]. Overexpression of Pramel7 and Pem/
Rhox5 in ES cells and cultivation in absence of LIF,
allowed the maintenance of pluripotency, as shown by
IHC with the typical pluripotency related markers OCT-3/
4 and SSEA-1 and with alkaline phosphatase staining,
indicating the importance of these proteins in maintain-
ing ES cells in a pluripotent state (Figure 4).
Conclusion
In summary the data presented here indicates that the
overexpression of functional STAT3-MER in FVB/N blast-
ocysts sustains and facilitates the establishment of germ-
line competent ES cells in absence of LIF. Our findings
open up the possibility of establishing germline compe-
tent ES cells from non-permissive mouse strains by
manipulation of the STAT3 signal transduction pathway.
Furthermore, gene expression analysis of these transgenic
cells cultivated in presence of OHT showed that 26 genes
were differentially expressed compared to WT cells culti-
vated in presence of LIF. By in situ hybridization analysis
it was possible to identify four up-regulated genes (Hex-
okinase II, Lefty2, Pramel7, PP1rs15B) whose expression
was restricted to the ICM of the blastocysts. Overexpres-
sion of two of the upregulated genes, Pem/Rhox5 and
Pramel7, in E14 cells and cultivation in absence of LIF
demonstrated that these two genes are able to maintain
the embryonic stem cells in a pluripotent state without
addition of LIF to the culture media.
Methods
Generation, Identification, and Maintenance of 
Transgenic Mice
The pCAGmusstat3ER plasmid containing the full length
sequence of murine STAT3 cDNA fused to the ligand-
binding domain of mouse estrogen receptor under the
control of the chicken ?-actin promoter [15] was propa-
gated in Escherichia coli DH5? and the minigene was
excised with NotI. The fragments were purified from a 1%
agarose gel with a Qiaquick extraction kit (Qiagen, Basel,
Switzerland) and processed as described. Nuclear injec-
tions into fertilized FVB/N oocytes were carried out by
conventional methods [27,28]. Transgenic founder were
identified by PCR using the ?-actin promoter specific
primer ggbactfor2: (5'-GGG TTC GGC TTC TGG CGT G-
3') and a STAT3 specific primer mmSTAT3back2: (5'-CCA
AGG TGC CAG GAA CTG CCG-3'). Two primers specific
for the TAG-1 gene (TAG82B: 5'-ACA CGA AGT GAC GCC
CAT CCG T-3'; TAG83F: 5'-GGA GGA GAG AGA CCC
CGT GAA A-3') were used as a positive control for both
wild-type and transgenic mice. ggbactfor2 and
mmSTAT3back2 generate a 397 bp band whereas TAG82B
and TAG83F generate a 300 bp product.
Cell culture
ES Cell Medium for FVB/N ES cells
KSR-KDMEM (Invitrogen) with 1000 units per ml human
LIF, KSR-KDMEM w/o LIF and KSR-KDMEM w/o LIF with
1 ?M 4-hydroxytamoxifen (OHT, Sigma).
ES Cell Medium for E14 ES cells
G-MEM (Sigma) containing 100 mM sodium pyruvate
(GIBCO), 10%FBS, 50 mM ?-mercaptoethanol and con-
taining 107 U/ml ESGRO murine LIF (Chemikon Int.).
Embryonic feeder fibroblasts (MEF)
were derived from explanted day 14 foetuses of CD-1-M-
TKneo strain mice [29]. Prior to co-culturing with ES cells,
confluent layers of MEF (passage 2) cells were treated with
mitomycin C (10 ?g/?l) for 2.5 hrs and extensively
washed. Growth arrested fibroblasts were used as feeder
cells for up to one week.
Embryo recovery, embryo culture, isolation of ES cell lines
Donor females of strains FVB/N (RCC Füllinsdorf, Swit-
zerland and Harlan Horst Postbus, Netherlands) were
induced to ovulate by an intra peritoneal injection of 5
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I.U. of PMSG (Pregnant mare serum gonadotropin, Folli-
gon, Intervet), followed 46 h later by an intra peritoneal
injection of 5 I.U. HCG (human chorionic gonadotropin:
Chorulon, Intervet). Subsequently, donor females were
mated with STAT3-MER transgenic male mice. Morulae
were flushed from the uterotubal junction 3 days after
mating and cultured overnight in M16 medium (Sigma).
Fully expanded blastocysts were transferred onto MEF in
KSR-KDMEM, KSR-KDMEM without LIF with 1 ?M OHT
or KSR-KDMEM without LIF and cultured at 37°C in an
atmosphere of 10 % CO2 in air for 6–7 days without
media changes. Full-grown ICMs were picked from the
outgrown TE and transferred into droplets of trypsin-
EDTA solution (Invitrogen) by a mouth-controlled glass-
capillary. The ICMs were dissociated mechanically into
groups of cells and these aggregates reseeded onto embry-
onic feeder fibroblasts. 3–4 days later, compact stem cell
colonies could be identified. Single colonies were dissoci-
ated as described above and reseeded. Subsequently, non-
differentiating clonal lines were partly frozen, partly pas-
saged onto 6 cm plates, and split after 2–3 generations for
further characterization.
Karyotype and Sex Determination of ES cell lines
For chromosome counts, ES cells were pre-treated for 3
hrs with colcemide (Sigma, 0.05 ?g/ml) and metaphase
spreads were prepared according to Triman et al. (1975).
Sex determination was carried out using primers specific
for the smcy (Selected Mouse cDNA on Y) a gene that
maps to the short arm of the mouse Y-chromosome and
its X-chromosome homolog smcx (Selected Mouse cDNA
on X). The primers bind to both homologues but amplify
fragments of different sizes on the X and the Y chromo-
some. Female cell lines exhibit a single band of 341 bp
whereas male cell lines exhibit 2 bands of 341 and 312 bp
respectively. The following primers were used: SMC4-1:
5'-CTG AAG CCT TTG GCT TTG AGC AAG CTA C-3';
SMCX-1: 5'-CAA AGA ATT TGG CAG CGG TTT CCC T-3'.
Generation of injection chimeras
C57BL/6 host embryos were recovered at the morula stage
from the oviducts of hormonally treated females and cul-
tured overnight (see above). Blastocysts were transferred
into drops of M16 medium (Sigma) and ES cells into
drops of HEPES-buffered ES-medium. About 10–15 ES-
cells were injected into each blastocyst. After a recovery
period of about 2 hrs, injected blastocysts were transferred
into the uterine horns of pseudo pregnant NMRI foster
mothers (Harlan, England). Chimeric offspring were
identified by the absence of coat color pigmentation. Chi-
meric males were set up to breed at the age of about 8
weeks.
Western Blotting
ES cell cultures were homogenized with RIPA buffer (50
mM Tris-Cl pH 7.4, 1% NP-40, 0.25% Sodium Deoxycho-
late, 150 mM NaCl). Protein concentration was deter-
mined with BCA-Method (Pierce). Samples were
subjected to SDS-PAGE and blotted onto PVDF mem-
branes (Millipore, Volketswil, Switzerland) at 100 V for
1–2 h at 4°C. Immunodetection and chemiluminescent
visualization were performed as recommended by the
supplier of the chemiluminescence blotting kit (Roche
Diagnostics, Rotkreuz, Switzerland). Anti STAT3 antibody
(C-20) was purchase from Santa Cruz Biotechnology,
anti-phospho (Y705) was purchased from New England
Biolabs.
Immunohistochemistry and alkaline phosphatase staining
For alkaline phosphatase staining the cells were washed
with CMF-PBS and fixed in 4% paraformaldehyde in PBS.
The cells were washed with PBT (PBS with 0.1% triton X)
and incubated in alkaline phosphatase buffer (100 mM
Tris-Cl pH9.5, 50 mM MgCl2, 100 mM NaCl) containing
the AP-substrates nitrotetrazolium-blue and X-phosphate
(Roche Diagnostics, Rotkreuz, Switzerland).
For immunohistochemistry the cells were washed in PBS
and fixed with 4% paraformaldehyde in PBS. Cells were
washed with PBT and incubated with the primary anti-
bodies diluted in PBT containing 2% (v/v) horse serum.
Secondary fluorescence labelled antibodies were used for
detection. Anti OCT-3/4 (N-19) antibodies were pur-
chased by Santa Cruz Biotechnology, SSEA-1 (Mouse
mAb) by Chemicon International and Alexa Fluor 488
anti mouse and Alexa Fluor 594 anti rabbit secondary
antibodies were purchased from Molecular Probes.
cRNA labelling and Hybridization of microarrays
cDNA synthesis 1st round of amplification
RNA was combined with 1 ?g of T7-dT primer (5'-GGC
CAG TGA ATT GTA ATA CGA CTC ACT ATA GGG AGG
CGG-(dT)24-3') in a total volume of 12 ?l and incubated
at 70°C for 10 min. The reaction was placed on ice and
the following reagents added in a total volume of 20 ?l:
first strand buffer (1×), DTT (10 mM), dNTP mix (500
?M), and Superscript III (200 units, Invitrogen) and incu-
bated at 42°C for 2 h. Second strand synthesis was per-
formed by adding the following reagents in a total volume
of 150 ?l: second strand buffer (1×), dNTP mix (200 ?M),
E. coli DNA ligase (10 units), E. coli DNA polymerase (40
units), RNase H (2 units), and incubated at 16°C for 2 h.
T4 DNA polymerase (10 units) was then added to fill in
the ends of the cDNA and incubated at 16°C for an addi-
tional 15 min. Following phenol:chloroform extraction
and ethanol precipitation, the cDNA was resuspended in
RNase-free water. Transcription was performed using
Ambion's (Austin, USA) MEGAscript reagents. A 20 ?l
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reaction containing cDNA, NTP mix (7.5 mM), reaction
buffer (1×), and 2 ?l enzyme mix was incubated at 37°C
for 4 h and the primary cRNA was purified using the RNe-
asy kit (Qiagen, Chatsworth, CA) per the manufacturer's
specifications. Two hundred nanograms of the purified
cRNA were then carried forward in the secondary amplifi-
cation. Samples with less than 200 ng cRNA were concen-
trated to a 5 ?l volume and the entire sample used for the
next round of amplification.
cDNA synthesis 2nd round of amplification
First-strand cDNA was synthesized by incubating the
above cRNA with 1 ?g of random primers (Invitrogen,
Carlsbad, CA) at 70°C for 10 min. The reaction was then
placed on ice and the following reagents added in a 20-?L
reaction: first-strand buffer (1×), DTT (10 mM), dNTP mix
(500 ?M), and Superscript III (200 units). The reaction
was incubated at 42°C for 2 h. RNase H (2 units) was
added to the reaction and incubated at 37°C for 20 min
and then heat-inactivated. The cDNA was combined with
1 ?g of the T7-dT primer and incubated at 70°C for 10
min. The reaction was then placed on ice and the follow-
ing reagents added for a final volume of 150 ?l: second-
strand buffer (1×), dNTP mix (200 ?M), E. coli DNA
Polymerase (40 units), and then incubated at 16°C for 2
h. T4 DNA polymerase (10 units) was added to fill in the
ends of the cDNA and incubated at 16°C for an additional
15 min. The cDNA was purified with phenol:chloroform
and precipitated with ethanol.
Biotin secondary IVT
The secondary transcription reaction was performed using
the Enzo BioArray HighYield RNA kit (Affymetrix, Santa
Clara, CA). The secondary cDNA was incubated at 37°C
for 4 h in a 40 ?l reaction as indicated by in the manufac-
turer recommendations and the labelled cRNA purified
using the RNeasy kit.
Array Hybridizations and Analysis
The hybridizations were performed with the Murine
Genome U74v2 Set, consisting of three GeneChip® probe
arrays (U74Av2, U74Bv2 and U74Cv2), together they
contain probe sets corresponding to approximately
36,000 full-length mouse genes and EST clusters from the
UniGene database. The biotin-labeled cRNA was frag-
mented in 40 mM Tris-acetate buffer pH 8.1 containing
100 mM potassium acetate and 30 mM Magnesium ace-
tate. 15 ?g of every labelled cRNA was mixed with the
appropriate buffers and hybridized to respectively a
mouse U74Av2, U74Bv2 and U74Cv2 (Affymetrix) for 16
h at 45°C. Computer analysis of the resulting data was
performed using the dCHIP software package. Samples
were run on triplicate microarrays (three independently
cultivated, isolated and labelled WT probes and three
independently cultivated, isolated and labelled STAT3-
MER probes) and the resulting data combined into sub-
sets and compared using dCHIP. The 18 .CEL files gener-
ated by the Affymetrix Microarray Suite (MAS) were
converted in .DCP files using dCHIP. The .DCP files were
normalized and raw gene expression data generated.
Comparison was performed using the dCHIP software
wherein the three WT FVB ES cells were designated as
"baseline" (B) and the three STAT3-MER overexpressing
ES cells designated as "experiment" (E). Genes expressed
1.5 fold higher or lower in the WT versus STA3-MER cells
were then identified by defining the appropriate filtering
criteria in the dCHIP software (E/B < 1.5 or B/E > 1.5; E-B
> 100 or B-E > 100, P < 0.1, t-test). Calculations were per-
formed with both the PM/MM (perfect match/mismatch)
difference model and the PM (perfect match) only model
in order to compare the results. The microarray data is
deposited in the Gene Omnibus Repository (GEO), acces-
sion number GSE11398.
Real-Time Quantitative PCR (Q-PCR)
The total RNA from cultured ES cells was obtained using
Qiagen RNeasy mini-kit and reverse transcribed with
oligo-dT primers (Invitrogen) and SuperscriptIII (Invitro-
gen). Quantitative Real time experiments were performed
with the SyberGreen technology using the QuantiTect
SYBR kit (Qiagen) and a Rotorgene 6000 cycler (Corbett).
For quantitation of gene expression comparative Ct-
method was used after normalization with ?-actin. The
following primers were used:
?actin_fwd: 5'-cat cca ggc tgt gct gtc cct gta tgc-3'
?actin_bwd: 5'-gat ctt cat ggt gct agg agc cag agc-3'
Lefty2_fwd: 5'-aca gcg cgg atg tgg agg aga tgg-3'
Lefty2_bwd: 5'-atc ctc acg gac tct cag cca ttc a-3'
Eif2s2_fwd: 5'-tac atc gtc aac cca aac atc tcc ttg c-3'
Eif2s2_bwd: 5'-ggc acg gag ctg tgc tcg ctt-3'
Dppa3_fwd: 5'-agg gtc cgc act ttg ttg tcg gtg c-3'
Dppa3_bwd: 5'-gct cct aat tct tcc cga ttt tcg cat-3'
Hexokinase2_fwd: 5'-tgt ggt ggc cgt ggt aaa tg-3'
Hexokinase2_bwd: 5'-tct tga ggc gct ctg aga tg-3'
NDP5211_fwd: 5'-cat gag cag cta cag agg aag ca-3'
NDP5211_bwd: 5'-gtg cct cag att cac tgt gta gct aa-3'
Nanog_fwd: 5'-aca agg gtc tgc tac tga gat gc-3'
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Nanog_bwd: 5'-gga gac ttc ttg cat ctg ctg g-3'
Pem/Rhox5_fwd: 5'-ctt ccg tgg aca aga gga ag-3'
Pem/Rhox5_bwd: 5'-tgt cat agc cgg cat atg tg-3'
Ppp1r15b_fwd: 5'-gcc ttc aag ctg gtc tag tc-3'
Ppp1r15b_bwd: 5'-cat cgc tat caa agc cat cg-3'
Pramel6_fwd: 5'-cag gaa gac gag tgg caa agc acg t-3'
Pramel6_bwd: 5'-agc cct gga atc tca tag cct aca tc-3'
Pramel7_fwd: 5'-gag gag aag cag aac atc agc aag a-3'
Pramel7_bwd: 5'-ctc tta gag gcg tga cat cta ggt t-3'
Stat3_fwd: 5'-ggc aag ggc ttc tcc ttc tg-3'
Stat3_bwd: 5'-agc tgc tgc ttg ttg gtg tat gg-3'
Skp2_fwd: 5'-cag ctg ctc cag act gga tg-3'
Skp2_bwd: 5'-ggt tcc ctc tgg cac gat tc-3'
Socs3_fwd: 5'-cct cca gca tct ttg tcg gaa gac-3'
Socs3_bwd: 5'-tac tga tcc agg aac tcc cga atg-3'
Trim41_fwd: 5'-tga gcc gca tgt ttt gtc agg ctg c-3'
Trim41_bwd: 5'-c aca ctt cgc gct gga cta gga gct-3'
Quantitative RT-PCR for each gene was done in triplicates
and the values were normalized to the corresponding
amounts of ?-actin RNAs.
In situ hybridization
Templates for riboprobe-synthesis were obtained by
amplification through RT-PCR. Briefly, total RNA was iso-
lated from FVB/STAT3-MER ES cells cultivated in presence
of 4OHT and RT was performed with oligo-dT primers.
300–400 bp long fragments containing part of the ORF of
the genes of interest were amplified by PCR and cloned in
a pCRII® TOPO® dual promoter vector (Invitrogen). DNA
templates for riboprobe synthesis were digested with
appropriate enzymes to provide fragments for either sense
or antisense orientation of the PCR product respect to the
vector. Labelled riboprobes were synthesized by SP6 or T7
RNA polymerases by incorporation of digoxygenin-
labelled UTPs.
The embryos were transferred in a micro pore insert (12
?m) sitting in a well of a 4 well plate and fixed with freshly
prepared 4% PFA/PBS, washed twice in PBT and dehy-
drated once in 25%, 50%, 75% and twice in 100% meth-
anol/PBT. The dehydration was followed by rehydration
in the reverse order of the MeOH/PBT series 75%, 50%,
25% for 5 min each. The embryos permeabilized in RIPA
buffer and refixed in 4% PFA/0.2% glutaraldehyde. After
prehybridisation in hybridisation solution for ?2 hours at
70°C the embryos were incubated in hybridisation solu-
tion containing 1.6 ?g/ml of the corresponding ribo-
probe. As a control for the specificity of the labelling, in
each hybridization experiment control embryos were
hybridized with an equal concentration of a sense probe
transcribed from the same template as the antisense
probe. After high and low stringency washes hybridized
riboprobes were detected using an AP-coupled anti-digox-
ygenin antibodies (Roche Diagnostics, Rotkreuz, Switzer-
land) and the AP-substrate BM-Purple (Roche
Diagnostics, Rotkreuz, Switzerland). The staining reaction
was stopped by rinsing in 2 mM EDTA/PBT. Embryos
were subsequently post-fixed in 4% PFA/0.1% glutaralde-
hyde in PBT and cleared in a glycerol:PBT 1:1 solution.
Overexpression of Pramel7, Pem/Rhox5 and Nanog
The full length open reading frames (ORF) of Pramel7
and Pem/Rhox5 were amplified by RT-PCR and
sequenced. The full length cDNAs were cloned in the
pfloxedNanog expression vector [25] by exchanging the
Nanog cDNA with either the one of Pem/Rhox5 or
Pramel7. The expression vectors were completely
sequenced and finally electroporated in E14 ES cells. After
selection with puromycin single colonies were isolated
and their expression levels were determined by real time
PCR. The clones with the strongest overexpression were
chosen for further experiments.
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ABSTRACT
A unique and complex signaling network allows ESCs to
undergo extended proliferation in vitro, while maintaining
their capacity for multilineage differentiation. Genuine ESC
identity can only be maintained when both self-renewal and
suppression of differentiation are active and balanced. Here,
we identify Pramel7 (preferentially expressed antigen in
melanoma-like 7) as a novel factor crucial for maintenance
of pluripotency and leukemia inhibitory factor (LIF)-medi-
ated self-renewal in ESCs. In vivo, Pramel7 expression was
exclusively found in the pluripotent pools of cells, namely,
the central part of the morula and the inner cell mass of the
blastocyst. Ablation of Pramel7 induced ESC differentiation,
whereas its overexpression was sufficient to support long-
term self-renewal in the absence of exogenous LIF. Further-
more, Pramel7 overexpression suppressed differentiation in
ESCs in vitro and in vivo. This process was reversible, as
on transgene excision cells reverted to a LIF-dependent state
and regained their capacity to participate in the formation
of chimeric mice. Molecularly, LIF directly controls Pra-
mel7 expression, involving both STAT3-dependent transcrip-
tional regulation and PI3K-dependent phosphorylation of
glycogen synthase kinase 3b. Pramel7 expression in turn
confers constitutive self-renewal and prevents differentiation
through inactivation of extracellular signal-regulated kinase
phosphorylation. Accordingly, knockdown of Pramel7 pro-
motes ESC differentiation in presence of LIF and even on
forced STAT3-activation. Thus, Pramel7 represents a cen-
tral and essential factor in the signaling network regulating
pluripotency and self-renewal in ESCs. STEM CELLS
2011;29:474–485
Disclosure of potential conflicts of interest is found at the end of this article.
INTRODUCTION
ESCs are derived from the inner cell mass (ICM) of blasto-
cyst [1, 2] and represent an important tool for the study of
early embryonic development and the pluripotent state, mostly
because of their two distinctive properties, that is, their ability
to undergo indefinite mitotic self-renewal and to differentiate
into a range of specialized cell types. A tightly balanced inter-
play between different pathways is necessary to promote self-
renewal in ESCs. Some of these pathways act through the
repression of factors that initiate differentiation programs [3–
7]. STAT3, OCT3/4, SOX2, and Nanog are transcription fac-
tors that regulate various aspects of ESC fate and safeguard
the maintenance of the pluripotent state [3, 5].
Derivation and maintenance of murine ESCs were origi-
nally achieved by using feeders or the cytokine leukemia
inhibitory factor (LIF) in combination with fetal calf serum
or the growth factor bone morphogenetic protein. LIF
acts through the leukemia inhibitory factor receptor/gp130
complex to maintain pluripotency [8, 9]. Cultivation of ESCs
on Lif-deficient fibroblasts leads to differentiation, indicating
that they mostly provide LIF [10]. LIF-independent mainte-
nance of mouse ESCs with retention of pluripotency (adult
chimerism) has been previously described for cell lines, which
overexpressed Nanog or KLF2 [11, 12]. In vitro, the overex-
pression of PEM/RHOX5 also maintains pluripotency without
LIF, even though contribution to chimera has not yet been
proven [13, 14]. Nowadays, it is possible to bypass LIF,
feeders, and serum requirement by using two inhibitors (2i
conditions) which block mitogen-activated protein kinase
(extracellular signal-regulated kinases [ERKs]) and glycogen
synthase kinase 3b (GSK3b) [15]. Interestingly, maximal self-
renewal is obtained by combination of LIF and 2i confirming
LIF/STAT3 signaling as an essential component of self-
renewal in ESCs. Despite the importance of this pathway,
STAT3 downstream target genes have remained elusive. In a
recently performed microarray study, we found Pramel6 and
Pramel7 (preferentially expressed antigen in ESCs upon con-
ditional in melanoma like 6 and 7) strongly upregulated in
ESCs upon conditional overexpression of STAT3 [14]. These
findings indicate a potential role of these genes in the stabili-
zation of ESCs. In this work, we aimed at the functional char-
acterization of Pramel6 and particularly of Pramel7 in ESCs.
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Our results demonstrate that Pramel7 is a new direct STAT3
target gene, fundamental for the LIF-mediated maintenance of
pluripotency and for the inhibition of differentiation.
MATERIALS AND METHODS
Cell Culture
Medium for E14 129/Ola and transgenic ESCs (complete me-
dium [CM]-medium): Glasgow minimal essential (Sigma,
Buchs, Switzerland, www.sigmaaldrich.com/switzerland-
schweiz.html), 100 mM sodium pyruvate (Sigma), 10% fetal
bovine serum (Gibco, Invitrogen, Basel, Switzerland, www.in-
vitrogen.com), 50 mM b-mercaptoethanol (Gibco), 1! mini-
mal essential medium nonessential amino acids (Gibco), 200
mM L-glutamine. Medium supplemented or not with 1,000 U/
ml ESGRO murine LIF (Millipore, Chemikon, Zug, Switzer-
land, www.millipore.com). N2B27-medium: DMEM/F-12
(Invitrogen), Neurobasal (Invitrogen), 50 mM b-mercaptoetha-
nol (Gibco), 200 mM L-glutamine, N2-Supplement 100!
(Invitrogen), B27-Supplement 50! (Invitrogen). Medium sup-
plemented with two inhibitors: 3 lM CHIR99021 (Stemgent,
Cambridge, MA, www.stemgent.com) and 1 lM PD0325901
(Stemgent). Lif knockout fibroblast: Lif þ/# mice [16] were
mated and at E14.5 the fetuses were isolated. Heads and
placentas were used for genotyping, whereas the rest of the
embryo was trypsinized and cultured. Lif #/# fibroblasts
were expanded and treated with mitomycin-C (10 lg/ll).
Neural-differentiation medium: DMEM/F-12 (Invitrogen),
B27-Supplement 50! (Invitrogen), N2-Supplement 100!
(Invitrogen). For PI3K inhibition, 5 lM LY294002 were
added to the N2B27 medium not supplemented with
CHIR99021 and PD0325901.
Immunohistochemical Analyses
E14, transgenic, and recombined ESCs were cultivated for 11
days with CM-medium with or without LIF on Lif knockout
feeders. At day 11, all cell lines were analyzed for OCT3/4
and stage-specific embryonic antigen-1 (SSEA-1) expression.
For the serum- and feeder-free experiment, the same cells
were cultivated on gelatinized plates for 9 days. N2B27 me-
dium was supplemented with either both or one inhibitor or
only LIF. ESCs were fixed in 4% paraformaldehyde and incu-
bated overnight at 4$C with primary antibodies against OCT3/
4 (rabbit anti OCT3/4, Santa Cruz Biotechnology, Santa Cruz,
CA, www.scbt.com) and SSEA-1 (Mouse mAb, Millipore).
Secondary fluorescence-labeled antibodies were used for
detection (anti rabbit Alexa Fluor 594 and anti mouse Alexa
Fluor 488, Molecular Probes, Invitrogen). Nuclei of the cells
were counterstained with DAPI (Roche, Basel, Switzerland,
www.roche.ch).
Pramel7 Knockdown
shRNA vectors: four specific shRNA vectors against Pramel7
cloned in pGFP-V-RS vector (Origene, Rockville, MD,
www.origene.com) and one negative control shRNA pGFP-V-
RS vector. Sequences of shRNA are listed in Supporting In-
formation Table 2. ESCs were transiently lipofected with ei-
ther the shRNA constructs against Pramel7 or with the control
vector by using FuGENE HD Transfection Reagent (Roche)
and selected with puromycin. Transfection efficiency was
monitored by EGFP fluorescence and Pramel7 knockdown
was analyzed by real-time polymerase chain reaction (PCR).
Both E14 wild-type (wt) and STAT3MER transgenic cells
were cultivated on feeders with CM-medium either supple-
mented with LIF (E14 cells) or with hydroxy-tamoxifen
(OHT; STAT3MER cells). STAT3MER cells were analyzed
for alkaline phosphatase (AP) expression at day 8, respec-
tively 4 of the knockdown. For STAT3MER cells, all the AP-
positive colonies present in the 35-mm dishes were counted.
For E14 cells, colonies with greater than 80% staining were
classified as ‘‘undifferentiated,’’ 20%–80% staining as
‘‘mixed,’’ and less than 20% as ‘‘differentiated.’’
LIF Induction Experiment
wt ESCs, established under feeder- and serum-free conditions,
were cultivated on gelatinized 35-mm dishes in N2B27 þ 2i
medium. Cells were then incubated for 4 hours in N2B27 þ 2i,
N2B27 þ PD0325901, N2B27 þ CHIR99021, N2B27 þ
LY294002 or in N2B27 without inhibitors. After 4-hour incu-
bation, LIF was added to the media. Total RNA was extracted
after 30 minutes, 1 hour, 3 hours, and 5 hours of LIF incuba-
tion. Reverse transcription and real-time PCR were performed.
Part of Material and Methods is provided in the Support-
ing Information.
RESULTS
Characterization of Pramel6 and Pramel7 Genes
In the mouse, Pramel6 and Pramel7 cluster on chromosome
2(D) in opposite orientations (Supporting Information Fig.
1A). The amino acid composition of both proteins is very
similar (Supporting Information Fig. 1B). Search for recogniz-
able domains in the open reading frame of both genes using
SMART (http://smart.embl-heidelberg.de) and myHits (http://
myhits.isb-sib.ch/cgi-bin/motif_scan) revealed the presence of
conserved leucine-rich repeats (LRRs), which usually partici-
pate in protein-protein interactions. The presence of these
types of domains and the absence of conserved domains typi-
cal for transcriptional factors suggests that the Pramel family
might not directly regulate gene transcription but rather act
via protein-protein interaction.
Pramel6 and Pramel7 Expression Is Restricted to
the Late Preimplantation and is Silenced in the
Early Postimplantation Embryonic Stages
Whole mount in situ hybridization studies in the preimplanta-
tion embryos showed a homogeneous expression of Pramel6
in all cells of the morula and the blastocyst, whereas Pramel7
mRNA distribution was restricted to the interior part of the
morula and the ICM of the blastocyst (Supporting Information
Fig. 1C). Gene expression analyses of early postimplantation
embryos (E6.5) revealed that at this developmental stage Pra-
mel6 and Pramel7 genes are silenced (Fig. 1A). At this stage,
the embryos expressed, as expected, both Nanog and DPPA3.
The Nanog expression was restricted to the embryos, whereas
DPPA3 was detected in the embryo as well as in the decidua
(Fig. 1A).
In vitro, Pramel6 and Pramel7 are constitutively
expressed in ESCs (Fig. 1B) independent of whether the cells
are cultivated with serum, feeders, and LIF, or with N2B27 þ
2i (serum free, feeder free, and LIF free). Expression of both
genes disappears as soon as the cells differentiate. In accord-
ance with our previous results [14], the presence of LIF in the
medium resulted in an increased expression of both genes,
presumably because of a direct activation of STAT3
(Fig. 1B).
Taken together, these observations suggest a possible role
of both Pramel6 and Pramel7 in the maintenance of pluripo-
tency in vivo as well as in vitro.
Casanova, Shakhova, Patel et al. 475
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Pramel7 but Not Pramel6 Overexpression in
ESCs Induces General Upregulation of Known
Pluripotency-Related Genes
We generated ESCs conditionally overexpressing LoxP-
flanked open reading frames of Pramel6 or Pramel7, which
can be excised by Cre-recombinase simultaneously bringing
egfp under the CAG promoter (Supporting Information Fig.
2A). Overexpression experiments were performed in E14 129/
Ola (E14) ESCs and, if not specified, they were cultivated in
presence of feeders and serum (referred as CM). All clones
showed a high expression of the transgene, which reverted to
wt levels once recombined (Supporting Information Fig. 2B
and 2C). All transgenic clones showed the classical morphol-
ogy of pluripotent ESCs (Fig. 1C, 1E, and Supporting Infor-
mation Fig. 2E) and expressed the pluripotency markers AP,
SSEA-1, and OCT3/4 (data not shown). On the transcriptional
level, as assessed by real-time PCR, the overexpression of
Pramel7 induced a slight increase of most of the pluripotency
genes (Fig. 1D). Accordingly, on Cre-recombination the
expression of Nanog and OCT3/4 reverted to wt levels in
combination with an increase in fibroblast growth factor 5
(FGF5) (Fig. 1D). Overexpression of Pramel6 did not induce
significant changes on the expression of the investigated genes
(Fig. 1F). Nanog overexpression did not influence the tran-
scriptional levels of Pramel7, indicating that Pramel7 is not a
target of Nanog (Supporting Information Fig. 2D).
Overexpression of Pramel7 Liberates ESCs from
LIF Dependence and Maintains Pluripotency
We further analyzed the ability of ESCs overexpressing either
Pramel6 or Pramel7 to be propagated clonally on Lif-knockout
feeders [16] without LIF in the medium. After 11 days, E14
ESCs exhibited widespread differentiation and no longer
expressed the pluripotency markers OCT3/4, SSEA-1, and AP
(Fig. 2A, 2B and Supporting Information Fig. 3A). In con-
trast, Pramel7-overexpressing cells (referred as Pramel7 cells)
were undistinguishable from Nanog-overexpressing cells
(Supporting Information Fig. 3A) and only less than 10% of
Figure 1. Endogenous expression of Pramel6 and Pramel7 and characterization of the transgenic clones. (A): Expression of Pramel6, Pramel7,
Dppa3, and Nanog in early postimplantation embryos (E6.5). Pramel6 and Pramel7 expressions are absent in both decidual and embryonic tissue
but present in ESCs. Negative control (!). (B): Real-time polymerase chain reaction (PCR) analysis of wild-type (wt) ESCs cultivated in pres-
ence of LIF and feeders (MEF) or in presence of the extracellular signal-regulated kinases and glycogen synthase kinase 3 inhibitors (2i). Expres-
sion levels of Pramel7, Pramel6, and Oct3/4 are compared with differentiated ESCs. (C, E): Representative morphology of Pramel7 and Pramel6
overexpressing cells and Cre-reverted (EGFP expressing) ESCs cultivated in presence of LIF and feeders. (D, F): Real-time PCR analyses of
known pluripotency-related genes in Pramel7, Pramel6, and in Cre-reverted ESCs. Data were normalized to the expression level in the wt ESCs.
Abbreviations: D, decidual tissue; E, embryonic tissue; ES, ESC; LIF, leukemia inhibitory factor; MEF, mouse embryonic fibroblasts.
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the colonies showed no AP activity (Fig. 2C). Accordingly,
Cre-recombined Pramel7 ESCs (referred as Cre-Pramel7 cells)
behaved like wt ESCs and exhibited more than 80% of differ-
entiated colonies (Fig. 2C). In contrast, only about one-third
of the colonies in Pramel6-overexpressing clones remained
completely undifferentiated (Fig. 2C and Supporting Informa-
tion Fig. 3A). Our data reveals that overexpression of Pra-
mel7, but not of Pramel6, is sufficient to liberate ESCs from
LIF dependence and to promote self-renewal.
Finally, we investigated whether cells maintained in a
self-renewing pluripotent state exclusively through overex-
pression of Pramel7 were retaining their embryo colonization
capacity. Excision of Pramel7 restored LIF dependence and
these cells contributed to the generation of healthy live
chimeras upon morula aggregation (Fig. 2D and Supporting
Information Table 3).
Pramel7-Overexpressing ESCs Fail
to Differentiate In Vitro
To investigate the role of Pramel7 in ESC differentiation,
embryoid bodies were generated with Pramel7, Cre-Pramel7,
and Nanog-overexpressing ESCs. As assessed by reverse tran-
scription and PCR, expression of pluripotency markers, such
as OCT3/4, Nanog, and REX1, was persisting after 10 days in
Pramel7 cells as well as in the Nanog-overexpressing cells,
whereas it was completely abolished in Cre-revertants (Fig.
3A). To further assess the capacity of Pramel7 cells to
undergo defined differentiation, cells were cultivated with
neural differentiation medium. E14 cells differentiated,
whereas the majority of Pramel7 cells showed a large number
of cells with pyknotic nuclei (Fig. 3B, 3C) indicating a high
degree of cell death.
Pramel7 Maintains Pluripotency In Vitro Through
Gradual Suppression of ERK Phosphorylation
ERK phosphorylation is known to be an early signaling event
required for the differentiation of ESCs, and it has been pro-
posed that the balance between LIF-induced activation of
STAT3 and ERK may determine the efficiency of self-
renewal and thereby influence stem cell fate [17, 18]. To fur-
ther understand the mechanism underlying Pramel7-mediated
Figure 2. Characterization of Pramel7 and Pramel6 transgenic ESCs. (A): Immunostaining for OCT3/4 and SSEA-1 in E14 wt, Pramel6 and
Pramel7 overexpressing ESCs cultivated for 11 days in absence of leukemia inhibitory factor (LIF) on a layer of Lif knockout feeders. Magnifica-
tion: !20. (B, C): Alkaline phosphatase (AP) staining and quantification of AP-positive colonies after 11 days in absence of LIF (100 colonies
were counted). (D): Contribution of Pramel7 Cre-deleted cells to embryo and adult chimeric animals. Chimerism was assessed by green fluores-
cence. Wild-type pup (EGFP negative), EGFP-positive Cre-reverted Pramel7 pup and the adult chimera are shown. Abbreviations: DAPI, 40,6-dia-
midino-2-phenylindole; SSEA-1, stage-specific embryonic antigen-1.
Casanova, Shakhova, Patel et al. 477
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Figure 3. Pramel7 overexpression results in differentiation defects in vitro and in vivo. (A): Expression levels of pluripotency genes (Pramel7,
Nanog, Oct3/4, Pem/Rhox5, Stat3, Sox2, Rex1, Dppa3), endoderm (Gata-6), primitive ectoderm (Fgf5), and mesoderm (Brachyury-T) were meas-
ured by semiquantitative RT-PCR in ESCs (control) and in embryoid bodies generated from Pramel7-overexpressing cells, Pramel7-Cre revertants,
and Nanog-overexpressing cells. Number of PCR cycles is annotated. (B, C): In vitro neural differentiation of Pramel7-overexpressing cells and pa-
rental E14 cells. Pramel7-overexpressing clones exhibited an extensive number of cells with pyknotic nuclei, as shown by DAPI staining. Magnifica-
tion: !20. Number of live and dead cells after 4 days of neural differentiation: Cells which showed condensed nuclei were defined as dead cells,
whereas normal nuclei were considered as live cells. (D): Western blotting for phospho-Erk after LIF stimulation of wt and Pramel7-overexpressing
ESCs for 10, 30, or 60 minutes reveals that Pramel7 maintains pluripotency through gradual suppression of pERK. (E): Morula aggregation of Cre-
reverted Pramel7 cells (EGFP positive) and Pramel7-overexpressing cells (RFP labeled). Pramel7-overexpressing cells do not correctly take part to
the development, whereas Cre-reverted Pramel7 cells integrate into the developing embryo and at E5.5 they are part of the epiblast. (F–H):
Teratoma formation reveals impaired in vivo differentiation potential of Pramel7-overexpressing cells. Efficiency of teratoma formation in E14 wt
ESCs, Nanog, Pem/Rhox5, Pramel6, and Pramel7-overexpressing cells was assessed by number of teratomas generated (F) and tumor volume
(mm3) measurement (G), as well as by degree of tumor differentiation (H) analyzed by immunostaining for SMA, TuJ1, and GFAP. Magnification:
!10. Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; ERK, extracellular signal-regulated kinase; GFAP, glial fibrillary acid protein; LIF,
leukemia inhibitory factor; MEF, mouse embryonic fibroblasts; pERK, phosphorylated ERK; SMA, smooth muscle actin; TuJ1, bIII-tubulin.
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self-renewal, we investigated by Western blotting activation
of ERK in E14, Pramel6, Pramel7, and in Cre-recombined
ESCs on LIF stimulation. Twenty-four hours LIF-depleted wt,
Pramel6-, and Cre-Pramel7 cells showed progressive phospho-
rylation of ERK (pERK) on LIF induction (Supporting Infor-
mation Fig. 3B). In Pramel7 cells, however, pERK was only
detectable 10 minutes after LIF stimulation and drastically
decreased after 30 minutes (Fig. 3D). Taken together, this
data suggests that Pramel7 overexpression prevents ESCs
from differentiation by promoting ERK dephosphorylation.
Pramel7 Cells Are Unable to Form Teratomas and
to Contribute to Embryo Development
To test the capacity of Pramel7 cells to contribute to embryo
development, we genetically labeled these cells with red fluo-
rescent protein (RFP) and performed morula aggregations. Af-
ter being transferred into the uterus of foster mothers, at E5.5
the embryos were isolated and analyzed. Embryos aggregated
with Pramel7-RFP cells exhibited malformations (Fig. 3E and
Supporting Information Table 3), indicating that Pramel7 cells
do not enter normal development.
We further investigated the ability of Pramel6 and Pra-
mel7 cells to form teratomas. We transplanted 106 ESCs sub-
cutaneously into immunoincompetent nonobese diabetic/
severe combined immunodeficiency mice (Fig. 3F). After 3
weeks, wt and Cre-Pramel7 ESCs produced teratomas of simi-
lar size (Fig. 3G and Supporting Information Fig. 4A) con-
taining derivatives of all three germ layers (Supporting Infor-
mation Fig. 4B). Pramel6 cells generated similar teratomas but
with smaller volume than the ones generated by the control
clones (Fig. 3G and Supporting Information Fig. 4A, 4B). Intri-
guingly, 14 independent injections with two different Pramel7
ESC-clones overexpressing similar amounts of Pramel7 never
generated teratomas, even after 2 months incubation. Seeing
that no previous publication describes a similar behavior of
pluripotent cells, we tested the potential of teratoma formation
of ESCs overexpressing Nanog or PEM/RHOX5. A total of
100% of the injections with Nanog-overexpressing ESCs pro-
duced teratomas undistinguishable in size (Fig. 3G) and histo-
logical composition from the ones generated from wt and Cre-
revertant cells (Fig. 3H, Supporting Information Fig. 4A and
4B). This data indicates that Nanog overexpression is not suffi-
cient to prevent differentiation in the context of teratoma.
ESCs-overexpressing PEM/RHOX5 were previously shown
to form teratomas containing undifferentiated cells [13]. Inter-
estingly, 75% of the injections with PEM/RHOX5-overexpress-
ing cells failed to generate teratomas, in a similar way to the
Pramel7 cells (Fig. 3G). Nevertheless, the only teratoma iso-
lated contained differentiated tissue similar to the wt and
Nanog cells (Fig. 3H). In summary, overexpression of Pramel7
impairs the capacity of ESCs to generate teratomas and the
inability to differentiate probably causes the death of the cells.
Pramel7 Is Necessary for LIF- and STAT3-
Dependent Maintenance of Pluripotency in ESCs
To investigate whether Pramel7 is required for maintenance
of pluripotency in ESCs, we performed knockdown experi-
ments in E14 wt ESCs cultivated in the presence of LIF.
Figure 4. Pramel7 expression is indispensable for LIF/STAT3-dependent maintenance of pluripotency and is a direct STAT3 target gene. (A,
B): Representative appearance of AP-stained colonies (A) after Pramel7 knockdown in E14 ESCs in presence of LIF. Control (E14 mock), Pra-
mel7 knockdown (E14 shPramel7). Quantification of AP-positive colonies (B) after Pramel7 knockdown in E14 wt cells. Colonies that showed
more than 80% positive cells were identified as ‘‘undifferentiated,’’ 20%–80% as ‘‘mixed,’’ and less than 20% as ‘‘differentiated’’. (C): Pramel7
knockdown in STAT3MER cells cultivated in presence of 4-hydroxy-tamoxifen. Total number of AP-positive colonies is presented. (D): Time-
pulse assay with LIF in E14 wt ESCs. Phosphorylation levels of STAT3 (pSTAT3) were monitored by Western blot, whereas the amount of Pra-
mel7 mRNA was measured by real time-polymerase chain reaction (PCR). (E): Real-time PCR analysis of Pramel7 mRNA expression in wt and
Stat3 null ESCs cells after LIF stimulation for 1 or 24 hours. (F): STAT3 directly transcribes Pramel7 gene. Real-time PCR analysis of Pramel7
mRNA expression in E14 wt ESCs deprived from LIF for 24 hours followed by LIF stimulation for 1 or 3 hours in the presence or absence of
cycloheximide (50 lg/ml). Abbreviations: AP, alkaline phosphatase; LIF, leukemia inhibitory factor.
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Knockdown was achieved by transient ESCs transfection with
a cocktail of four shRNA-containing vectors specific for Pra-
mel7. Four days after transfection, Pramel7 mRNA was com-
pletely silenced, although the efficiency decreased 4–5 times
in comparison with the control cells at day 6 (data not
shown). Despite the presence of LIF, knockdown of Pramel7
induced loss of AP activity and differentiation (Fig. 4A, 4B),
whereas control cells did not. The data indicates that LIF-
mediated self-renewal in ESCs depends on Pramel7
expression.
To further assess whether self-renewal induced by STAT3
overexpression also depends on Pramel7, we exploited
STAT3MER ESCs, which conditionally express a STAT3
fusion protein with a mutated estrogen receptor. These cells
maintain pluripotency in the absence of LIF by the sole acti-
vation of STAT3MER with 4-OHT [19] and were shown to
upregulate Pramel7 [14]. Surprisingly, STAT3MER activation
failed to promote stem cell maintenance in Pramel7 knock-
down cells, resulting in a drastic decrease in the total number
of AP-expressing colonies (Fig. 4C). These results clearly
indicate that the expression of Pramel7 is essential for both
LIF- and STAT3-mediated maintenance of pluripotency.
Pramel7 Is a Novel Direct Downstream Target of
STAT3 in the LIF/STAT3 Pathway
On the basis of our previous [14] and recent results, we
assessed whether Pramel7 might represent a novel effector of
the LIF/STAT3-pathway. We therefore first monitored STAT3
phosphorylation and Pramel7 mRNA expression in response
to three cycles of 10 minutes of LIF incubation. Depletion of
LIF for 24 hours (t0) and successive incubation with LIF-con-
taining medium for 10 minutes (t1) induced in E14 cells a
fast phosphorylation of STAT3 (pSTAT3) as assessed by
Western blotting (Fig. 4D). Concomitantly, mRNA levels of
Pramel7 strongly increased during this period (Fig. 4D). The
same behavior was observed also after the third round of LIF
incubation, suggesting that Pramel7 is a downstream target of
LIF/STAT3.
To test the robustness of this hypothesis, we monitored
Pramel7 expression after LIF induction in Stat3 null cells [12]
cultivated in N2B27 þ 2i medium without LIF. In the wt
cells, LIF induced an upregulation of Pramel7 mRNA,
whereas Stat3 knockout cells failed to regulate Pramel7
expression (Fig. 4E). These results clearly indicate that Pra-
mel7 transcription is STAT3-dependent. Furthermore, LIF
stimulation in wt ESCs, in the presence of the protein synthe-
sis inhibitor cycloheximide, resulted in strong activation of
Pramel7 transcription (Fig. 4F) confirming that STAT3
directly drives Pramel7 transcription.
Pramel7 Expression Is Regulated Through the
Parallel Circuitry of the LIF Signal Pathways
We observed that within 10 minutes LIF induces a rapid up-
regulation of Pramel7 transcripts under standard culture con-
ditions (Fig. 4D). Interestingly, the presence of 2i causes a
significant delay in the LIF-dependent Pramel7 upregulation
(Fig. 4E). In the presence of 2i, LIF supply is dispensable and
the cells can be propagated in the absence of active LIF/
STAT3 pathway [15]. We therefore considered whether the
retarded responsiveness of Pramel7 transcription to LIF was
due to the absence of active STAT3 or to the presence of the
ERK- and/or GSK3b-inhibitors.
We examined induction of Pramel7 on addition of LIF in
absence of 2i or in presence of either PD0325901 (ERK-in-
hibitor) or CHIR99021 (GSK3b-inhibitor). ESCs were then
incubated for 30 minutes, 1 hour, 3 hours, or 5 hours with
LIF. Intriguingly, the presence of CHIR99021 completely
blocked Pramel7 transcription (Fig. 5A) indicating that the in-
hibition of GSK3b activity impairs STAT3-mediated tran-
scription of Pramel7. We therefore analyzed the effect of
LY294002, a phosphoinositide-3-kinase (PI3K) inhibitor on
Pramel7 regulation. Because of the known apoptotic effect of
PI3K inhibition, cells were incubated with low inhibitor con-
centrations and for a short time. STAT3 mRNA expression
was not influenced by the presence of the PI3K inhibitor and
as expected, increased during the LIF incubation times.
Whereas the level of Pramel7 transcripts remained unaltered
even after 5 hours of LIF stimulation (Fig. 5B). We can there-
fore conclude that Pramel7 transcription is mediated by the
parallel activity of the LIF/STAT3 and the PI3K/GSK3b
pathways.
It is known that the sole inhibition of ERK or GSK3b is
not sufficient for maintaining ESCs undifferentiated. To test
whether Pramel7 overexpression can overcome this situation,
we cultivated wt and Pramel7 cells in N2B27 medium supple-
mented only with CHIR99021. After 5 days, wt cells showed
significant upregulation of the differentiation markers Bra-
chyury-T, GATA6, and GATA4, and after 9 days, the expres-
sion of REX1, Nanog, OCT3/4, and SOX2 was reduced (Fig.
5C). Immunohistochemistry for OCT3/4 and SSEA-1 showed
a reduced expression in wt cells and colonies started to spread
out loosing their compact shape (Fig. 5D). In contrast, Pra-
mel7 cells formed high compact colonies, which were homo-
geneously positive for both pluripotency markers (Fig. 5D).
Moreover, they formed more than 70% undifferentiated,
homogenously AP-positive colonies, whereas E14 cells were
only about 25% (Fig. 5E). This demonstrates that overexpres-
sion of Pramel7 in combination with the GSK3b-inhibitor is
sufficient to maintain ESCs undifferentiated, indicating that
the presence of Pramel7 can compensate for the need of
MEK/ERK inhibition.
Pramel7 Overexpression Under Feeder- and
Serum-Free Conditions Is Only Partially
Able to Maintain Pluripotency
We asked next if Pramel7 is able to maintain ESCs undiffer-
entiated in N2B27 medium in the absence of feeders. E14 and
Pramel7 ESCs were adapted to the N2B27 þ 2i conditions
(without LIF) by extensive passaging and both cell lines after
11 passages showed homogenous AP staining (Fig. 6A). We
therefore used these cells for our further experiments. We first
investigated if overexpression of Pramel7 is sufficient for pro-
longed cell expansion in N2B27 medium without 2i and LIF,
a condition that normally does not support self-renewal. After
two passages at clonal density, wt cells died, whereas Pramel7
cells could be split for one more passage, but finally they also
died (Fig. 6B). This indicates that the sole overexpression of
Pramel7 is not sufficient for prolonged cells expansion under
these conditions. We therefore investigated if Pramel7 cells
were able to self-renew in N2B27 medium supplemented with
LIF alone, a condition that is also normally not sufficient for
maintaining ESCs. After passaging, almost all the E14 cells
either died or stopped to self-renew. However, Pramel7 cells
showed higher self-renewing rate and formed round, compact
colonies (Fig. 6C). OCT3/4 and SSEA-1 expression was
detected only in the transgenic cells, but not in the wt E14
cells (Fig. 6D). Quantification for AP-positive colonies
showed that Pramel7 cells exhibited 5% of completely undif-
ferentiated colonies and about 50% of partially differentiated
colonies when stained for AP (Fig. 6E). In contrast, more
than 80% of the wt cells were completely differentiated and
showed no AP activity at all (Fig. 6E). This was also
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confirmed by real-time PCR (Fig. 6F). In summary, the com-
bination of Pramel7 overexpression and LIF increases self-
renewal capacity of ESCs, facilitating the maintenance of the
undifferentiated state. Nevertheless, this synergistic effect was
only partial, as complete elimination of differentiation was
not observed.
DISCUSSION
The JAK/STAT3-pathway was shown to be essential and suf-
ficient in mouse ESCs to mediate LIF signals thereby contrib-
uting to the maintenance of pluripotency [19, 20]. Even
though a complete bypass of LIF signaling is possible under
certain circumstances [15], optimal self-renewal is obtained
by combination of LIF and 2i, confirming LIF/STAT3-path-
way as an essential component in ESCs. Moreover, STAT3-
activation was recently described to be a limiting factor for
reprogramming to ground state pluripotency [21]. Expression
of Pramel6 and Pramel7 was increased upon overexpression
of STAT3 in ESCs [14] and therefore represent potential can-
didates involved in regulating the homeostasis of ESCs [14,
22, 23].
Here, we demonstrate that Pramel7 is not only a direct
target of STAT3 but also that STAT3-mediated maintenance
of pluripotency strongly depends on Pramel7 expression. Dur-
ing the preimplantation embryo stages the LIF/gp130 pathway
is dispensable for early development without diapause [24].
Nevertheless, even in the absence of LIF stimuli, Pramel7 is
expressed in the inner part of the morula and in the ICM of
the embryo. Intriguingly, in Stat3-knockout cells, where the
LIF/STAT3-pathway is not active, Pramel7 expression was
upregulated compared with the wt cells. These findings sug-
gest that there might be LIF/STAT3 compensatory mecha-
nisms or factors, which drive and regulate Pramel7 expres-
sion. We exclude the possibility of an autoregulatory activity
of Pramel7, as the protein lacks the characteristic domains
Figure 5. Transcriptional regulation of Pramel7. (A): Quantitative real-time polymerase chain reaction (PCR) analysis of Pramel7 gene expres-
sion in E14 wild-type (wt) ESCs stimulated with LIF in presence of 2i, PD0325901 (PD), or CHIR99021 (CHIR) at different time points. (B):
Quantitative real-time PCR analysis of Pramel7 and Stat3 expression in E14 wt ESCs stimulated with LIF in presence of LY294002. (C): Gene
expression analyses in E14 wt cells cultivated for 5 or 9 days in the presence of CHIR99021. (D): Immunostaining for SSEA-1 and OCT3/4 of
E14 and Pramel7 cells after 5 days in N2B27 medium supplemented only with CHIR99021. Transgenic Pramel7 cells retained the expression of
OCT3/4 and SSEA-1 markers, whereas E14 wt cells differentiated. (E): Quantification of alkaline phosphatase-positive colonies after 9 days of
culture in N2B27 medium supplemented only with CHIR99021. Abbreviation: LIF, leukemia inhibitory factor.
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Figure 6. The sole Pramel7 overexpression in serum- and feeder-free condition is not completely sufficient for maintaining the undifferentiated
state of ESCs. (A): Representative appearance of alkaline phosphatase (AP)-positive colonies in E14 wt and Pramel7-overexpressing cells after
11 passages in N2B27 þ 2i medium (feeders free and LIF free). Both cell lines show AP activity. (B): Representative morphology of wt and Pra-
mel7 ESCs after three passages in N2B27 medium in absence of 2i and LIF. (C): E14 and Pramel7 cells cultivated for four passages in N2B27
medium supplemented with LIF only. (D): Immunostaining for OCT3/4 and SSEA-1 expression in wt and Pramel7-overexpressing cells culti-
vated in N2B27þLIF. E14 cells lost OCT3/4 and SSEA-1 expression, whereas Pramel7 cells remained undifferentiated. (E): Quantification of
AP-positive colonies after 9 days of culture in N2B27 medium supplemented only with LIF. (F): Gene expression analysis of ESCs cultivated 5
and 9 days in N2B27þLIF. E14 cells showed progressively downregulation of pluripotency genes and upregulation of differentiation marker
genes. Abbreviations: LIF, leukemia inhibitory factor; SSEA-1, stage-specific embryonic antigen-1.
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typical for transcriptional factors but contains LRR domains
mediating protein-protein interactions [25].
Pramel7 regulation occurs through a parallel circuit involv-
ing both the STAT3 and the PI3K-pathway. The regulation of
GSK3b by PI3K is involved in the transcription of Pramel7
upon LIF stimulation and thus for the maintenance of LIF-
mediated control of ESC self-renewal. We suggest that GSK3b
is directly involved in the control of STAT3-mediated Pramel7-
transcription, but the exact nature of this regulation remains to
be elucidated. Interestingly, recent data suggests that STAT3-
activation is dependent on GSK3b [26]. Beurel et al. reported
that GSK3b does not function upstream of STAT3-activating
tyrosine kinases but instead is required for the recruitment of
STAT3 to the receptor and for its tyrosine phosphorylation-
mediated activation. Even though the authors did not directly
analyze ESCs, they demonstrated that the dependence of
STAT3-activation on GSK3b was a widespread regulatory
interaction observed with multiple stimuli and in several types
Figure 7. Hypothetical transcriptional mechanisms, which drive Pramel7 expression. (A): Schematic representation of Pramel7 transcription
directly controlled by the LIF/STAT3-pathway and also by the LIF/PI3K-pathway. LIF/gp130 receptor leads to the activation of three different
pathways, that is, the LIF/STAT3, the LIF/PI3K/GSKb3, and the LIF/MEK/ERK-pathway. Pramel7 transcription is directly controlled by the
transcription factor STAT3, whereas its phosphorylation is probably regulated by the GSK3b kinase. The combinatorial effect of LIF/STAT3 and
GSK3b drives and controls Pramel7 transcription, which in turn blocks phosphorylation of ERK and therefore ESCs differentiation. (B): Sche-
matic representation of Pramel7 expression and effects in vivo and in vitro. In the late preimplantation embryo, Pramel7 expression is only de-
tectable in the inner part of the morula and in the ICM of the blastocyst. Immediately after implantation Pramel7 expression disappears, when
differentiation processes occur in the embryo. In vitro wild-type (wt) ESCs do express Pramel7 but need LIF for self-renewing. After LIF deple-
tion wt ESCs differentiate into different cell types and also form EBs. In Pramel7-overexpressing cells, addition of LIF in the medium is not nec-
essary anymore for maintaining the undifferentiated and self-renewing state of the cells. These cells are not able to differentiate and either form
undifferentiated embryoid bodies or die. Once the overexpression of Pramel7 is reverted to the wt level, these cells are able to differentiate and
take part to embryo development. Abbreviations: EBs, embryoid bodies; ERK, extracellular signal-regulated kinase; ICM, inner cell mass; LIF,
leukemia inhibitory factor; MEK, MAPK/ERK Kinase; pERK, phosphorylated ERK.
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of cells [26], suggesting that the same molecular process likely
occurs in ESCs. This is interesting because it was previously
shown that in ESCs, STAT3 is not a target of PI3K action and
that the loss of self-renewal and the consequent differentiation
of the cells after inhibition of PI3K was due to an increase in
pERK upon LIF-stimulation [27]. The ERK-pathway is continu-
ously activated in undifferentiated ESCs predominantly by sig-
naling through FGF receptor [28]. It is widely accepted that in
self-renewing ESC cultures, the provision of LIF and the fol-
lowing activation of STAT3 acts downstream of pERK to over-
ride the auto inductive capacity of FGF4. In this study, we iden-
tify for the first time Pramel7 as a protein that links the three
LIF/gp130-induced pathways (LIF/STAT3, LIF/MEK/ERK,
and LIF/PI3K/GSK3b). We suggest that the concerted activity
of STAT3 and GSK3b controls Pramel7 transcription, which in
turn regulates the phosphorylation of ERK leading to an abroga-
tion of ESC differentiation (Fig. 7A).
Importantly, Pramel7 blocks teratoma formation capacity
and differentiation potential in vitro and in vivo, indicating
that Pramel7 silencing is an absolute requirement for differen-
tiation (Fig. 7B). Similar to Pramel7 overexpression, forced
expression of Nanog confers LIF-independent self-renewal
and prevents differentiation of ESCs [11]. Unlike Pramel7-
overexpressing cells, though, Nanog-overexpressing clones
were able to generate teratomas-containing derivatives of all
three germ layers. Even though forced expression of both
genes in absence of LIF leads to self-renewal of ESCs, our
data highlights a different reaction to differentiation stimuli
and therefore a different function of these genes in maintain-
ing pluripotency. Nanog is expressed at similar levels in both
ICM and ESCs, whereas Pramel7 expression is higher in the
ICM than in ESCs [22]. Moreover, it was reported that the
essential function of Nanog is to define the pluripotent pool
of cells of the ICM and the germ cells, and once the cells are
established, its function is dispensable, so that Nanog null
ESCs are able to self-renew [29]. Our data also confirms the
idea that Nanog is important for the pluripotent identity of the
ICM and of ESCs, whereas Pramel7 is more probably
involved in allowing/blocking the start of differentiation
rather than actively taking part in the processes maintaining
pluripotency. In agreement with this hypothesis, elimination
of Pramel7 expression by knockdown induces ESC differen-
tiation independently if LIF or even STAT3 overexpression is
present. Taken together, this suggests that Nanog is priming a
cell to become pluripotent, whereas Pramel7 inhibits a pluri-
potent ESC from commitment and suggests that Pramel7 acts
as the judge in the trial between pluripotency and differentia-
tion. Its presence maintains the cells in a self-renewing state
by retarding commitment.
Assuming that Pramel7 is not directly acting as a transcrip-
tional factor but solely through binding to other proteins, fur-
ther experiments aimed at the identification of potential Pra-
mel7 binding partners are necessary to reveal the mechanisms
underlying maintenance of pluripotency through Pramel7.
CONCLUSION
Our data show that the combined activity of STAT3 and GSK3
controls Pramel7 transcription, which in turn regulates the
phosphorylation of ERK leading to the inhibition of ESC
differentiation. Accordingly, Pramel7 ablation causes ESC
differentiation, whereas its overexpression sustains long-term
self-renewal in the absence of LIF. These observations prove
Pramel7 as an essential factor of the signaling network regulating
pluripotency and self-renewal in ESCs.
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Materials and methods 
Endogenous Pramel7 expression in postimplantation embryos 
Embryos were isolated at E6.5 from time-mated females. Six embryos were pooled together and total 
RNA was extracted from the decidua and from the embryos (QIAGEN RNeasy mini-kit). 0.3 µg of 
total RNA were reverse transcribed and cDNAs were used for RT-PCR. Primers are listed in 
Supplemental Table 1. 
 
Generation and characterization of transgenic ESCs 
Vector cloning, generation and characterization of transgenic ESCs overexpressing the selected genes 
were performed as previously described (Cinelli et al., 2008). Primers for real-time PCR are listed in 
Supplemental Table 1. The Pramel6 clones P6-2 and P6-9 and the Pramel7 clones P7-B5 and P7-2D4 
possessed the strongest overexpression and were chosen for further experiments. For Cre-excision, 
overexpressing ESCs were transiently electroporated and further examined by fluorescent microscopy 
for EGFP expression. Single colonies were picked and analyzed by real-time PCR. The clones with 
wt-like gene expression were chosen for in vitro experiments and for generation of chimeras.  
 
Long-term culture under serum- and feeder-free conditions 
E14 and Pramel7 cells were cultivated on gelatinized dishes with N2B27+2i medium and passaged till 
the feeders were eliminated. After 11 passages both cell lines were tested for AP activity. Cells were 
then cultivated with N2B27-medium supplemented either with 2i, only CHIR99021 or only LIF for 9 
days. At day 5 and 9 cells were taken for RNA extraction and for immunohistochemical analyses. 
Total RNA was reverse transcribed and gene expression was monitored by real-time PCR. 
 
Real-time PCR  
0.5 to 2 µg of total RNA from cultured ESCs were reverse transcribed with Oligo-dT primers 
(Invitrogen) and Superscript III (Invitrogen). Real-time PCR was performed in triplicates and analyzed 
with Delta Ct-method. β-Actin was used for normalization. Primers are listed in Supplemental Table 
1.  
 
Western blotting 
Cells were homogenized with RIPA buffer (50 mM Tris-Cl pH 7.4, 1% NP-40, 0.25% sodium 
deoxycholate, 150 mM NaCl). Protein concentration was determined with BCA-Method (Pierce). 
Samples were subjected to SDS-PAGE and blotted onto PVDF membrane (Millipore, Volketswil, 
Switzerland) at 100 V for 1.5h at 4°C. Immunodetection and chemiluminescent visualization were 
performed as recommended by the supplier of the chemiluminescence blotting kit (Roche Diagnostics, 
Rotkreuz, Switzerland). Each lane was loaded with 10µg of protein. Antibodies: against STAT3 (C-
20, Santa Cruz Biotechnology), against phosphorylated STAT3 (Y705, New England Biolabs), anti 
ERK and phosphorylated ERK (Thr202/Tyr204, Cell Signaling Technology). 
 
In vitro differentiation 
Embryoid bodies were maintained in suspension for 10 days in CM-medium without LIF on 
bacteriological Petri dishes. At day 10 total RNA was isolated, reverse transcribed and RT-PCR was 
performed. Primers are listed in Supplemental Table 1.  
For monoculture neural differentiation, 2x105 ESCs were plated onto gelatinized 35mm dishes. The 
cells were cultivated for 4 days with neural differentiation medium. At day 4 cells were fixed and 
stained with DAPI. For pyknotic nuclei quantification: 10 pictures of the cells were randomly taken 
with 40x magnification. Every single cell was counted as dead when the nucleus was condensed, as 
live if the DAPI staining showed normal morphology of the nuclei. 
 
Teratoma formation  
1x106 cells were injected subcutaneously into each dorsal flank of NOD/SCID mice. Three weeks 
after injection, teratomas were dissected and fixed in 4% paraformaldehyde. Sections were stained 
with haematoxylin/eosin, anti bIII-Tubulin (Sigma), anti smooth muscle actin (Sigma), and with anti 
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glial fibrillary acid protein antibodies (Sigma). The Veterinary Office of the Canton of Zurich, 
Switzerland approved all animal experiments.  
 
Chimera generation with Cre-reverted Pramel7 cells 
Cre-recombined EGFP expressing ESCs were aggregated with CD-1 morula according to standard 
procedures. Embryos were transferred into the uterine horns of pseudo pregnant CD-1 females. 
Chimerism of the pups was assessed by visualizing EGFP fluorescence. Number of the obtained 
chimeric animals is listed in Supplemental Table 3. The Veterinary Office of the Canton of Zurich, 
Switzerland approved all animal experiments. 
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TABLE 1: primer used 
 
Gene name Sequence 
βactin_bwd 5'-gat ctt cat ggt gct agg agc cag agc-3' 
βactin_fwd 5'-cat cca ggc tgt gct gtc cct gta tgc-3' 
Brachyury_bwd 5'-aga ggc tgt aga aca tga tt-3' 
Brachyury_fwd 5'-atg cca aag aaa gaa acg ac-3' 
Dppa3_bwd 5'-gct cct aat tct tcc cga ttt tcg cat-3' 
Dppa3_fwd 5'-agg gtc cgc act ttg ttg tcg gtg c-3' 
Fgf5_bwd 5'-ctt cag tct gta ctt cac tgg-3' 
Fgf5_fwd 5'-aaa gtc aat ggc tcc cac gaa-3' 
Gata6_bwd 5'-ctc ttg gta gca cca gct ca-3' 
Gata6_fwd 5'-gca atg cat gcg gtc tct ac-3' 
Nanog_bwd 5'-gga gac ttc ttg cat ctg ctg g-3' 
Nanog_fwd 5'-aca agg gtc tgc tac tga gat gc-3' 
Oct3/4_bwd 5’-ctc gaa cca cat cct tct ct -3’ 
Oct3/4_fwd 5’-ggc gtt cgc ttt gga aag gtg ttc -3’ 
Pem/Rhox5_bwd 5'-tgt cat agc cgg cat atg tg-3' 
Pem/Rhox5_fwd 5'-ctt ccg tgg aca aga gga ag-3' 
Pramel6_bwd 5'-agc cct gga atc tca tag cct aca tc-3' 
Pramel6_fwd 5'-cag gaa gac gag tgg caa agc acg t-3' 
Pramel7_bwd 5'-ctc tta gag gcg tga cat cta ggt t-3' 
Pramel7_fwd 5'-gag gag aag cag aac atc agc aag a-3' 
Rex1_bwd 5'-agg gaa ctc gct tcc aga ac-3' 
Rex1_fwd 5'-aga aag cag gat cgc ctc ac-3' 
Sox2_bwd 5'-ttg cct taa aca aga cca cga aa-3' 
Sox2_fwd 5'-tag agc tag act ccg ggc gat ga-3' 
Stat3_bwd 5'-agc tgc tgc ttg ttg gtg tat gg-3' 
Stat3_fwd 5'-ggc aag ggc ttc tcc ttc tg-3' 
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TABLE 2: shRNA against Pramel7 sequences 
 
shRNA Sequence 
GI580382 GGA GCA GTA GAA GTG TCT AAG GTC AGG AA 
GI580383 AGC CTG GTG AGG AAT GAA GTA TTG ACC GT 
GI580384 AAT GTA TCC TGC TCC ATC AGA GGT CTA TA 
GI580385 TCA CTC AAG AGG AGA AGC AGA ACA TCA GC 
 
 
TABLE 3: List of Morula Aggregations 
 
Morula aggregation with Cre-reverted Pramel7 ESCs 
 
 transferred 
embryos 
obtained 
chimeras 
Aggregation for 
isolation of E17.5 
embryos 
102 6 
Aggregation for 
postnatal chimera 
formation 
40 3 
 
Morula aggregation with RFP-labeled Pramel7 overexpressing cells 
 
ESCs used for 
aggregation 
Aggregate embryos 
transferred to foster 
mother 
Chimeric embryos 
(E5.5) 
normal 
Chimeric embryos 
(E5.5) 
abnormal 
Cre-reverted Pramel7 
cells (EGFP) 65 8 - 
Pramel7 
overexpressing ESCs 
(RFP) 
103 - 10 
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Supplemental Figure 1: In silico characterization of Pramel6 and Pramel7 genes and expression in 
the preimplantation embryo. A. Localization of Pramel6 and Pramel7 genes on chromosome 2(D) in 
the mouse. The genes are oriented in opposite directions and separated from a genomic fragment of 16 
kb. B. Aminoacid alignment of Pramel6 and Pramel7 proteins shows high similarity (51%) and the 
presence of highly conserved leucine-rich repeats (LRRs). The alignment was generated with TCoffee 
and shaded with respect to Pramel6, red to yellow to green indicates the degree of conservation of the 
aminoacids, being red the highest and green the lowest degree. C. In situ hybridization of Pramel6 and 
Pramel7. Pramel6 exhibits a general expression in all cells of the morula and of the blastocyst whereas 
Pramel7 expression is restricted to the cells of the inner part of the morula and to the ICM in the 
blastocyst. Sense probes in the same concentration of the antisense probes were used as negative 
controls for the hybridization. Magnification 40x. 
 
Supplemental Figure 2: Generation and characterization of transgenic ESC lines. A. Scheme of 
floxed Pramel’s expression vector: The LoxP sites are positioned in the second exon of the CAG 
cassette and between the terminator sequence and egfp, such that following Cre-mediated 
recombination CAG directly controls expression of egfp. B. Real-time PCR analysis of Pramel7 
overexpressing clones and their respective Cre-revertants. Fold changes were measured compared to 
the wt E14 cells. Actin was used for normalization. C. Pramel6 overexpressing clone with the 
respective Cre-revertant. Pramel6 expression was assessed by real-time PCR. D. Gene expression in 
Nanog overexpressing clone. Real-time PCR analyses of known pluripotency related genes. E. 
Representative morphology of wt E14 and the transgenic clones (Cre-reverted Pramel7 clone 2D4_3; 
Pramel7 overexpressing cells clone 2D4; Pramel6 overexpressing cells clone 2; Nanog overexpressing 
cells).  
 
Supplemental Figure 3: A. Phase pictures of all the transgenic ESC lines. Parental E14 cells, Cre-
reverted Pramel7, Pramel6, Pramel7 and Nanog overexpressing cells were cultivated on Lif knockout 
feeders in absence of LIF in the medium for 11 days. B. Western blot for LIF-dependent phospho-Erk 
levels. Pramel7 maintains pluripotency through gradual suppression of ERK phosphorylation. E14 wt 
cells, Pramel6, and Cre-reverted Pramel7 cells showed gradual phosphorylation of ERK increasing 
with the LIF incubation times. Only Pramel7 overexpressing cells showed dephosphorylation of ERK 
after 30min incubation with LIF. Total ERK was used as a loading control.  
 
Supplemental Figure 4: A. Size of teratomas generated with Nanog-overexpressing cells (Nanog), 
E14 wt cells, Cre-reverted Pramel7 cells (P7Cre) and Pramel6 overexpressing cells (P6). B. Various 
tissues present in teratomas derived from E14 wt cells, Cre-reverted Pramel7 cells, Nanog 
overexpressing and Pramel6 overexpressing cells. Magnification 10x. 
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Supplemental Figure 1 
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Supplemental Figure 2 
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Supplemental Figure 3 
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Supplemental Figure 4 
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Abstract  
 
The transition between morula and blastocyst stage during preimplantation development represents the 
first differentiation event of embryogenesis. Morula cells undergo the first cellular specialization and 
produce two well-defined populations of cells, the trophoblast and the inner cell mass (ICM). 
Embryonic stem cells (ESCs) with unlimited self-renewal capacity are believed to represent the in 
vitro counterpart of the ICM. Both mouse and rat ESCs can be derived from the ICM cells, but their in 
vitro stability differs.  
In this study we performed a microarray analysis in which we compared the transcriptome of mouse 
and rat morula, blastocyst, and ICM. This is the first study investigating the gene expression changes 
during the transition from morula to blastocyst in the rat preimplantation development. Moreover, it 
represents a new example of statistical approach for cross species analysis, applicable also to other 
species comparisons, that allows to highlight the species-specific behavior of genes within important 
pathways and families. In order to identify alternative regulation of important molecular mechanisms 
the investigation of differential gene expression between the two species was extended at the level of 
signaling pathways, gene families, and single selected genes of interest. This study reports for the first 
time that in the pluripotent pool of cells of the rat and mouse preimplantation embryo substantial 
differential regulation of genes is present, which might explain the difficulties observed for the 
derivation and culture of rat ESCs using murine conditions. Some of the genes differentially expressed 
are already known to be important factors in the maintenance of pluripotency in ESCs, like for 
example Sox2 or Stat3, or play a role in reprogramming somatic cells to pluripotency like c-Myc, Klf4 
and p53 and would therefore represent interesting candidates to further analyze in vitro in the rat 
ESCs.  
 
Author Summary  
 
In this study we analyzed the molecular mechanisms controlling the transition between morula and 
blastocyst during preimplantation development in mice and rats in order to identify differences in the 
establishment of the pluripotent pool of cells in both species. Comparing the molecular processes 
taking place during the transition from morula to blastocyst in the mouse and in the rat represents a 
good model for understanding the differences in derivation and cultivation of ESCs observed in the 
two species.  
In the present work cross-species comparison allowed the identification of differences in the 
regulation of important developmental pathways and factors, and of genes involved in the 
maintenance of pluripotency and reprogramming. These results are of interest for the optimization of 
the derivation and cultivation of rat ESCs. 
 
Introduction 
 
The period of time that lasts from the fertilization of the egg to the implantation of the blastocyst 
represents an attractive model for studying regulatory networks that determine cell fate decisions. Of 
particular interest is the transition between morula and blastocyst stages, the first differentiation event 
of embryogenesis, a period where pluripotent cells are formed. Morula cells undergo the first cellular 
specialization and produce an outer rim of cells, the so-called trophoblast that surrounds an inner core 
of cells the inner cell mass (ICM). The signals that regulate the differentiation of the trophectoderm 
are largely unknown. One of the key discoveries of the last century was the observation that after 
transferring blastocyst stage embryos in an artificial context it is possible to establish cells, which 
retain the pluripotent state. These cells, also known as embryonic stem cells (ESCs) are derived from 
the ICM of the blastocysts (Evans and Kaufman, 1981; Martin, 1981) and exhibit unique 
characteristics: They unlimitedly self-renew in vitro and are able to contribute to the formation of all 
cells of an adult organism. Understanding how this population of cells is formed and maintained is of 
fundamental importance not only for developmental biology but also for regenerative medicine and 
cancer biology. Nowadays, ESCs are routinely derived from mouse blastocyst embryos, even though 
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not with any difficulties. The mouse has represented for many years the sole organism where 
pluripotent and germline competent ESCs could be derived. Only recently, almost 30 years after the 
establishment of the first murine ESC line, genuine rat ESCs have been generated (Buehr et al., 2008; 
Li et al., 2008). The real identity and stability of these cells is not yet completely understood, 
especially because murine ESCs and rat ESCs are derived and cultivated under different conditions. 
Mouse ESCs can be maintained in medium containing inhibitors of the fibroblast growth factor 
(FGF)/mitogen-activated protein kinase (MEK)/extracellular signal-related kinase (ERK1/2) and of 
the glycogen synthase kinase 3 (GSK3) inhibitor. These culture conditions are known as the 3i or 2i 
culture conditions (Ying et al., 2008) and have been also used for the successful establishment of 
murine ESCs from non-permissive mouse strains such as the non-obese diabetic (NOD) mice (Nichols 
et al., 2009a). Molecularly, rat ESCs express the same pluripotency markers like murine ESCs (Buehr 
et al., 2008; Li et al., 2008) but can be established and maintained in vitro only under defined culture 
conditions and additionally in the presence of LIF and feeders.  The difference between the two 
species is also mirrored at the preimplantation development level. Mouse embryos reach the blastocyst 
stage at day E3.5 whereas the rat at day E4.5 (Fig. 1A), nevertheless both species give birth at day 
E21. These differences highlight the complexity of the mechanisms that define the pluripotent state of 
a cell and let to assume that in the rat other molecular mechanisms might be involved in the 
maintenance of the pluripotent state in vitro compared to the mouse.  
Extending the knowledge of the molecular processes driving the establishment of pluripotency in vivo 
is decisive for understanding the identity and properties of ESCs in vitro. We therefore reasoned that a 
comparison of the gene expression profiles in preimplantation embryos in the mouse and in the rat 
would be of advantage for improving the comprehension of the pluripotent state and eventually for 
optimizing derivation and cultivation of rat ESCs. With this purpose we examined and compared with 
a molecular genetic approach the global gene expression in morula, blastocyst, and in isolated ICM of 
mouse and rat. With this cross species gene expression comparison we were able to highlight different 
regulation not only of important developmental pathways like Wnt and Notch, but also of genes 
known to play important roles in the maintenance of pluripotency in ESCs and in reprogramming 
processes like for example Sox2, Klf4, c-Myc and p53. 
 
Results and Discussion 
Statement of grounds and experimental design 
During early embryogenesis, pluripotency is a characteristic property of a distinct number of cells of 
the morula and the ICM of the blastocyst, from where pluripotent ESCs are established (Fig. 1B). We 
collected morula and blastocysts stage embryos from mouse and rat and, by immunosurgery, we 
isolated the ICM cells from the blastocysts. All the embryos and ICMs were pooled into two groups 
for every developmental stage (Fig. 1C). Pooling of embryos for RNA extraction in this study was 
chosen mainly because of the low amounts of RNA that can be isolated from preimplantation 
embryos, and in addition because of the heterogeneity of the cell populations present in the embryos. 
For the analysis we pooled a large number (n>100) of the independent isolated embryos to achieve a 
sufficient accuracy of biological pooling (Fig. 1C).  Due to the difficulties to isolate a larger number of 
embryos from mice and rats, we performed the microarray study by using two replicate samples per 
developmental stage (Fig. 1D). Data obtained in such a way are not sufficient to compute p-values 
from statistical tests, but allows quantification based on fold changes of gene expression between the 
three different cell populations. The direction, magnitude and shape of the profile of fold changes were 
used as a main basis for the whole genome inter-species comparison (Fig. 1D).  
The global significance analysis of the mouse and rat expression profiles is depicted on the Figure 2A 
and 2B. Top 20 differentially expressed probesets for the mouse (Fig. 2A) and for the rat (Fig. 2B) 
have been selected in each of the pairs of treatments and then used at the input of hierchical clustering 
for the heatmap. The heatmap shows that each pairwise comparison has a group of upregulated and 
downregulated genes, however on the global level there is hardly any overlap in terms of orthologs 
(just one gene in common in the heatmap built with over 50 genes from the three top 20 lists). This 
leads to the conclusion that prior biological knowledge should be used for the search of meaningful 
relationships. We therefore gathered the information present in the GeneGo pathways in order to 
investigate the similarities and differences locally, within the context of pathways and gene families.  
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Identification of differentially expressed genes in the three cell populations  
To reveal similarities and differences in the regulatory mechanisms controlling mouse and the rat 
development of morula and blastocyst, we first analyzed the data of the mouse and the rat microarray 
study separately. We selected the genes that had a fold change (understood as the difference between 
log2 signal values) higher than 1.5 in the three comparisons: ICM versus blastocyst (ICM vs B), 
blastocyst versus morula (B vs M), and ICM versus morula (ICM vs M). The genes with a positive 
value are always upregulated in the first cell population of the comparison, whereas those with a 
negative value are higher expressed in the second cell population of the comparison. 
For the mouse study we found that out of 17’973 genes 166 were differentially regulated between the 
ICM and the blastocysts (Fig. 2C and Supplemental Table 1A). A higher number of differentially 
regulated genes was found in the comparison B vs M, where 1’621 genes had a fold change higher 
than 1.5 (Fig. 2C and Supplemental Table 1B). In the comparison ICM vs M we found 1’370 genes, 
957 of which were also differentially expressed between blastocyst and morula (Fig. 2C and 
Supplemental Table 1C). Between the 957 genes found in both the comparisons ICM vs M and B vs 
M a clear upregulation of the transcription factor Stat3 (Signal Transducers and Activators of 
Transcription 3) and the Lif receptor Lifr were present. Both genes were upregulated in the blastocyst 
or the in ICM compared to the morula but were not differentially expressed in the comparison ICM vs 
B (Supplemental Table 1B and 1C), confirming their specific expression in the blastocyst. This is 
interesting because previous data suggested that the LIF/STAT3 pathway is dispensable during the 
preimplantation embryo development in the absence of diapause (Li et al., 1995; Nakashima et al., 
1999; Nichols et al., 2001; Stewart et al., 1992). Nevertheless, this pathway plays a fundamental role 
in vitro in the maintenance of pluripotency and derivation of ESCs (Casanova et al., 2011b; Cinelli et 
al., 2008; Matsuda et al., 1999; Niwa et al., 1998). Our data highlight the possibility that the 
characteristic expression of these genes at the blastocyst stage might indeed play an important role, 
and that the previously performed studies with knockout embryos could have been biased by the 
induction of compensatory mechanisms.  
Only 23 genes were differentially expressed in both the comparisons ICM vs B and B vs M (Fig. 2C). 
Between them, the Celf5 gene, a member of the CELF gene family (Ladd et al., 2001), showed a 3.5 
fold upregulation in the comparison B vs M and a -2.5 fold downregulation in ICM vs M, indicating a 
potential function in the trophoblast cells of the blastocyst.  
In order to reduce the number of differentially expressed genes we further selected for mouse genes 
with a fold change higher than 3 (Fig. 2D) aiming at the identification of genes that are 
characteristically expressed in the ICM. The gene Fos had a fold change of 3.5 in the comparison ICM 
vs B and -3.9 in the comparison B vs M (Supplemental Table 1A and 1B) indicating that Fos 
expression is high in the morula and persists in the ICM cells of the blastocyst. Interestingly, it has 
been shown that Fos is also expressed in vitro in undifferentiated ESCs and disappears as soon as the 
cells undergo differentiation (Yang et al., 2009). A second gene with characteristic ICM expression is 
Egr1, which was upregulated 4 times in the comparison ICM vs B and was strongly downregulated in 
the comparison B vs M (Supplemental Table 1C). This data suggests that Egr1 plays an important role 
in the mouse ICM.  
 
For the rat study we identified 192 out of 12’102 genes that had a fold change higher than 1.5 in the 
comparison ICM vs B (Supplemental Table 2A), among these 71 were also found differentially 
regulated in the comparison ICM vs M (Fig. 2E) and 7 of them showed a fold change higher than 3 
(Fig. 2F). The genes Nqo1, Ddhd1, Hmox1 and Chac1 had a positive fold change in both the 
comparisons ICM vs B and ICM vs M (Supplemental Table 2C), indicating that they are upregulated 
exclusively in the ICM cells of the rat blastocyst. None of these 7 genes was found in the mouse study 
in the comparison ICM vs B and ICM vs M, except for the Nqo1 (NAD(P)H quinone oxidoreductase) 
that was upregulated in the ICM compared to the morula, nevertheless with a factor of 1.5. It has been 
shown that inhibition of NQO1 causes degradation of p53 in various cell types (Asher et al., 2001) 
therefore NQO1 supports the accumulation of p53, which leads to the induction of growth arrest 
(Levine, 1997; Vogelstein et al., 2000) and/or apoptosis (Lowe et al., 1993). The finding that in the rat 
ICM Nqo1 is upregulated compared to the blastocyst with a fold change of 4.5 and compared to the 
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morula with a factor of 5 indicates that this enzyme could play an important role in the ICM cells of 
the rat blastocyst.  
Interestingly, in the rat study the transcription factor Stat3 was not identified in the list of genes 
differentially regulated with a fold change of at least of 1.5. However, we identified the genes Stat2 
and Stat6, the former had a fold change 1.9 and 1.6 in the comparisons B vs M and ICM vs M, the 
latter Stat6 had a fold change respectively of -2.1 and -2.4 (Supplemental Table 2B and 2C). Thus, 
Stat2 is upregulated in the blastocyst and in the ICM whereas Stat6 has a higher expression in the 
morula. The STAT proteins are a group of transcription factors that transmit signals from the 
extracellular surface of cells to the nucleus and they are involved in growth, differentiation, apoptosis, 
and carcinogenic transformation of the cells. Interestingly, in previously performed microarray studies 
with mouse preimplantation embryos, Stat2 was shown to be upregulated in the 8-cells stage embryo 
and then downregulated in the blastocyst stage. The Stat6 indeed, was found upregulated in the 
blastocyst and downregulated in the 8-cells stage (Zeng et al., 2004). We found that in the rat embryo 
the expression of these two genes showed exactly the opposite behavior.  
 
In a second step we performed a global analysis of these datasets with the GeneGo software using 
Metacore annotation database to assign functional biological processes to each individual species 
dataset. For every comparison we selected the 20 more significant processes present in the 1.5 fold 
change gene groups (Supplemental Fig. 1). This analysis highlighted that in the three comparisons 
there are different biological processes taking place in the two species. Seen that the rat 
preimplantation embryo development is shifted compared to the mouse of about 24 hours, it is 
reasonable to assume that processes like cell cycle or proliferation differs in the two species at these 
developmental stages (Supplemental Fig. 1). 
In summary, by comparing the gene expression in the morula and blastocyst from the mouse and from 
the rat, we demonstrated that there are differential regulations of factors between the two species. 
Further analyses are needed in order to understand if these genes could have a function in the 
establishment of ESCs. Of special interest are those upregulated in the comparison ICM vs B in the 
mouse and in the rat, because they might represent new factors involved in the establishment and 
maintenance of the ICM cells, and therefore they might be as well critical factors in the ESCs.  
 
Cross species analysis of selected pathways 
The purpose of this study was to identify molecular pathways or genes, which are differentially 
expressed between the mouse and the rat, in order to gain insight into the molecular processes 
governing pluripotency in the rat. We analyzed fold changes between mouse and rat in 11 selected 
pathways from GeneGo (GeneGo Maps). A list of all the genes and the selected pathways as well as 
the gene fold changes is reported in the Supplemental Table 3. For every comparison (B vs M, ICM vs 
B, and ICM vs M) we generated a plot comparing the fold change value of the selected genes in the 
mouse with the ones of the same gene in the rat. Every dot represents a gene. Red dots correspond to 
genes that have similar fold change values between the two species. Green dots label genes with 
different fold change values between rat and mouse in the selected comparison. Interesting genes are 
highlighted with a special label that allows following the expression through all the three comparisons. 
This representation depicts some interesting genes with different expression pattern in the two species.  
 
The Notch pathway 
The Notch pathway is a highly conserved cell signaling system present in most multicellular 
organisms; it influences differentiation, proliferation, and apoptotic events at all stages of 
development. The Notch proteins are situated on the cell membrane and most of the ligands are 
transmembrane proteins, therefore the Notch pathway is important for the cell-cell communication, 
where the signaling is trigged only from direct cell-to-cell contact. Notch controls the cell fate choices 
depending on the differential expression of ligands and receptors in apposing cells, and the pathway 
has been implicated in different aspects of stem cell biology.  
We analyzed 27 genes present in the pathway “Development Notch Signaling Pathway” in GeneGo. In 
the comparison B vs M most of the 27 genes behaved similar in both species and where therefore 
marked in red (Fig. 3A). Our study however identifies Notch1, one of the four known Notch receptors, 
Annex 3 
 87 
being upregulated in the mouse and downregulated in the rat in the comparison ICM vs B as well as in 
ICM vs M (Fig. 3A). Thus, Notch1 is upregulated in the mouse ICM but downregulated in the rat ICM 
(Fig. 3B). Activated Notch1 can promote, depending from the context, either differentiation processes 
or maintenance of stem cell proliferation (reviewed in (Artavanis-Tsakonas et al., 1999; Kadesch, 
2004)). Due to its variety of molecular functions, the finding that Notch1 is differentially expressed in 
the mouse and rat preimplantation embryos could indicate a different role in the two species.  
We also observed significant changes in the expression levels of other 5 genes: Aph1a, Jag1, Maml1, 
Tle2, and Tle4 (Fig. 3B). The gene Aph1a (anterior pharynx defective) was upregulated in the mouse 
but only slightly changed in the rat in the comparison B vs M (Fig. 3A and Supplemental Table 3). 
This gene encodes the membrane protein APH-1 that is an essential member of the γ-secretase, which 
cleaves single-pass transmembrane proteins at residues within the transmembrane domain. The γ-
secretase plays a critical role also in processing the Notch proteins (Francis et al., 2002). Moreover, it 
has been shown that APH-1a is the major mammalian APH-1 isoform required for Notch signaling 
during embryogenesis (Ma et al., 2005).  
Interestingly, the Notch ligand Jag1 (Jagged1) showed an opposite expression pattern compared to the 
one observed for the Notch1 receptor (Fig. 3A). Jag1 had fold change in the comparison B vs M of -1 
for the mouse and -3.4 for the rat. This indicates that Jag1 is highly expressed in the morula cells in 
both species but this upregulation is much stronger in the rat than in the mouse (Fig. 3B).  
The gene Maml1 (Mastermind-like 1) is involved in the regulation of the transcriptional activation of 
Notch target gene expression. Maml1 was strongly upregulated in the mouse in the comparison B vs 
M and ICM vs M (Fig. 3A). In the rat however, Maml1 was not changed in the comparison B vs M but 
showed an upregulation in both the comparisons ICM vs B and ICM vs M, indicating a higher 
expression in the cells of the ICM (Fig. 3B).  
The most important targets of the Notch1-complex are the HES (hairy and enhancer of split) genes, 
which are transcriptional repressors that rely on the general corepressor Groucho/Transducin-like 
enhancer of split (TLE) protein family (Giagtzoglou et al., 2003). Thus, TLE corepressors represent a 
key effecter of the Notch pathway. We found that in the comparison B versus M, Tle2 and Tle4 have a 
similar expression patterns in the rat and in the mouse (Fig. 3A). However, in both the comparisons 
ICM vs B and ICM vs M Tle2 and Tle4 were downregulated in the rat, indicating a lower expression 
in the ICM cells (Fig. 3B).  
In our study we showed that the expression of important factors like Notch1, Tle2 and Tle4 differs in 
the mouse and in the rat in the three cell populations analyzed. This leads to the assumption that the 
signaling pathway is differentially activated in the two species.  
 
Analysis of regulators of the cell cycle  
As previously mentioned there are strong differences during the preimplantation development of 
mouse and rat embryos. Mouse embryos need around three days to reach the blastocyst stage, what 
leads to a mean cell division time during this period of about 14h (Nagy et al., 2003). In reality every 
cell division cycle during the preimplantation development has different lengths (reviewed by 
(Ciemerych and Sicinski, 2005)). Of especial importance is the generation at the morula stage of 
blastomeres, which differ in size and cell division dynamic, and at the blastocyst stage they 
differentiate into trophoblast and the ICM cells. A typical characteristic of ESCs, isolated from the 
ICM, is that they exhibit an exceptional cell cycle distribution, where the S phase represents about 
75% of the total cell cycle and the G1 phase last for about 1h (Savatier et al., 1994; Savatier et al., 
1996). In the rat the formation of the blastocyst is almost 24h delayed compared to the mouse, the 
reason why the rat blastomeres are dividing slower than the mouse ones is largely unknown. In order 
to elucidate the events linked with cell cycle progression in both species we analyzed 11 genes of the 
GeneGo pathway “Cell cycle Influence of Ras and Rho proteins on G1/S Transition” that clearly 
showed differential expression in the three cell populations (Supplemental Table 3). 
The genes cyclin D1 (Ccnd1) and cyclin E1 (Ccne1) showed different expression pattern in the mouse 
and the rat preimplantation embryos. The Ccnd1 was downregulated for the mouse and upregulated 
for the rat in both the comparisons B vs M and ICM vs M (Fig. 4A). Thus, Ccnd1 is in the rat 
predominantly expressed in the ICM cells of the blastocyst and in the mouse in the cells of the morula 
(Fig. 4B). CCND1, in complex with CDK4/6, phosphorylates during the S phase transition the product 
of the retinoblastoma (Rb). Rb is involved in the initiation of DNA replication through the activation 
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of E2F, which in turn activates the transcription of Ccne1 (Harbour and Dean, 2000). The expression 
of Ccne1 in the mouse showed a similar pattern like Ccnd1, although the downregulation was more 
remarkable (Fig. 4A). This indicates that in the mouse there is a predominant expression of both 
cyclins in the morula cells than in the blastocyst cells. In the rat however, only Ccne1 was upregulated 
in the cells of the morula (Fig. 4B). Thus, both cyclins seems to have different expression pattern in 
the two species in the three analyzed cell populations. As mentioned before Rb is involved in the 
transcription of Ccne1. We observed an upregulation of Rb in the mouse for the comparisons B vs M 
and ICM vs M and a downregulation in the comparison ICM vs B (Supplemental Fig. 2A), indicating 
an increase in Rb expression from the morula stage to the blastocyst stage (Supplemental Fig. 2B).  
Skp2 (S-phase kinase-associated protein 2) is a component of the ubiquitin ligase complex SCF, which 
is responsible for the ubiquitin-dependent degradation of regulators of the cell cycle. Precisely, Skp2 
is involved in the degradation of the Cyclin-dependent kinase (Cdk) inhibitor p27 (Carrano et al., 
1999), inducing therefore cell cycle progression. p27 prevents cell cycle progression by inhibiting the 
Cyclin E-Cdk2 complex formation; in the presence of the Skp2-SCF complex p27 is degraded leading 
to the activation of the Cyclin E-Cdk2 complex, which causes the entrance into the S phase.  
The expression of Skp2 was for the mouse downregulated in both the comparisons B vs M and ICM vs 
M (Fig. 4A) showing a similar expression trend like Ccne1: Higher in the morula cells, low in the 
whole blastocyst, and very low in the ICM cells (Fig. 4B). Interestingly, the expression of Skp2 in the 
rat was higher in the cells of the ICM and lower in the whole blastocyst, highlighting a possible 
different role (Fig. 4B). 
During mitosis the cells undergo profound changes in the microfilament structure. The myosin 
regulatory light chains (Myls) control these morphological changes through their phosphorylations 
(Moussavi et al., 1993; Somlyo and Somlyo, 1994). The phosphorylation of Myls is controlled by the 
myosin light chain kinases (Mylks). It has been shown that the Rho kinases (ROCK) are also involved 
in the phosphorylation of Myls (Amano et al., 1996; Kimura et al., 1996). The phosphorylation sites 
on the Myls vary during the cell cycle progression, inducing their activation or inhibition (Totsukawa 
et al., 1999; Yamakita et al., 1994). Interestingly, the expression of Myl9, Mylk, Mylk3, and Rock2 was 
differentially regulated within the three comparisons in both species (Fig. 4A and 4B), demonstrating 
once more essential differences between mouse and rat preimplantation development.  
 
In the analysis of the pathway “Cell cycle Influence of Ras and Rho proteins on G1/S Transition” we 
identified two members of the phosphoinositide-3-kinase pathway (PI3K-AKT): The regulatory 
subunit 1 (Pik3r1) and 3 (Pik3r3). Interestingly, in the rat both genes were specifically downregulated 
in the cells of the ICM (Fig. 4A and 4B). The PI3K-AKT pathway has been implicated in many 
cellular processes like regulation of cell cycle progression, apoptosis, migration, and cell adhesion. We 
performed the cross species analysis on the pathway “Development Growth hormone signaling via 
PI3K/AKT and MAPK cascades” from GeneGo (Supplemental Fig. 3A), where we analyzed the 
expression of Pik3r1 and Pik3r3 together with other members of the PI3K-AKT pathway 
(Supplemental Fig. 3B).  
In the cross species analysis we examined the expression level of the proto-oncogene c-Myc. c-MYC 
plays important roles in various physiological processes like cell growth, proliferation, apoptosis, and 
loss of differentiation. In the comparisons B vs M and ICM vs M c-Myc was downregulated in both 
species, however in a more remarkable manner in the rat (Fig. 4A). Interestingly, the expression of c-
Myc was downregulated in the rat ICM, while it was expressed at equal levels in the mouse blastocyst 
(Fig. 4B). This is interesting, since c-Myc represents an important factor in stem cell biology; 
moreover it is able in vitro in combination with three other transcription factors (Oct3/4, Sox2, and 
Klf4) to reprogram differentiated cells into pluripotent cells (Takahashi and Yamanaka, 2006).  
The expression of Gsk3β (Glycogen synthase kinase 3 β) was found similarly regulated in both 
species (Fig. 4A). Nevertheless, in the rat Gsk3β was specifically downregulated in the cells of the 
ICM (Fig. 4B). It has been shown that authentic rat ESC can be derived and maintained in culture only 
in the presence of a GSK3β inhibitor (Buehr et al., 2008). On the contrary, pluripotent mouse ESCs 
can be established and maintained also under other culture conditions (Smith et al., 1988; Ying et al., 
2008; Ying et al., 2003). Our data report a downregulation of Gsk3β in the cells of the ICM in the rat 
but not in the mouse, letting assume that a low level of Gsk3β is fundamental in the rat for maintaining 
the pluripotent state in vivo as well as in vitro.  
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Another important signaling that influences the cell cycle is the p53 pathway (Supplemental Fig. 2A 
and 2B). Interestingly, the gene p53 (known in the mouse as Trp53 and in the rat as Tp53) was 
upregulated in the rat in both the comparisons ICM vs M and B vs M (Supplemental Fig. 7A), whereas 
in the mouse the expression was constant in all the three cell populations (Supplemental Fig. 7B). This 
could explain why in the rat the gene Nqo1 (responsible for the degradation of p53) was strongly 
upregulated in the ICM (Fig. 2F and Supplemental Table 2A). Other genes involved in the regulation 
of cell proliferation are reported in the Supplemental Figure 4, where we performed the cross species 
analysis on the pathway “Development SSTR2 in regulation of cell proliferation” from GeneGo. 
 
During embryo development, the proliferation kinetics of the cells affects their fate determination, so 
that different cell lineages show faster or longer cell cycle progression (Ciemerych and Sicinski, 
2005). Also in the ESCs in vitro a rigorous regulation of the cell cycle is fundamental for the 
maintenance of pluripotency. This study made apparent that critical factors involved in the cell cycle 
and proliferation are differentially expressed in the morula and the blastocyst of mouse and rat. These 
genes could therefore increase the list of players involved in the maintenance of pluripotency in the 
ESCs from both these two species.  
 
The TGF and the Wnt signaling 
The pathways transforming growth factor β (TGF-β) and Wingless (Wnt) are critically involved 
during the early embryo development. We analyzed 112 genes present in the pathway “Cytoskeleton 
remodeling TGF, WNT and cytoskeletal remodeling” from GeneGo. We highlighted 8 genes, which 
had a clear differential expression between the three comparisons and between the two species (Fig. 
5A and 5B).  
The Wnt pathway plays crucial roles in controlling genetic programs of embryonic development and 
adult homeostasis. Wnt signals are transduced depending on their functions through different receptors 
and members: The canonical Wnt pathway is known to be involved in transmitting signals for cell fate 
determination, whereas the non-canonical Wnt pathway is involved in controlling cell movements and 
tissue polarity. The gene caveolin 1 (Cav1) was downregulated in the blastocyst and ICM cells of the 
mouse (Fig. 5A), whereas it was almost not expressed in the rat cells (Fig. 5B). Cav1 is an essential 
component of the caveolae, where it acts as a regulator of caveolae-dependent lipid trafficking and 
endocytosis (Drab et al., 2001; Nabi and Le, 2003). Cav1 can act as a positive as well as a negative 
regulator of important signaling pathways (reviewed in (Shatz and Liscovitch, 2008)), for example it 
negatively regulates the Wnt pathway by recruiting β-catenin and therefore blocking the transcription 
of the β-catenin target genes (Galbiati et al., 2000). The two membrane receptors frizzled homolog 4 
(Fzd4) and frizzled homolog 5 (Fzd5) were upregulated in our analysis in the mouse ICM and 
blastocyst compared to the morula (Fig. 5A). However, in the rat we detected a very low expression of 
both receptors in all the three cell populations (Fig. 5B). This indicates that the Wnt pathway is 
differentially active in the two species (see also Supplemental Fig. 5). The gene Axin2 is a downstream 
target of the Wnt pathway that acts as a negative regulator by directing β-catenin for proteasomal 
degradation (Jho et al., 2002). It has been shown that stable β-catenin and elevated Axin2 transcription 
indicates the activation of the Wnt pathway (Lustig et al., 2002). In our cross species analysis Axin2 
was upregulated in the mouse in both the comparisons B vs M and ICM vs M (Fig. 5A), indicating a 
higher expression in the cells of the blastocyst and of the ICM (Fig. 5B). Interestingly, in the rat the 
expression of Axin2 decreased specifically in the cells of the ICM (Fig. 5B). The three regulators of 
the Wnt pathway, namely β-catenin (Supplemental Fig. 2B), Axin2 (Fig. 5B), and the Gsk3β (Fig. 4B) 
had a similar expression pattern in the rat embryos: A reduced expression in the ICM cells compared 
to the morula and whole blastocyst cells. In the mouse embryos the expression of these three factors 
was almost constant except for Axin2 that was upregulated in the ICM and blastocyst compared to the 
morula.  
The expression of the serine/threonine kinase mTOR (mechanistic target of rapamycin), which controls 
many biological and cellular processes such as cell growth, proliferation, and different types of 
differentiation (Hay and Sonenberg, 2004; Wullschleger et al., 2006), was upregulated in the mouse 
ICM (Fig. 5A) but showed a decreasing expression in the rat from the morula to the blastocyst stage 
(Fig. 5B).  
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The Wnt and TGF pathways control fundamental processes during the embryo development, and here 
we highlighted that the regulation of these pathways differ between the mouse and the rat. 
Interestingly, analysis of the expression of genes involved in the apoptotic and survival processes 
revealed as well differential expression between the two species. We analyzed 13 genes from the 
pathway “Apoptosis and survival NGF signaling pathway” (Supplemental Fig. 6A and 6B) and 20 
genes from the pathway “Apoptosis and survival Apoptotic Activin A signaling” (Supplemental Fig. 
7A and 7B) from GeneGo. For example the apoptosis related gene Caspase3 (Casp3) was upregulated 
in the rat in all the three comparisons (Supplemental Fig. 6A) indicating a higher expression in the 
cells of the blastocyst (Supplemental Fig. 6B). On the contrary in the mouse, Casp3 was upregulated 
in the cells of the morula and then the expression decreased in the blastocyst (Supplemental Fig. 6B).  
 
In summary, this study identified within important signaling pathways interesting candidates 
differentially expressed in the mouse and in the rat preimplantation embryos. We believe that these 
differences observed in vivo might reflect also the differences observed between the mouse and the rat 
ESCs, for instance in their derivation efficiency and maintenance. Further analyses are needed in order 
to clarify which roles do they have in ESCs, and furthermore if they might represent new pluripotency 
factors.  
 
Cross species analysis of the expression patterns of selected gene families 
Based on the genes present on GeneChip® Mouse Genome 430 2.0 arrays and, for the rat on the 
GeneChip® Rat Genome 230 2.0 arrays, we selected the families of genes. With the same approach 
used for the analysis of the pathways in the morula and in the blastocyst stage, we further 
characterized the expression pattern of the genes in the three cell populations for the mouse and for the 
rat. The complete list of the selected families of genes as well as the fold changes in the three 
comparisons are listed in the Supplemental Table 4.  
 
The BMP-ligands and -receptors family with the intracellular SMADs-family 
The bone morphogenetic proteins (BMPs) are members of the transforming growth factor (TGF) 
super-family and are involved in a variety of processes during embryo development like in the 
generation and maintenance of organs, in which stem cells play important roles. The signaling 
pathway starts when the secreted BMP proteins bind to the type I and type II BMP receptors, inducing 
the activation of the intracellular substrates, the SMAD proteins.  
Here we analyzed the expression of 10 BMP proteins, 4 BMP receptors, and 6 SMAD proteins in the 
morula, the blastocyst and the isolated ICM, from the mouse and from the rat (Supplemental Table 4). 
The genes Bmp15 and Bmp4 showed in both species the same expression pattern: Being the former 
downregulated and the latter upregulated in both the comparisons B and ICM vs M (Fig. 6A). This 
indicates that Bmp15 is prevalently expressed in the cells of the morula whereas Bmp4 is upregulated 
in the cells of the blastocyst and ICM. It is interesting to note that in vivo the pluripotent cell 
population (ICM) of the rat and the mouse has a similar expression of Bmp4. It has been shown that in 
vitro, murine ESCs can be maintained in serum-free culture in the presence of BMP4 or BMP2 in 
combination with LIF (Ying et al., 2003). Nevertheless, withdrawal of LIF and retention of BMP4/2 
causes differentiation into epithelial-like cells, leading to the conclusion that the self-renewal response 
to BMP is dependent on continuous LIF signaling and that the BMP main function is to antagonize the 
neural differentiation induced by LIF in the absence of serum (Ying and Smith, 2003). All the 
attempts to derive rat ESCs in serum-containing medium failed in the last years so that nowadays it is 
possible to establish rat ESCs only under defined, serum-free conditions (Buehr et al., 2008). Taken 
together, seen that the expression of Bmp4 in the ICM of the mouse and the rat blastocyst is similar, it 
would be interesting to analyzed the role of BMP4 in rat ESC derivation and maintenance. The 
expression analysis of other Bmp-ligands revealed a general upregulation in the mouse and 
downregulation in the rat (Fig. 6A) whereas no major differences in the two species could be observed 
for the Bmp receptors (Fig. 6B). In the comparison ICM vs M the sole gene that was differentially 
expressed between mouse and rat was Bmpr1a that was upregulated in the rat but did not have 
differential expression in the mouse (Fig. 6B).  
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In the BMP signaling pathway the activated receptors recruit the SMAD molecules, which transmit the 
signal from the cell surface to the nucleus (Supplemental Table 4). The expression of the receptor-
regulated Smad1, -2, -3 had a similar expression pattern in both the species in all the three 
comparisons (Fig. 6C). The products of these genes are transcription factors that form complexes with 
SMAD4 and regulate gene transcription. The expression of Smad4 was found for the mouse higher in 
all the cells of the blastocyst than in the morula (Fig. 6C) whereas in the rat expression of Smad4 
persisted from the morula to the blastocyst but was specifically upregulated in the cells of the ICM 
(Fig. 6C). SMAD6 and SMAD7 are both negative regulators of the BMP pathway. They bind to the 
receptor-regulated SMADs and block their ability to interact with the Co-SMAD (SMAD4). In the 
comparisons ICM vs B and ICM vs M the expression of Smad7 was in both cases downregulated in 
the mouse but upregulated in the rat cells (Fig. 6C). It is interesting to notice, that in the mouse we 
observed an upregulation of the transcription factors Smad3 and Smad2 in the cells of the ICM and the 
blastocyst, together with an upregulation of the Co-regulator Smad4, whereas the expression of Smad7 
is specifically downregulated in the ICM (Fig. 6E).  
Analysis of the pathway called “Development BMP signaling” from GeneGo revealed that other genes 
involved in this pathway are differentially regulated in the morula, ICM, and blastocyst of the mouse 
and the rat (Fig. 6D). The BMP pathway plays important roles in the differentiation of ESCs in vitro. 
Rat ESCs seems to be more sensitive to differentiation stimuli than mouse ESCs, therefore the 
differential regulation observed in vivo of the factors involved in this pathway might reflect also a 
differential expression in vitro, in mouse and rat ESCs.  
 
The FGF-factors and FGFR-receptors family  
The fibroblast growth factor (FGF) ligands and receptors have been implicated in different phases of 
the early embryogenesis (Goldfarb, 1996). The FGF signaling controls proliferation and differentiation 
of the cells, cell survival, cell morphology and migration, through the activation of important 
cytoplasmic signal transduction pathways like for example the Ras/ERK pathway and the AKT 
pathway (Dailey et al., 2005; Mohammadi et al., 2005).  
We analyzed the expression in the three cell populations of 21 FGF factors and 7 cell surface FGF 
receptors present on the mouse and the rat microarray chip (Supplemental Table 4). The expression of 
Fgf4 was constant in the mouse morula and blastocyst, in the rat embryos however, Fgf4 expression 
was upregulated in the comparison B vs M and downregulated in the ICM vs B (Fig. 7A). Thus, the 
expression of Fgf4 in the rat preimplantation embryo is low in the ICM cells but higher in the 
trophoblast cells of the blastocyst. This observation is interesting, since it was reported that in the 
mouse embryo the expression of Fgf4 was first detected in the whole blastocyst (Niswander and 
Martin, 1992) and its expression persists also in vitro, in murine ESCs. A recent study reported the 
generation of trophoblast stem (TS) cells from rat blastocysts (Asanoma et al., 2011). Mouse TS cells 
are generated from 3.5 blastocyst stage embryos and are maintained and cultivated in vitro through the 
activation of the factor FGF4/FGF receptor 2 (Tanaka et al., 1998). Rat TS cells share many 
similarities with the mouse TS cells, like the FGF4-dependance (Asanoma et al., 2011). Nevertheless, 
rat TS cells showed a differential expression of some important markers compared to the mouse cells. 
The authors concluded that the rat TS cell population isolated from E4.5 blastocysts, show features 
more developmentally advanced in comparison to the TS cell population isolated from mouse 
blastocysts (Asanoma et al., 2011). The fact that we observed a higher expression of Fgf4 in the rat 
blastocyst and specifically in the trophoblast cells, compared to the mouse, could explain the 
differences observed in the derivation of TS cells in the two species.  
The family of the FGF receptors consists in four genes: Fgfr1, -2, -3, -4. After alternative splicing they 
generate a variety of receptors with differential affinities for their ligands (Zhang et al., 2006). The 
gene Fgfr4 was in the mouse downregulated in both the comparisons ICM vs B and ICM vs M, 
indicating an expression in the morula and trophoblast cells of the blastocyst (Fig. 7B), its expression 
was however not changed in the rat cell populations. The expression of Fgfr2 increased for both 
species in the blastocyst, although the upregulation was more predominant in the rat than in the mouse 
(Fig. 7B). The analysis of the pathway “Development FGFR signaling pathway” from GeneGo also 
highlighted differential expression patterns of genes in the two species (Fig. 7C). For example the 
expression of the gene Raf1 (v-raf-leukemia viral oncogene 1) was similar in the cells of the morula in 
the mouse and in the rat. However, for the mouse it was downregulated in the ICM cells and 
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upregulated in the whole blastocyst, whereas for the rat it was upregulated in the ICM and 
downregulated in the whole blastocyst (Fig. 7D). Raf1 is a member of the MAPK/ERK pathway 
(mitogen-activated protein kinase/extracellular receptor kinase), which is stimulated by the FGF 
factors during embryo development. In a previous study the expression of Raf1 was detected in both 
the ICM cells and the trophoblast cells of the mouse blastocyst in a similar amount (Wang et al., 
2004). We measured however, a downregulation of Raf1 expression in the ICM cells and an 
upregulation in the trophoblast cells of the blastocyst. This is in agreement with its involvement in the 
activation of the FGF signaling that is responsible for the maintenance of the trophoblast cells. 
Interestingly, the expression of Raf1 in the rat was downregulated in the trophoblast cells (Fig. 7D) 
and upregulated in the ICM cells, leading to the assumption that this member of the MAPK pathway 
plays a role in the ICM cells of the rat blastocyst. The family of MAPKs consists in serine/threonine 
kinases that play essential roles in signal transduction and are involved in a variety of biological 
processes. We analyzed 13 members of this family and we found differences in the expression of 
several genes in the three cell populations of the mouse and the rat (Supplemental Fig. 8A and 
Supplemental Table 4). 
 
The Wnt-ligands family  
We have already reported some important changes in the expression of members of the Wnt pathway 
(Fig. 5 and Supplemental Fig. 5). Wnt genes encode a large family of secreted, cysteine-rich proteins 
that play key roles as intercellular signaling molecules in developmental processes. Here we analyzed 
17 members of the Wnt-secreted factors and interestingly, we observed that the expression of many 
Wnt genes is differentially regulated in the mouse and in the rat (Supplemental Table 4). For example 
Wnt6 was upregulated in the trophoblast cells of the mouse blastocyst whereas it was upregulated in 
the cells of the morula in the rat embryos (Fig. 8A). The opposite expression pattern was observed for 
the gene Wnt4, that was upregulated in the mouse in the morula and in the rat in the blastocyst cells. 
Interestingly, in the rat Wnt5a was highly expressed in the cells of the morula and in a lesser extend in 
the ICM cells (Fig. 8A), whereas in the mouse its expression showed only minor differential 
regulation between the three comparisons (Supplemental Table 4). The role of the Wnt5a ligand has 
been extensively studied since it acts through both the canonical and non-canonical Wnt pathway 
(Mikels and Nusse, 2006). Importantly, the canonical Wnt pathway has been implicated in the 
maintenance of pluripotency in murine ESCs. The WNT5A ligands, together with WNT6, WNT3, and 
WNT3A were reported to be sufficient for maintaining murine ESCs in an undifferentiated state in the 
absence of LIF (Hao et al., 2006). Although the precise mode of action of the Wnt pathway in 
maintaining pluripotency in ESCs needs still to be clarified, it is important to note that factors like 
Wnt5a and Wnt6 are differentially regulated in the mouse and in the rat in the pluripotent cell 
compartment of the blastocyst (Fig. 9A).  
 
The Stat family  
The Signal transducer and activator of transcription (STAT) proteins are cytoplasmic transcription 
factors that transmit the information received from the transmembrane receptors directly to the nucleus 
of the cells, where they target the promoter of genes involved in survival, proliferation, and 
differentiation (Frank, 2007). Here we analyzed the expression of 5 members of the STAT family 
(Fig. 8B and Supplemental Table 4). The type I interferons (IFN) are involved in antiproliferative, 
apoptotic, and antiviral processes, and they are responsible for the activation of STAT1 and STAT2 
(Fu et al., 1992). In the rat Stat2 was upregulated in the blastocyst cells, however in the mouse Stat2 
was upregulated in the cells of the morula compared to the blastocyst (Fig. 8B). The Stat6 expression 
was upregulated in the rat in the cells of the morula, whereas it did not show differential expression in 
the mouse cell populations (Fig. 8B).  
In the comparison ICM vs B all the Stats showed a similar expression in the mouse and in the rat. 
Only Stat5a and Stat5b were differentially regulated, being the former higher expressed in the 
trophoblast cells of the mouse blastocyst whereas the latter was upregulated in the trophoblast cells of 
the rat blastocyst (Fig. 8B).  
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This analysis showed that members of the Stat family are differentially regulated in the mouse and rat 
preimplantation embryos, advising a possible different implication in the development of the morula 
and blastocyst in the two species.  
 
Expression pattern analysis of genes related to pluripotency  
The goal of this study was to give a general overview on the regulation of the molecular mechanisms 
that take place during the development of the mouse and the rat preimplantation embryo form the 
morula to the blastocyst stage, in order to highlight similarities and differences that could help in the 
derivation and maintenance of rat ESCs. The LIF/gp130 pathway that leads to the activation of the 
transcription factor STAT3, plays a fundamental role in the maintenance of pluripotency in mouse 
ESCs (Casanova et al., 2011b; Cinelli et al., 2008; Matsuda et al., 1999; Niwa et al., 1998; Smith et 
al., 1988) as well as in rat ESCs (Buehr et al., 2008; Li et al., 2008). Controversially, although ESCs 
show LIF dependence (under certain culture conditions), early epiblast cells do not require LIF 
stimulation. In fact, Lif -/- embryos develop into later stages (Stewart et al., 1992) and embryos 
carrying mutations on the LIFβR and gp130 receptor develop normally, at least until mid-gestation (Li 
et al., 1995; Nakashima et al., 1999). Nevertheless, the LIF/STAT3 pathway is indispensable during 
the preimplantation development, in case of diapause (Nichols et al., 2001). This observation could 
explain why embryos do express all the component of this pathway and moreover, why ESCs that are 
directly derived from the ICM of the blastocyst, are LIF-dependent (reviewed in (Graf et al., 2011)). 
Due to the importance of the LIF/gp130-STAT3 pathway in the maintenance of pluripotency in ESCs, 
we selected 11 genes involved in this pathway and we analyzed their expression in the mouse and rat 
morula, blastocyst, and ICM. 
Interestingly, the expression of Lif increased in the mouse from the morula to the blastocyst, having a 
lower expression in the cells of the ICM. On the contrary, in the rat its expression was stable in the 
ICM cells as well as in the whole blastocyst (Fig. 9A). A behavior similar in the two species was 
observed for Jak2 (Janus kinases2) that was specifically downregulated in the ICM but upregulated in 
the blastocyst (Fig. 9A). Jak1 expression indeed, showed in the mouse an analog expression pattern 
like Lif, whereas in the rat it was specifically downregulated in the cells of the ICMs (Fig. 9A). The 
binding of the cytokine LIF to the receptor results in the heterodimerization of the LIFβR and gp130 
that causes the activation of receptor-associated JAKs, which are responsible for the phosphorylation 
and activation of STAT3. JAK1 is necessary for the transmission of the LIF-induced signaling, 
whereas JAK2 is dispensable. Thus, due to the higher LIF-dependence of rat ESCs in comparison to 
murine ESCs, it would be of interest to analyze the expression of Jak1 in rat ESCs. Interestingly, also 
the expression of Stat3 was reduced in the rat ICM cells compared to the whole blastocyst, whereas in 
the mouse it was constant. Nevertheless, at the morula stage both mouse and rat showed a similar 
expression level of Stat3 (Fig. 9B). The transcription of the Socs genes (Suppressor of cytokine 
signaling) is directly controlled by STAT3. Socs3 is responsible for the negative regulation of the 
LIF/STAT3 signaling (O'Sullivan et al., 2007). Although we observed a general upregulation in the 
mouse preimplantation embryo of the components of the LIF pathway, the expression of Socs3 was 
downregulated in the ICM and in the whole blastocyst (Fig. 9B). Interestingly, in the rat embryos 
Socs3 expression increased in a similar manner like Stat3, from the morula to the blastocyst stage (Fig. 
9B) suggesting again that a well-balanced LIF/STAT3 activation is crucial in the rat.  
In parallel to the activation of the STAT3 pathway, binding of LIF to the LIFβR/gp130 receptor leads 
the activation of the mitogen-activated protein kinase (MAPK) and the phosphatidylinositol-3 
phosphate kinase (PI3K) pathways. Active gp130 receptor can associate with the protein tyrosine 
phosphatase SHP-2 (Fukada et al., 1996), which leads to the activation of the kinases RAS/RAF and 
finally ERK1/2. The expression of Shp2 was specifically downregulated in the rat ICM cells whereas 
it was upregulated in the mouse ICM (Fig. 9C). However, the expression of Raf1 had exactly the 
opposite expression pattern: Downregulated in the mouse ICM cells and upregulated in the rat ICM, 
indicating a differential expression in both the ICM cells and the trophoblast cells in the two species 
(Fig. 9C). ERK regulates early differentiation processes in vivo as well as in vitro (Kunath et al., 2007; 
Nichols et al., 2009b), so that it has been shown that inhibition of this pathway together with the 
inhibition of GSK3 is sufficient for maintaining pluripotency in ESCs in the absence of LIF (Ying et 
al., 2008).  
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A downstream effector of the PI3K pathway is the serine/threonine protein kinase B (PKB, also 
known as AKT). AKT has been implicated in many cellular processes like regulation of the cell cycle 
progression, cell death, adhesion, migration, metabolism and tumorigenesis. In the mouse and in the 
rat preimplantation embryo we observed a similar expression pattern of Akt1, which increased from 
the morula to the blastocyst stage, although in the mouse the increase was more prominent (Fig. 9C).  
The genes Sox2, Klf4, and Klf2 are involved in ESCs in the maintenance of pluripotency (Hall et al., 
2009; Masui et al., 2007; Niwa et al., 2009). Moreover, Sox2 and Klf4 together with cMyc and Oct3/4 
are the four factors used for reprogramming differentiated cells into induced pluripotent stem cells 
(iPSC) (Takahashi and Yamanaka, 2006). 
SOX2 is a member of the sex-determining region of the Y chromosome-related (SRY-related) high-
mobility group (HMG) box (SOX) family of transcription factors. Sox2 expression is downregulated 
in cells with restricted developmental potential. We observed an upregulation of Sox2 expression in 
the mouse from the morula to the blastocyst stage (Fig. 9D). Interestingly, in the rat embryos Sox2 was 
expressed in a lower level compared to the mouse; moreover it was slightly downregulated in the 
blastocyst compared to the morula (Fig. 9D).  
Some of the Klf genes (Krüppel-factors) have been proposed as downstream targets of LIF/STAT3 
pathway in ESCs (Hall et al., 2009; Niwa et al., 2009). In our analysis we observed that Klf4 
expression increased in the cells of the rat ICM and was downregulated in the whole blastocyst, 
whereas in the mouse embryos the upregulation of Klf4 was less strong in the ICM cells (Fig. 9D). 
Also Klf2 in the rat was upregulated in the ICM and blastocyst but it was downregulated in the mouse 
blastocyst and ICM cells (Fig. 9D). This is interesting since Klf2 and Klf4 have been implicated with 
important pluripotency factors in murine ESCs (Hall et al., 2009). Thus, the fact that they are 
differentially regulated in the morula and blastocyst from the rat compared to the mouse, could be a 
contributing factor for the differences observed between murine and rat ESCs in the derivation 
efficiency and culture conditions.  
 
The higher genetic diversity of the rat compared to the mouse (Canzian, 1997) has made the rat an 
optimal animal model for the investigation of human diseases, such as infectious and autoimmunity 
diseases, or for toxicology and drug development. Moreover, the rat has other advantages compared to 
the mouse like for instance the bigger size or the higher learning capacity that make it a convenient 
research animal model. Nevertheless, the impossibility for many years to generate authentic rat ESCs 
has give the mouse a clear advantage over the rat as a model for biomedical research.  
With this study we aimed at the identification of differences at the transcriptional level between the 
mouse and the rat during the embryo development in which the ICM cells are formed, since they 
represent the source of ESCs derivation. The differential regulation of critical genes could represent 
the starting point for analyzing their function in vitro in mouse and rat ESCs. Furthermore, this 
knowledge could be critical for the improvement of the derivation and maintenance of rat ESCs. 
Although recently rat ESCs have been generated (Buehr et al., 2008; Li et al., 2008) there are still 
many questions open. A broader knowledge on the molecular mechanisms that occur in rat ESCs 
would improve the efficiency of establishing stable authentic pluripotent rat ESCs and therefore it 
would facilitate the generation via gene targeting of transgenic rat models, which are indispensable for 
the biomedical research.  
This is the first study that investigated the gene expression changes during the transition from morula 
to blastocyst in the rat preimplantation development. Moreover, our study represents a new example of 
statistical approach for cross species analysis that could be applicable also for other species. The so-
obtained data allows highlighting the species-specific behavior of genes within important pathways 
and families through the creation of own gene networks. An example of network of genes that behave 
in a different way in mouse and rat is presented in Figure 10. 
The presented genome wide cross species analysis in the three cell populations (morula, blastocyst, 
and isolated ICMs) highlights differential expression within the two species of important genes like β-
catenin, Bmp4, or Smad4. All of them are part of essential signaling pathways that play critical 
functions during the embryo development, and their differential regulation strongly affects the 
activation or inhibition of the pathways in which they are involved. Some of the genes are also known 
to be important factors in the maintenance of pluripotency in ESCs, like for example Sox2 or Stat3, or 
play a role in reprogramming somatic cells to pluripotency like c-Myc, Klf4 and p53 and would 
therefore represent interesting candidates to further analyze in vitro in the rat ESCs.  
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In conclusion, this study represents a good starting point for further analysis aimed at the identification 
of new factors related to pluripotency in both the species.  
 
Materials and Methods  
 
Mouse and Rat strains 
Mouse: Hybrid B6D2F1 mice (female C57BL/6 x male DBA/2). Rat: Outbreed Wistar Han rats. 
Animals were housed under controlled lighting (lights on at 0600–1800h), temperature (23 ± 2°C) and 
humidity (50 ± 5%), with free access to food and water. The Veterinary Office of the Canton of 
Zurich, Switzerland approved all animal experiments. Housing and experimental procedures were in 
accordance with the Swiss animal protection law and conformed to the European Convention for the 
protection of vertebrate animals used for experimental and other scientific purposes (Council of 
Europe no. 123, Strasbourg 1985). 
 
Collection of mouse embryos  
3 to 5 weeks old B6D2F1 females were superovulated with 5IU pregnant mare’s serum gonadotropin 
(PMSG) (Folligon® Intervet) and 48h later, with 5IU human chronicle gonadotropin (hCG) (Chorulon® 
Intervet). Superovulated females were mated with B6D2F1 males for 24h and then housed separately 
to the males. At embryonic day 2.5 (E2.5) pregnant females were sacrificed and morula stage embryos 
were collected from the oviducts. Morula were either frozen for further RNA extraction, or cultivated 
over night in M16 medium (Sigma) at 37C°, under 5% CO2 in air. Under these conditions morula 
developed to the blastocyst stage. Blastocyst embryos were either stored at -80°C for further RNA 
extraction or immunosurgery was performed for the isolation of the inner cell masses (ICMs).  
 
Isolation of ICMs by immunosurgery with mouse blastocyst stage embryos 
Zona pellucida was removed by shortly incubating the blastocysts with Tyrode’s solution (Sigma). 
Consequently zona-free blastocysts were washed several times with M2 medium (Sigma) and 
immunosurgery was performed, by incubating the embryos 30min with rabbit anti-mouse serum 
(Sigma). Afterwards, embryos were washed several times with DMEM medium (GIBCO) 
supplemented with 10% of fetal bovine serum. The embryos were then incubated (37C°, 5% CO2) 
with guinea pig complement serum (Sigma) for another 30 min. Rabbit anti-mouse serum was used 
1:30 diluted in DMEM medium; guinea pig complement serum was diluted 1:3 in DMEM. The 
isolated ICMs were stored at -80°C till total RNA was extracted.  
 
Collection of rat embryos 
6 to 12 weeks old Wistar females were check for estrus by using the Estrus Cycle Monitor EC40 (Fine 
Science Tools, Foster City, CA) as previously described (Ramos et al., 2001). All the positive females 
were breaded with Wistar males for 24h and then housed separately to the males. At day E4 of 
pregnancy Wistar females were sacrificed and morula embryos were isolated and stored for later RNA 
extraction. Blastocyst embryos were isolated at E4.5 and either collected for further RNA extraction or 
processed for immunosurgery.  
 
Immunosurgery with rat blastocyst stage embryos 
After removal of the zona pellucida, blastocysts were incubated for 3 hours (37C°, 5% CO2) in rabbit 
anti-rat serum (Sigma). Afterwards, embryos were washed several times with DMEM medium 
(GIBCO) supplemented with 10% of fetal bovine serum and incubated with rat serum (made in-house) 
for 20 min (37C°, 5% CO2). Rabbit anti-rat serum was used 1:5 diluted in DMEM medium; rat serum 
was diluted 1:5 in DMEM. The isolated ICMs were stored at -80°C till total RNA was extracted.  
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Total RNA extraction from mouse and rat embryos 
Till the desired amount of embryos were reached, embryos were stored in RLT buffer supplemented 
with 1% of β-mercaptoethanol (first lyses buffer of the RNeasy Micro Kit (QIAGEN) protocol) at -
80°C. Two pools of embryos for each developmental stage where formed (Fig. 1C). Total RNA was 
extracted by using RNeasy Micro Kit (QIAGEN) according to the manufactures’ recommended 
protocols. All RNA samples were kept at -80°C till they were processed for microarray hybridization.  
 
Mouse and Rat Microarray Experiment Description 
cRNA preparation: The quality of the isolated RNA was determined with a NanoDrop ND 1000 
(NanoDrop Technologies, Delaware, USA) and a Bioanalyzer 2100 (Agilent, Waldbronn, Germany). 
The cDNA was prepared from total RNA using a primer mix and reverse transcriptase (RT) 
(WTOvation Pico System, NuGEN, 3300-12). The primers have a DNA portion that hybridizes either 
to the 5’ portion of the poly (A) sequence or randomly across the transcript. SPIA amplification, a 
linear isothermal DNA amplification process, was used to prepare single-stranded cDNA in the 
antisense direction of the mRNA starting material. Single-stranded cDNA quality and quantity was 
determined using NanoDrop ND 1000 and Bioanalyzer 2100. Fragmented and biotin-labeled single-
stranded cDNA targets were generated with the FL-Ovation cDNA Biotin Module V2 (NuGEN, 4200-
12). 
Array hybridization: Biotin-labeled single-stranded cDNA targets (5μg) were mixed in 220μl of 
Hybridization Mix (Affymetrix Inc., P/N 900720) containing a Hybridization Controls and Control 
Oligonucleotide B2 (Affymetrix Inc., P/N 900454). The six mouse samples were hybridized to 
GeneChip® Mouse Genome 430 2.0 arrays for 18h at 45°C the same procedure was used for the six 
rat samples that were hybridized to GeneChip® Rat Genome 230 2.0 arrays. Arrays were then washed 
using an Affymetrix Fluidics Station 450 FS450 0004 protocol. An Affymetrix GeneChip Scanner 
3000 (Affymetrix Inc.) was used to measure the fluorescent intensity emitted by the labeled target. 
 
Processing of microarray data  
Raw data processing was performed using the Affymetrix AGCC software. After hybridization and 
scanning, probe cell intensities were calculated and saved in appropriate CEL files. The CEL files 
have been processed by scripts in R, prepared with Bioconductor (Gentleman et al., 2004) libraries: 
affy, simpleaffy, limma, gplots and biomaRt. Mouse CEL files have been grouped for summarization 
with Brainarray (Dai et al., 2005) custom CDF file Mouse4302_Mm_ENSG (16860 gene product 
summaries), while rat CEL files had the probes grouped by Rat2302_Rn_ENSG CDF file (11462 gene 
product summaries). Summarization was performed with standard RMA algorithm (Irizarry et al., 
2003). 
 
Mapping of genes between the species 
The table of mouse-rat orthologs, labeled with Ensembl gene identifiers, has been prepared with 
biomart interface (http://biomart.org) to Ensembl database (Flicek et al., 2011) (Ensembl genes v60, 
mouse genome NCBIM 37, rat genome RGSC 3.4). All the mouse genes present in the Brainarray 
summary file have been translated to rat orthologs, resulting in the translation table that includes 
13’139 mouse genes (ca 77.9% of those in the array summary) and 9’083 rat genes (79.2% of those in 
the array summary). The table has been used to map mouse genes to rat orthologs and vice versa.  
 
Selection of gene sets from pathways and families 
The pathways and the genes included in them have been extracted from Metacore database via 
GeneGo tool (Thomson Reuters, http://portal.genego.com, (Nikolsky et al., 2009)). For all the 
pathways, a list of genes with Ensembl identifiers has been extracted and the genes that have mouse-
rat ortholog pairs in the mapping table have been selected. The pathways (groups of genes belonging 
to the same pathway map in GeneGo Metacore database) and gene families have been selected on the 
basis of the relevance to various developmental processes. All the analyses have been repeated for the 
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groups of genes belonging to the selected pathways and families. For the graphical overview of the 
sample processing and data analysis see Fig. 1D.  
 
Discovering patterns of similarities and differences within groups 
For all the pairs of tissues (blastocyst versus morula, ICM versus blastocyst, and ICM versus morula), 
the fold changes have been calculated for both: mouse and rat separately. To find the genes that have 
expression characteristics similar or different in each of the pairs of samples the heuristics have been 
defined. As similar are regarded genes with the difference of fold change smaller than a specific 
threshold (0.2 on log2 scale). On the scatterplots these genes are marked with red. As different are 
marked those that have the absolute difference of fold changes bigger than a threshold of 0.4, but also 
having both mouse and rat fold changes absolute value bigger than a threshold of 0.2 - to choose the 
genes that are not on the fold change scatterplot diagonal, but excluding the genes not differentially 
expressed in one of the specie. Genes that satisfy the "differential inter-species fold change 
conditions" are marked green. The rest of genes that do not fulfill “different” or “similar” condition, 
are marked plain black on the scatterplot.  
“similar” pattern genes (red): 
 
€ 
g : FCmouse (g) − FCrat (g) < 0.2  
 
“different” pattern genes (green): 
 
€ 
g : FCmouse (g) − FCrat (g) > 0.4∧ FCmouse (g) > 0.2∧ FCrat (g) > 0.2  
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Figure Legends 
 
Figure 1. Mouse and rat late preimplantation embryo development: a cross species analysis. A. 
Schema of mouse and rat embryo development length. M: morula stage embryo; B: blastocyst stage 
embryo. E: embryonic day. B. Schema of the three cell populations used for the cross species analysis 
of gene expression. The blastocyst embryo consists in the inner cell mass (ICM) and in the trophoblast 
cells. Embryonic stem cells (ESCs) are derived in vitro from the ICM cells. C. Numbers of embryos 
collected for the whole genome expression analysis. D. Schematic overviews of the screening strategy 
used in this study. M1 and M2: pool 1 and pool 2 of morula stage embryos; B1 and B2: the two pools 
of blastocysts; ICM 1 and ICM2: the two pools of isolated ICMs. B vs M: blastocyst versus morula; 
ICM vs B: ICM versus blastocyst; ICM vs M: ICM versus morula.  
 
Figure 2. Global significant analysis. A. Mouse B. Rat heatmaps. The genes are selected by the 
highest fold change – 20 genes in each pair wise comparison of sample means. M1 and M2: morula 
samples 1 and 2; B1 and B2: blastocyst samples 1 and 2; ICM1 and ICM2: isolated inner cell mass 
(ICM) cells samples 1 and 2. C-F. Venn diagrams of the overlap of mouse and rat genes with 
significant differential expression (fold change higher than 1.5 and higher than 3) in the three 
comparisons: ICM versus (vs) Blastocyst, Blastocyst versus Morula, and ICM versus Morula.  
 
Figure 3. Cross species analysis of the genes in the Notch pathway. A. Fold change scatterplots. 
Cross species comparison of the fold changes expression of the genes in the pathway “Development, 
Notch Signaling Pathway” from GeneGo. In green are marked the genes for which fold change differ 
in mouse and rat within the three comparisons: Blastocyst versus (vs) Morula, ICM versus Blastocyst, 
and ICM versus Morula. In red are marked those genes that have a similar fold change pattern in the 
two species in each comparison. With a special marker there are highlighted 6 selected genes that have 
differential expression patterns in the two species. The complete list of all the genes analyzed with 
their fold changes is reported in the Supplemental Table 3. B. Expression signal profile plots. The 
expression level of 6 selected genes from the Notch pathway. In blue are marked the expression levels 
of the genes in the mouse and in red the one in the rat embryos. MO: Morula, ICM: Inner cell mass, 
BL: Blastocyst.  
 
Figure 4. Cross species analysis of cell cycle component. A. Fold change scatterplots. Cross species 
comparison of the fold changes expression of the genes in the pathway “Cell cycle, Influence of Ras 
and Rho proteins on G1/S transition” from GeneGo (see also Supplemental Table 3). The data were 
analyzed as described in Fig. 3A. Thirteen genes have been highlighted in order to follow their 
expression in the three comparisons. B. Expression signal profile plots. Expression level of 13 selected 
genes involved in the regulation of the cell cycle. In blue are marked the expression level of the genes 
in the mouse and in red the one in the rat embryos. MO: Morula, ICM: Inner cell mass, BL: 
Blastocyst.  
 
Figure 5. Cross species analysis of the genes in the Wnt and TGF pathways. A. Fold change 
scatterplots. Cross species comparison of the fold changes expression of the genes in the pathway 
“Cytoskeleton remodeling, TGF, WNT and cytoskeletal remodeling” from GeneGo (see also 
Supplemental Table 3). The data were analyzed as described in Fig. 3A. Eight genes have been 
marked with a special label. B. Expression signal profile plots. Expression level of 8 genes in the 
morula, the ICM, and the blastocyst in the mouse (blue) and in the rat (red). MO: Morula, ICM: Inner 
cell mass, BL: Blastocyst.  
 
Figure 6. Cross species analysis of regulators of the BMP pathway. A. The BMP protein family. 
Scatterplots of the fold changes measured in the three comparisons for 9 members of the BMP protein 
family in the mouse and in the rat. The complete list of all the genes analyzed as well as their fold 
changes are reported in the Supplemental Table 4. B-C. Same analysis like for the BMP proteins was 
performed for 4 members of the BMP receptor family (B.) and for 6 members of the SMAD protein 
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family (C.). D. Fold change scatterplots. Cross species comparison of the fold changes expression of 
the genes in the pathway “Development, BMP signaling” from GeneGo (see also Supplemental Table 
3). The data were analyzed as described in Fig. 3A. E. Expression signal profile plots. Expression 
level analysis of 4 selected genes from the BMP pathway. Mouse: blue; Rat: red; MO: Morula; ICM: 
Inner cell mass; BL: Blastocyst.  
 
Figure 7. Cross species analysis of regulators of the FGF pathway. A-B. Scatterplots of the fold 
changes measured in the three comparisons for 21 members of the FGF factor family (A.) and for 7 
FGF receptors (B.) in the mouse and in the rat. The complete list of all the genes analyzed as well as 
their fold changes are reported in the Supplemental Table 4. C. Fold change scatterplots. Cross species 
comparison of the fold changes expression of the genes in the pathway “Development, FGFR 
signaling pathway” from GeneGo (see also Supplemental Table 3). The data were analyzed as 
described in Fig. 3A. D. Expression signal profile plots. Expression level analysis of 5 selected genes 
from the FGFR pathway. Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst. 
 
Figure 8. Cross species analysis of the Wnt ligands family and the STAT family. A-B. Scatterplots 
of the fold changes measured in the three comparisons for 11 members of the Wnt family (A.) and for 
5 STAT family members (B.) in the mouse and in the rat. The complete list of all the genes analyzed 
as well as their fold changes are reported in the Supplemental Table 4. 
 
Figure 9. Expression signal profile plots for 11 genes involved in the LIF/gp130 signaling. 
Expression signal profile plots. A. Expression level analysis of Lif, which encode the ligand that binds 
on the LIFβR/gp130 receptor, and of Jak2 and Jak1 the receptor-associated Janus Kinases involved in 
the propagation of the extracellular signaling. B. Expression level analysis of Stat3 and Socs3. The 
transcription factor STAT3 directly controls the transcription of the negative regulator SOCS3. C. 
Expression level analysis of Shp2, Raf1, and Akt1. The products of these three genes lead to the 
activation of the ERK- and PI3K/AKT-pathways. D. Expression level analysis of Sox2, Klf4, and Klf2. 
These genes are involved in the maintenance of pluripotency in ESCs. Mouse: blue; Rat: red; MO: 
Morula; ICM: Inner cell mass; BL: Blastocyst. 
 
Figure 10. Network of selected differentially expressed genes between mouse and rat in the 
comparison blastocyst versus morula. Network of selected genes that show different expression 
patterns in mouse and rat in the comparison blastocyst versus morula. The genes come from the 
pathway and family gene lists (Supplemental Table 3 and 4), the graph has been created with GeneGo 
network editor tool. 
 
Supplemental Figures 
 
Suppl. Figure 1. Most significantly enriched Gene Ontology Biological Process terms according to 
GeneGo.  The lists of genes counted for the enrichment are those that have been used for the Venn 
diagram with 1.5 fold change differences.  
 
Suppl. Figure 2. Cross species analysis of the genes in the p53 pathways. A. Fold change 
scatterplots. Cross species comparison of the fold changes of the genes of the pathway “Transcription, 
p53 signaling pathway” from GeneGo (see also Supplemental Table 3). The data were analyzed as 
described in Fig. 3A. B. Expression signal profile plots. Expression pattern analysis of 4 genes from 
the p53 pathway. Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst. 
 
Suppl. Figure 3. Cross species analysis of PI3K/AKT and MAPK cascades. A. Fold change 
scatterplots. Cross species comparison of the fold changes of the genes in the pathway “Development, 
growth hormone signaling via PI3K/AKT and MAPK cascades” from GeneGo (see also Supplemental 
Table 3). The data were analyzed as described in Fig. 3A. B. Expression signal profile plots. 
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Expression pattern of 6 genes. Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell mass; BL: 
Blastocyst. 
 
Suppl. Figure 4. Cross species analysis of factors involved in the regulation of cell proliferation. 
A. Fold change scatterplots. Cross species comparison of the fold changes of the genes in the pathway 
“Development, SSTR2 in regulation of cell proliferation” from GeneGo (see also Supplemental Table 
3). The data were analyzed as described in Fig. 3A. B. Expression signal profile plots. Expression 
pattern of 3 genes. Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst. 
 
Suppl. Figure 5. Cross species analysis of the Wnt pathway. A. Fold change scatterplots. Cross 
species comparison of the fold changes of the genes in the pathway “Development, WNT signaling 
pathway. Part 2” from GeneGo (see also Supplemental Table 3). The data were analyzed as described 
in Fig. 3A. B. Expression signal profile plots. Expression pattern of 6 genes. Mouse: blue; Rat: red; 
MO: Morula; ICM: Inner cell mass; BL: Blastocyst. 
 
Suppl. Figure 6. Cross species analysis of apoptotic processes. A. Fold change scatterplots. Cross 
species comparison of the fold changes of the genes in the pathway “Apoptosis and survival, NGF 
signaling pathway” from GeneGo (see also Supplemental Table 3). The data were analyzed as 
described in Fig. 3A. B. Expression signal profile plots. Expression pattern of 4 genes. Mouse: blue; 
Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst. 
 
Suppl. Figure 7. Cross species analysis of apoptotic processes. A. Fold change scatterplots. Cross 
species comparison of the fold changes of the genes in the pathway “Apoptosis and survival, 
Apoptotic Activin A signaling” from GeneGo (see also Supplemental Table 3). The data were 
analyzed as described in Fig. 3A. B. Expression signal profile plots. Expression pattern of 5 genes. 
Mouse: blue; Rat: red; MO: Morula; ICM: Inner cell mass; BL: Blastocyst. 
 
Suppl. Figure 8. Cross species analysis of MAPK family. Fold change scatterplots. Scatterplots of 
the fold changes measured in the three comparisons for 12 members of the MAPK family in the mouse 
and in the rat. The complete list of all the genes analyzed as well as their fold changes are reported in 
the Supplemental Table 4. 
 
Supplemental Tables 
 
Suppl. Table 1. Mouse Venn diagram 1.5 fold change gene list. A. ICM versus Blastocyst. B. 
Blastocyst versus Morula. C. ICM versus Morula. 
 
Suppl. Table 2. Rat Venn diagram 1.5 fold change gene list. A. ICM versus Blastocyst. B. 
Blastocyst versus Morula. C. ICM versus Morula. 
 
Suppl. Table 3. Pathway analysis. List of genes and fold changes in the mouse and in the rat for the 
three comparisons (blastocyst versus morula, ICM versus blastocyst, ICM versus morula).  
 
Suppl. Table 4. Gene family analysis. List of genes and fold changes in the mouse and in the rat for 
the three comparisons (blastocyst versus morula, ICM versus blastocyst, ICM versus morula).  
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Figure 4A. 
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Figure 4B. 
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Figure 5. 
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Figure 6. 
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Figure 7. 
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Figure 8. 
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Figure 9. 
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Figure 10. 
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Supplemental Figure 1. 
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Supplemental Figure 2. 
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Supplemental Figure 3. 
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Supplemental Figure 4. 
 
 
Annex 3 
 119 
Supplemental Figure 5. 
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Supplemental Figure 6. 
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Supplemental Figure 8. 
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